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The molecules used in the pharmaceutical industry often display complex architectures.  These species 
may be built up from smaller subunits.  Bringing these pieces together to more complex structures costs 
energy; commonly more than is present under ambient conditions.  While increasing temperature allows 
the barrier to reactivity for some units to be overcome, this principle is often not the case.  For this 
reason, activated and specialty reagents, known as so-called catalysts, have been used.  Catalysts 
lower the activation barrier required for chemical transformations to take place, but –unlike reagents– 
are not consumed in the reaction; thus, these species may be recovered after the reaction and re-used.  
In this thesis the focus has been on catalysing reactions in a way that all molecules of the starting 
materials end up in the products; no waste is formed.  Such a so-called atom-economic transformation 
has been achieved through the subtle and careful design and tuning of both reagents and products.  
Indole is a very useful nitrogen-containing unsaturated molecule found in many natural products and 
drug compounds.  Typically, this compound is biased in its intrinsic reactivity, and favours reaction at a 
specific site of the molecule (at carbon number 3).  In this thesis, a metal-based catalyst has been 
developed that forces an unusual reaction at a different more challenging position (at carbon number 
2).  This transformation allows the formation of previously unreported and inaccessible products.  
Another part of work has been devoted to stabilising specific chemical compounds that are highly 
reactive and may decompose upon exposure to ambient conditions.  While this high level of reactivity 
makes the compounds delicate to handle, the high reactivity may be also channelled to a unique 
reactivity with other molecules.  We have used a metal-free carbon species in its so-called low-oxidation 
state “0” –as catalysts– in order to facilitate the addition of unreactive compounds, such as commonly 
used solvents, to so-called unsaturated acceptors; with the aim to create more complex motifs.  Metal-
based species had been shown to fail to catalyse this transformation.  The unique reactivity of these 
carbon(0) compounds was found to surpass all other potential catalysts examined.  This work also 
represents the first time that such a carbon(0) species has been used as a catalyst at all.  The catalytic 
transformations in both parts of this thesis project have proved to be quite versatile allowing great 




The focus of this PhD project dealt with the development of base-catalysed transformations towards 
novel and pharmaceutically relevant molecules. 
The first chapter was intended to be an application of our previously reported catalyst, Na–N(SiMe3)2, 
to a new substrate class, i.e., N-unprotected indoles.  Rather than the anticipated C3-selective Mannich-
type addition to imines, which would represent the indole’s intrinsic Friedel–Crafts-type reactivity, a 
reaction mixture containing an unexpected C2-functionalised indole was obtained.  The optimisation of 
this serendipitous transformation led to a three-component catalyst system for this unusual C2–H bond 
activation: copper(I) chloride, sodium tetrafluoroborate, and lithium carbonate.  Key features of this 
transformation are as follows: rare example of a C2–C(sp3) bond formation with N-unprotected indoles; 
unprecedented C2-selective Mannich-type reaction with N-unprotected indoles; sparse example of the 
catalytic use of a metal carbonate in organic synthesis.  A wide range of both indoles and imines proved 
to be tolerated under the mild reaction conditions; this transformation was even amenable to a three-
component reaction, i.e., the in situ-generation of the imines from aldehydes and ortho-anisidine.  
Mechanistic and control experiments were carried out in order to elucidate the identity of the catalytically 
active species and to gain insight into the C2–H bond activation mode.  At this stage, it was suggested 
that a copper(I)/lithium heterobimetallic carbonate was critical for the C2-selectivity, and a traceless 
directing-group hypothesis was proposed. 
The second chapter of this thesis was focused on the development of the catalytic use of a so-called 
carbodiphosphorane (CDP), an unusual carbon(0) species, in C–C bond formation.  The intended 
reaction comprised the conjugate addition of aliphatic nitriles to ,-unsaturated amides; a decent 
substrate scope was developed.  Other organocatalysts including Schwesinger and Verkade super 
bases as well as carbenes [carbon(II) species] proved to be substantially less efficient; likewise, various 
metal–bases were found to be poor in reactivity.  Key features of this transformation are as follows: 
unprecedented catalytic use of a CDP in organic synthesis under metal-free conditions; unprecedented 
example of a carbone catalysis in C–C bond formation; extremely low catalyst loading in the context of 
organocatalysis (down to 0.25 mol%).  Preliminary mechanistic experiments were carried out to identify 
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1 Catalytic Indole functionalisation  
1.1 Use of metal amides in catalysis  
Classical transition metal-catalysed cross-coupling strategies enable the formation of a range of C(sp2)–
C(sp2),1 C(sp2)–C(sp3),2 and N–C(sp3)3 bonds between various reaction partners.  Such efficient 
transformations have been used extensively in industrial applications for the production of a variety of 
fine chemicals.  However, there are several drawbacks to these processes, chiefly the lack of (complete) 
atom economy; even for coupling reactions relying on C–H (rather than C–X) bond activation there may 
be still incomplete incorporation of all starting material components into the product, although the waste 
production may be minimal (H2), e.g. in cross dehydrogenative coupling (CDC) reactions.4,5  In the 
context of Brønsted base catalysis non-toxic metal species may be used in a deprotonative strategy 
with 100% atom economy while still producing synthetically useful molecules; such approach would rely 
on a (formal) C–H or N–H bond activation with subsequent addition across an unsaturation.  In particular 
regarding (toxic) transition metal catalysis, some palladium complexes have been shown to leach metal 
traces into the reaction mixture that may be intractable from the final product and therefore retained in 
the final (fine) chemical.6,7  Regarding Brønsted base catalysis, non-toxic metal compounds were shown 
to be applicable in (formal) C–H and N–H bond activation strategies.  A large focus in this area has 
been related to catalytic hydroamination reactions.8  A nice example of such transformations is the 
catalytic asymmetric formation of isoindolines through intramolecular 5-exo-trig C–N bond formation in 
ortho-aminomethyl styrenes (Scheme 1); this type of reaction was catalysed by a chirally modified 
lithium amide leading to an excellent asymmetric induction in the final product.9 
Scheme 1: Asymmetric intramolecular hydroamination triggered by a chirally modified lithium amide. 
 
In a similar context, a lithium amide catalyst was used in the intermolecular C–C bond formation 
between aromatic terminal alkynes and a variety of carbodiimides (Scheme 2).10  With pKa values of ~ 
29 (in DMSO),11 phenyl acetylene is a similarly challenging substrate as amines with pKa values of ~ 
26–32 (in DMSO).12  In the present example, using Li–HMDS (pKBH+ ~ 30; in DMSO), the deprotonative 
C(sp)–H bond activation proceeded smoothly to generate the corresponding addition products in high 
yields.  





In 2015, Kobayashi et al. reported the catalytic asymmetric conjugate addition of esters and amides to 
various ,-unsaturated amides (Scheme 3).13  These reactions were catalysed by a chirally modified 
potassium amide, and proceeded with modest and excellent syn:anti ratios for the use of esters and 
amides, respectively.  In addition, alkyl aza-arenes14 and alkyl sulfonamides15 have been used as pro-
nucleophiles in a similar context.  More recently, esters and amides were also shown to add across 
styrenes under similar potassium amide catalysis conditions.16  Likewise, O’Shea’s base was used to 
catalytically activate alkyl arenes with subsequent addition to imines17 and styrenes,18 which proceeded 
with the expected regioselectivity.19 
Scheme 3: Potassium amide-catalysed asymmetric Michael additions of esters and amides.13 
 
Earlier work in the Schneider group has addressed the allylic C(sp3)–H bond activation of aromatic 
alkenes and their subsequent nucleophilic addition to various aldimines by using Na–HMDS as a sole 
metal–base catalyst and/or initiator (Scheme 4).20  The corresponding homoallylic amine products were 
formed in high yields with complete regioselectivity and with >20:1 E selectivity.  This transformation 
was shown to proceed through the in situ generation of a nucleophilic allyl–Na intermediate, which 
represents a significant advance compared to earlier studies.  Indeed, when Pd(II) catalysts were used 
for such C–H bond activation, the resulting allyl–Pd intermediates were revealed to be exclusively 
electrophilic;21 nucleophilic allyl–Pd species had been only accessible when allyl–metalloid substrates 
(Sn, Si, B) were used.22,23 
Scheme 4: Sodium amide-triggered allylic C(sp3)–H bond activation of alkenes. 
 
 
The broad range of functional group tolerance displayed in both allyl benzenes and aldimines triggered 
our interest in exploring a similar catalyst system that would lead to a robust and operationally simple 




tryptophan, variously functionalised N-unprotected indole motifs appear in many natural products and 
molecules of pharmaceutical significance; thus, the functionalisation of N-unprotected indoles is 
synthetically significant (Scheme 5).   
Scheme 5: Natural products containing 3-substituted indoles. 
 
The intrinsic nucleophilic character of this electron-rich heteroaromatic substrate at the C3 position has 
been exploited in classical Friedel–Crafts-type chemistry.  Based on the earlier work in our group, we 
were interested in using imines as potential electrophiles, i.e. developing catalytic Mannich-type C–C 
bond formations.  Several examples of such chemistry were reported in the literature prior to our 
investigations.  Indeed, a variety of enantiomerically enriched hydrogen bond donors were used to 
mediate catalytic asymmetric C3-selective Mannich-type reactions between N-unprotected indoles and 






 1.2  Catalytic transformations of N-unprotected indoles 
The combined use of N,N-dimethylaminopyridine (DMAP) and enantiomerically enriched 
bis(phosphonyl)imides proved to be effective for the use of both aromatic and aliphatic N-tosyl-protected 
aldimines (Scheme 6).24,25  An enantiomerically enriched cinchona alkaloid-derived thiourea26 and an 
enantioenriched squareamide27 was used as a catalyst for the same transformation (Scheme 5). 
Scheme 6: Organocatalytic asymmetric C3-selective Mannich reaction with an N-unprotected indole. 
 
 
In addition to organocatalysis, chiral metal phosphine complexes have been used for the Mannich 
reaction between indoles and a glyoxal derived tosyl-imine (Scheme 7).28  This transformation has 
been catalysed by several different systems.29-32  
Scheme 7: Metal catalysed asymmetric C3-selective Mannich reaction with an N-unprotected indole. 
 
Aziridines33 as well as epoxides34 and nitroalkenes35 have also been successfully used as electrophiles.  
Good yields and high ees were achieved.  






We aimed to build on the knowledge and experience gained in the previous work with regards to the 
concept of metal–amide catalysis.  The aim was to explore unbiased N-heterocycles, such as N-
unprotected indoles and derivatives, as synthetically challenging pro-nucleophiles in catalytic C–C bond 
formations.  More specifically, we wanted to exploit the indole’s intrinsic Friedel–Crafts reactivity (C3 
regioselectivity) with a variety of electrophiles: preferentially imines (Mannich-type chemistry); 
alternatively Michael acceptors and strained ring systems.  While the corresponding reaction products 
may be literature-known through other catalytic processes (vide supra), the approach would be 
conceptually different.  Our metal-base approach would rely on the deprotonation of the indole’s 
“enamine” moiety thus forming an “enamide” that could add more smoothly to a suitable electrophile 
(Figure 1).  A Lewis acid activation of the electrophile by the present metal ion (of the catalyst) would 
further facilitate the intended C–C bond formation to form initially a Wheland intermediate, which would 
tautomerize to the functionalised product-base.  In order to provide turn-over, the product-base may be 
protonated either by the conjugate acid of the catalyst (catalysis; right cycle), or by another molecule of 
the indole starting material (initiation; left cycle). 
Figure 1: Concept of metal–amide-triggered Friedel–Crafts chemistry with N-unprotected indoles. 
 





1.4 Reaction optimisation 
1.4.1 Initial investigation into the metal‒base‒catalysed Mannich reaction.  
In light of the significant impact of both metal Lewis acid and Brønsted base moiety on the activity of 
the corresponding metal–base catalyst in the allylic C(sp3)–H bond activation,20 a screening of various 
metal–bases was carried out using N-unprotected indole and the benzaldehyde-derived N-phenyl-
protected imine in THF at 30 oC (Scheme 9).  In the earlier work dioxane was used leading to the 
recovery of starting materials in most cases (except Na–HMDS and K–HMDS), whereas the use of THF 
resulted in a generally higher activity of metal amides (albeit with low product selectivity). In the present 
case, the reactions were heated to 80 oC when only starting materials were observed in the initial run.  
Based on the pKa value of ~21 for the indole’s N‒H moiety (in DMSO)],37 it was expected that the strong 
metal–base catalysts used would form the metallated enamide required for subsequent nucleophilic 
addition to the imine.  However, similar to the study with allyl benzene as pro-nucleophile, the catalytic 
use of alkali metal hydrides as well as s-, p-, d-, and f-block metal amides proved to be inefficient.  Under 
forcing conditions, the use of K–HMDS as catalyst afforded the product of double addition [bis(C3)] 23 
in 4% yield; the expected C3 product (24) was not detected. 






[a] The NMR yield was determined by 1H NMR spectroscopic analysis of an aliquot of the reaction mixture using dibenzyl ether 
(DBE) as the internal standard.  [b] 50 mol% catalyst loading.  
It was postulated that enhancing the electrophilicity of the imine through coordination to an external 
metal Lewis acid may switch on reactivity for this model transformation.  Thus, under otherwise identical 
reaction conditions, K–HMDS (10 mol%) was used as a Brønsted base catalyst in combination with 
various commercially available metal triflates as Lewis acid co-catalyst (10 mol%; Scheme 10).  The 
use of alkali metal, alkaline earth metal, and rare earth metal triflates resulted only in the recovery of 
starting materials.  However, when certain main group and transition metal triflates were used, three 
products could be identified: the expected mono-adduct in C3 position 23,37 the corresponding double 
addition product 24, and the unexpected mono-adduct in C2 position 25.  The use of main group metal 
triflates favored the Friedel–Crafts products 23 and 24.  Generally, among the reactive transition metal 
triflates, the formation of the double-adduct 24 was predominant.  Interestingly however, the use of 
copper triflates displayed a higher level of the unusual C2 selectivity. 
Scheme 10: Influence of external metal Lewis acid catalyst on both reactivity and selectivity. 
 
[a] Both conversion and regioselectivity were determined by 1H NMR spectroscopic analysis of an aliquot of the reaction mixture.  
[b] NR = no reaction; no products were detected – only starting materials were recovered.  
The unexpected C2 regioselectivity is of significance and substantial value for several reasons: 
(1) The pKa value of the C2–H bond is substantially higher than the one of the N–H bond (38.1 vs. 
21);38 thus, the C2-selective transformation is much more challenging than the common 




(2) A variety of natural products and drugs contain an N-unprotected indole core, functionalized in 
C2 position (Figure 3). 
(3) There is an interesting reminiscence with the initially C2-selective oxidation chemistry of 
tryptophane and its derivatives in Nature (Scheme 13). 
(4) There is limited precedence in synthetic organic chemistry regarding the selective formation of 





1.4.2 Contextualization of the Unexpected C2 Functionalisation of N-Unprotected 
Indoles 
Literature precedence of indole C2 functionalisations has been dominated by rather common arylation 
chemistry, i.e. C(sp2)–C(sp2) bond formation through e.g. palladium-catalysed cross coupling reactions 
(Table 1).   While several different approaches with regards to coupling partner, catalyst and conditions, 
appear in the literature the overall scope and reactivity is generally poor.  Incorporation of a protecting 
groups which functions to direct metalation to C2 have been exploited to allow C-2: amination39-43, 
cyanation44-46, alkenylation47-54, and phosphoramidation55.  
Table 1: C2-selective arylation of indoles using neutral coupling partners. 
 





















Pd(OAc)2 (5 mol%), 
 PPh3 (20 mol%), MgO (1.2 equiv.) 
 
Pd(OAc)2 (5 mol%), 
 CuI (2 equiv.) 
 
Pd(OAc)2 (1 mol%), 
 CsOAc (2.8 equiv.) 
 
Pd(OAc)2 (5 mol%), 
 AcOK (3 equiv.), dppm (5 mol%) 
 
PdCl2(MeCN)2 (10 mol%), 
 K2CO3 (2 equiv.),  
norbornene (2 equiv.) 
Dioxane/DMF 
(1:2), 150 oC, 18 h 
 
DMF,  
140 oC, 48 h 
 
DMA,  
125 oC, 24‒48 h 
 
H2O,  
110 oC, 24 h 
 
DMA, H2O 
70 oC, 17 h 





















Pd(OAc)2 (5‒10 mol%), 
  
 
Pd0/MIL-101 (0.5 mol%) 
AcOH, O2 (1 atm), 
RT, 10 h  
 
DCM/ AcOH (1:4), 







These reactions typically form C(sp2)–C(sp2)-coupled products in contrast to our observed C(sp2)–
C(sp3) products.  With respect to the latter transformation, far fewer reactions have been described.63,64  
Unbiased alkylation has also been reported more recently again typified by palladium chemistry.  The 
use of norbornene as a traceless directing group analogous to the Catellani reaction65 has gathered 




ortho C–H functionalisation proceeds in a similar fashion to that reported in Figure 2 using aryl halides.  
Alkyl iodides67, α-bromo esters68, and alkyl bromides have all been successfully coupled69.   
 
Table 2: Catalytic C2-alkylation of N-unprotected indoles. 
 















Pd(acac)2 (15 mol%), 
dibenzoylmethane (0.4 equiv), 
norbornene (2 equiv.),  
KHCO3 (2 equiv.) 
 
Pd(PhCN)2Cl2 (10 mol%), 
norbornene (2 equiv),  
NaHCO3 (4 equiv) 
DMF,  




DMF/H2O (2:1),  














PdCl2(MeCN)2 (10 mol%) 
Norbornene (2 equiv) 
K2CO3 (2 equiv) 
DMA 





The initial assumption was that the indole added to the norbornene through the enamine at C3.  This 
sets up carbopalladation to C2 allowing further functionalisation.  Through mechanistic investigation the 
true pathway was shown to go via a N-palladation rather than C3.  Deprotonation of NH and addition to 
norbornene forms 32.  Carbometallation and deprotonation at C2 forms palladacycle 33. After oxidative 








Figure 2: Ir-catalysed C2-alkylation of N-unprotected indoles using a traceless directing group. 
 
In addition to the norbornene directed alkylation, iridium has been used for the incorporation of unusual 
alkyl fragments.  Bicyclic olefins were efficiently introduced at the C2 position with good substrate scope 
for the indole fragment.72 In addition photocatalytic C2‒H functionalisation with alkyl bromides was 






Scheme 11: Ir-catalysed C2-alkylation of N-unprotected indoles. 
  
Cai et al. reported recently on a Ni-catalysed C2-selective dehydrogenative cross-coupling of N-
unprotected indoles with cyclic ethers (Scheme 12). This reaction demonstrates good functional group 
tolerance for both indoles and cyclic ethers.  
Scheme 12: Ni-catalysed C2-selective dehydrogenative cross-coupling of indoles with cyclic ethers. 
 
To the best of our knowledge, the only example of a C2-selective Mannich-type reactivity of the indole 
core was reported by Kanai et al. (Scheme 13)73.  However, their cobalt catalysis relies on the use of 
N-pyrimidyl-protected indoles 46 to induce metalation at C2 with subsequent C–C bond formation using 
highly electrophilic N-sulfonyl-protected imines 47.  Here, it is noted that a reaction was not observed 















1.4.3 Significance in pharmaceuticals and natural products 
The indole core derived from the natural aminoacid tryptophan is a common motif in naturally occurring 
molecules.  Thus, most natural products bear indole fragments substituted at C3, e.g. tryptamine and 
its derivatives.  Nature can modify tryptophans via oxidative C2 functionalisation and subsequent 
cleavage of the N-heterocyclic ring (Scheme 14). 74,75 Tryptophan 2,3-dioxygenase and indoleamine 
2,3-dioxygenase are heme-containing enzymes responsible for the oxidative cleavage of tryptophan 
along the kynurenine pathway.  
Scheme 14: Oxidative C2 functionalisation of tryptophan in Nature. 
 
The naturally occurring duocarmycins and several drug molecules were isolated from Streptomyces 
bacteria, and show very high cytotoxicity76 that is exploited in the treatment of cancerous cells and 
arises from DNA alkylation (Figure 3)77.  Additional synthetic duocarmycins have shown enhanced 
absorbance and signs of remision in patients.78  Isomeridianin G belongs to the family of meridianins, 
which inhibit protein kinases;79 synthetic analogues show promise as GSK-3 inhibitors.80  The natural 
product angustilobine B was first isolated from Alstonia angustiloba81 and more recently from Alstonia 
scholaris.82  Atevirdine has been identified as a reverse transcriptase inhibitor for the treatment of 
HIV.83,84  
Figure 3: Naturally occurring C2-functionalised N-unprotected indoles. 
 
While we are able to negate the requirement for a protecting group for C2 functionalisations the 







1.5 Optimisation of the Catalyst System 
1.5.1 Optimisation of the Brønsted Base Component 
So far, the best result in terms of both reactivity and C2 selectivity was obtained using K–HMDS and 
copper(I) triflate as a catalyst system (Table 3, entry 1).  However, strong amide bases may hamper a 
good functional group tolerance in the substrate scope.  Thus, various weaker potassium bases were 
screened under otherwise identical conditions (Table 3, entries 2–4).  Gratifyingly, the intended C2 
product was still observed when decreasing the basicity of the potassium catalysts; the carbonate 
catalyst was chosen to further optimise the system (Table 3, entries 5–9).  A slight increase in the 
selectivity of the C2 product was observed in the presence of lithium carbonate over other tested 
carbonates (Table 3, entry 5).  Thus, lithium carbonate was used as a more convenient Brønsted base 
catalyst in subsequent experiments.  The catalytic use of metal carbonates in organic synthesis has 
been reported, but few examples of intermolecular C–C bond formations exist.  Potassium carbonate 
has been used for the cyanosilylation of aldehydes and ketones.85  Caesium carbonate has been used 
in several transformations; notable the formylation and methylation of amines with CO2.86-90  Silver 
carbonate sp σ-coordination has been used for the synthesis of pyrroles89-91 and structurally diverse 





Table 3: Influence of a weaker base on both reactivity and C2 selectivity.a 
 
Entry M–base yield (%)[a] 
selectivity 
25:C3 [23:24][a] 
1 KHMDS 60 1.2:1 (1:>99) 
2 KOtBu 60 1.4:1 (1:>99) 
3 KOAc 78 1.5:1 (1:>99) 
4 K2CO3 78 1.5:1 (1:>99) 
5 Li2CO3 77 2.0:1 (1:>99) 
6 Na2CO3 63 1.4:1 (1:>99) 
7 CaCO3 56 1:1.4 (1:>99) 
8 SrCO3 56 1:1.6 (1:>99) 
9 Ag2CO3 28 1:1.5 (1:>99) 
[a] Both NMR yield and regioselectivity were determined by 1H NMR spectroscopic analysis of an aliquot of the reaction mixture 






1.5.2 Optimisation of the Lewis Acid’s Counteranion 
Next, the effect of the counteranion in the Lewis acidic copper(I) salt was investigated (Table 4).  Thus, 
prior to the catalytic C–C bond formation a metathesis reaction was carried out at 25 oC for 1 h between 
copper(I) chloride and a variety of sodium or silver salts bearing weakly coordinating counteranions [in 
situ generation of a more Lewis acidic copper(I) salt].  Such reactions are well documented in the 
literature.94 When copper(I) chloride and lithium carbonate were used as the catalyst system, selectivity 
for the C2 product was 2:1 (Table 4, entry 1).  In case of silver co-catalysts, selectivities remained 
essentially unchanged (entries 2–5).  On the other hand, the use of sodium salts proved to be more 
effective (entries 6–9); among these, sodium tetrafluoroborate was found to be the best mediator giving 
the intended C2 product in a 7.8:1 ratio, albeit in low yield (entry 7). 
Table 4: Influence of the counteranion on both reactivity and selectivity. 
 
entry additive  yield (%)[a] 
selectivity  
C2:C3 [C3:bis(C3)][a] 
1 none 77 2:1 (1:>99) 
2 AgOTf 56 2.0:1 (1:>99) 
3 AgBF4 37 2.0:1 (1:>99) 
4 AgPF6 59 2.0:1 (1:>99) 
5 AgSbF6 58 1.7:1 (1:>99) 
6 NaOTf NR[b] – 
7 NaBF4 34 7.8:1 (1:>99) 
8 NaPF6 10 2.8:1 (1:>99) 
9 NaSbF6 79 4.2:1 (1:>99) 
[a] Both NMR yield and regioselectivity were determined by 1H NMR spectroscopic analysis of an aliquot of the reaction mixture 
using dibenzyl ether (0.25 M in mesitylene) as an internal standard. Catalyst components were pre-stirred at 25 oC for 1 h. [b] A 





1.5.3 Optimisation of the Substrate Ratio 
Next, the indole-to-imine ratio was investigated.  Indeed, it was found earlier that gradual addition of the 
indole over 15 h to a solution of the pre-stirred catalyst components, in the presence of the imine, gave 
a higher C2 selectivity than the reverse addition over the same period; these data suggested that a 
higher local concentration of the imine increased the C2 selectivity.  In turn, the effect of the imine 
equivalents (0.5–2.5 equiv), relative to the amount of indole, on both reactivity and C2 selectivity was 
investigated (Table 5).  First, it was found that the use of 2-methyl-THF was beneficial to both NMR 
yield and regioselectivity (entry 2 vs. entry 1).  When less than one equivalent of the imine was used, 
the C2 selectivity decreased (entries 3 and 4).  At two equivalents of imine a maximum was reached 
where adding additional equivalents began to decrease the C2 selectivity (entries 5–9).  
Table 5: Influence of the substrate ratio on both reactivity and selectivity.a 
 
entry imine equiv yield (%)[b] 
selectivity 
C2:C3 [C3:bis(C3)][b] 
  1[c] 1.0 34 7.8:1 (1:>99) 
  2 1.0 62 12:1 (1:>99) 
  3 0.5 quant 5.0:1 (1:>99) 
  4 0.6 quant 5.0:1 (1:>99) 
  5[d] 1.5 44 16:1 (1:>99) 
  6 2.0 90 22:1 (1:>99) 
  7 2.1 88 23:1 (1:>99) 
  8 2.2 80 23:1 (1:>99) 
  9[d] 2.5 38 20:1 (1:>99) 
[a] Catalyst components were pre-stirred at 25 oC for 1 h. [b] Both NMR yield and regioselectivity were determined by 1H NMR 
spectroscopic analysis of an aliquot of the reaction mixture using dibenzyl ether (0.25 M in mesitylene) as an internal standard.   
[c] THF was used as the solvent.  [d] Reaction time: 16 h. 
In addition to this C2-selective Mannich-type reaction (using an aldimine as the electrophile), a 
potentially C2-selective aldol reaction was attempted (using benzaldehyde as the electrophile; Scheme 




secondary alcohols, a conversion of the starting materials was not observed even under forcing 
conditions. 
Scheme 15: Attempted potentially C2-selective aldol reaction 
 
While this result was disappointing, it opened the possibility for the use of classic Mannich conditions, 
i.e. applying a three-component approach rather than the indole and an isolated imine.  Such strategy 
enables a faster screening of substrates and conditions because the need to prepare and purify imines 
is not necessary anymore.  Moreover, unstable imines could be generated in situ and reacted directly 





1.6 Investigation of a Three-Component System and Substrate Scope 
1.6.1 Initial Examination of a Three-Component System 
First, suitable N-protecting groups of the primary amine component were screened in order to see their 
effect on both reactivity and regioselectivity (Table 6).  Such information may be important due to the 
challenging N-deprotection of simple aniline-derived imines.  No reaction was observed for alkylamino 
protecting groups such as tert-butyl and benzyl (Table 6, entries 2 and 3) as well as aniline; unusual 
since this worked well as the isolated imine. Tert-butoxycarbonyl (boc) protected imines95 proved 
unreactive (Table 6, entry 1).  Other classic protecting strategies such as tosyl, pmp, hydrazones and 
hydrazides all failed to achieve reasonable selectivities.  Electron withdrawing groups such as fluoride 
enhanced the selectivity though this did not translate for 2-pyridylamine (Table 6, entry 4 vs 10).  O-
anisidine proved to be very selective for C2 possibly through ortho-complexation with a metal species.  





Table 6: Screening of N-protecting groups for a three-component system.a 
 




























































[a] Imine components were pre-stirred at 30 oC for 1 h prior to the reaction. Catalyst components were pre-stirred at 25 oC for 1 h.  
[b] Both NMR yield and regioselectivity were determined by 1H NMR spectroscopic analysis of an aliquot of the reaction mixture 






1.6.2 Examination of the Scope for N-OMP-Protected Imines 
Under the optimised conditions a range of functionalities were tolerated (Table 7).  The use of aromatic 
aldehydes displaying functional groups in ortho-, meta-, or para-position led to the formation of the 
corresponding Mannich adducts with C2:C3 ratios ranging from 30:1 to >50:1.  Both electron-donating 
and electron-withdrawing groups proved to be applicable.   
Table 7: Screening of aromatic N-OMP-protected aldimines.a 
 
 
[a] Both NMR yield and regioselectivity were determined by 1H NMR spectroscopic analysis of an aliquot of the reaction mixture 
using dibenzyl ether (0.25 M in mesitylene) as an internal standard. 
While the scope for aromatic aldehydes was very promising, aliphatic and more “exotic” carbonyl 
derivatives proved to be challenging substrates under the reaction conditions (Table 8).  Several 
attempts were made to use formaldehyde so to incorporate a simple amino methylene fragment onto 




Problems were also encountered with primary aliphatic aldehydes, such as octanal and hydro-
cinnamaldehyde, as well as a secondary aliphatic aldehyde, cyclohexane carbaldehyde.  Gratifyingly, 
cyclopropane carbaldehyde worked well and provided additional useful data regarding the mechanism 
(vide infra).  Attempts with Michael acceptors, such as acrolein and cinnamaldehyde, gave  
polymerisation.  This issue could be remedied to some extent by using -methyl cinnamaldehyde, but 
the regioselectivity turned out to be poor.  Replacing both -positions with phenyl rings resulted in a 
highly regioselective transformation.  The highly activated glyoxylate resulted in the exclusive formation 





Table 8: Screening of various N-OMP-protected aldimines.a 
 
 
[a] Both NMR yield and regioselectivity were determined by 1H NMR spectroscopic analysis of an aliquot of the reaction mixture 
using dibenzyl ether (0.25 M in mesitylene) as an internal standard. [b] NMR yield.   
In addition, heteroaromatic substrates –as potentially pharmaceutically relevant molecules– were 
examined (Table 9).  Here, the reactivity proved to be less general.  For instance, pyridyl groups were 
tolerated only at C3.  While a reaction was not observed with the N-unprotected pyrrole derivative, N-
Boc protection enabled reasonable selectivity and reactivity.  Furan and thiophene derivatives also 





Table 9: Screening of heteroaromatic OMP-protected aldimines.a 
 
 
[a] Both NMR yield and regioselectivity were determined by 1H NMR spectroscopic analysis of an aliquot of the reaction mixture 
using dibenzyl ether (0.25 M in mesitylene) as an internal standard. NMR yield compounds not isolated.   
Next, ketones were investigated (Table 10).  Their reactivity turned out to be poor; a reactivity was not 
observed with aliphatic, aromatic, and “mixed” ketones. The activated ketone pyruvate gave only 






Table 10: Screening of N-OMP-protected ketimines.a 
 
 
[a] Both NMR yield and regioselectivity were determined by 1H NMR spectroscopic analysis of an aliquot of the reaction mixture 





1.6.3 Examination of the Scope for Indoles 
Pleasingly, a wide range of functionalised indoles were tolerated under the reaction conditions (Table 
11).  While the majority of the scope was achieved using C5-substituted indoles, substitution at all 
positions was shown to be acceptable.  In addition to methyl groups, all halogen atoms (F, Cl, Br, I) 
allowing for further chemical transformations at these synthetic handles.  Similarly, both electron-
donating and electron-withdrawing groups were tolerated at the indole core.  Interestingly, amino and 
carbonyl groups could be tolerated as long as the imine was pre-formed at 30 oC for 1 h prior to its 





Table 11: Screening of ordinary indoles. 
 
[a] Both NMR yield and regioselectivity were determined by 1H NMR spectroscopic analysis of an aliquot of the reaction mixture 
using dibenzyl ether (0.25 M in mesitylene) as an internal standard. [b] NMR yield compound not isolated. [c] Imine components 
were pre-stirred in half amount of the solvent at 30 oC for 1 h. 
Aza-indoles represent interesting substrates, but are encountered sporadically in the scope of indole-
exploiting reactions in the literature.96 In our case, under the optimized conditions a reactivity was 




in a very poor reactivity (<5%); these substrates were not further pursued.  The use of some substituted 
7-aza-indoles gave moderate reactivity, but the poor regioselectivity made the transformations 
synthetically less useful.  However, good results were obtained by using 3-chloro-7-aza-indole and 5-
methoxy-7-aza-indole.  The use of several 3-functionalised aza-indoles proved to be unsuccessful. 
Table 12: Screening of various aza-indoles.a 
 
 
[a] Both NMR yield and regioselectivity were determined by 1H NMR spectroscopic analysis of an aliquot of the reaction mixture 














1.7 Investigations Towards the Mechanism of the C2-Selective Mannich 
 1.7.1 Significance of Individual Catalyst Components 
The optimization experiments regarding the most active and selective catalyst revealed that a three-
component catalyst system was most effective: CuCl, NaBF4, Li2CO3; in a molar ratio 1:1:1.  While the 
presence of all three components proved to be critical for both reactivity and selectivity, we wanted to 
gain further insight into the identity of the catalytically active species.  We hypothesized that copper(I) 
chloride [Cu(I)Cl] and NaBF4 would undergo an anion metathesis to generate in situ Cu(I)BF4.  Both 
reactivity and selectivity for the use of the commercially available Cu(I)BF4•(MeCN)4 in the presence of 
Li2CO3 –under otherwise identical conditions– were found to be disappointing; this poor result may be 
ascribed to the tightly bound ligand (MeCN) thus blocking coordination sights at the metal center.  In 
order to test such hypothesis and to carry out control experiments, Cu(I)BF497 and Cu(I)2CO398 were 
synthesized according to literature procedures. While literature procedures were followe purity of these 
compounds was not assayed.  
Next, a variety of experiments were carried out with our model transformation at 30 oC for 15 h with 
preformed imine (Table 13).  The use of the “standard three-component Cu(I) system” gave the product 
in 27% yield with a C2:C3 selectivity of 23:1 (entry 1).  In contrast, replacing Cu(I) with Cu(II) led to 47% 
yield but a substantially decreased C2:C3 selectivity (3.8:1; entre 2).  Gratifyingly, the use of the 
synthesized solvent-free Cu(I)BF4 gave the product in 67% yield with a C2:C3 selectivity of 24:1 (entry 
3).  Interestingly, when the anions were swapped here, the yield dropped but the selectivity remained 
similar (entry 4); this outcome could be explained by a distinct rate of anion metathesis leading to a 
lower catalyst loading in this particular case.  Overall, these experiments confirmed the critical presence 
of copper(I) for a high C2-selectivity.  The significance of lithium was then confirmed through using the 
synthesized solvent-free Cu(I)BF4 in combination with various other metal carbonates (Na, K, Cs; 
entries 5–7).  While the product yields proved to be similar to the case of Li (entry 3), the selectivity 
dropped badly (entries 5–7).  Interestingly, when the synthesized Cu(I)2CO3 was used as a sole catalyst, 
a reaction did not occur at all (entry 8).  Overall, these experiments confirmed the critical presence of 
lithium for a high C2-selectivity.  Finally, a control experiment was carried out using the combination of 
synthesized solvent-free Cu(I)BF4 and LiBF4; here, the reaction proceeded smoothly but the C2:C3 
selectivity was inversed (1:2.0; entry 9).  This experiment confirmed the critical presence of carbonate 
for a high C2-selectivity.  Overall, we propose a double anion metathesis starting from all three 
components leading to a mixed Cu(I)/Li carbonate, which may be the active metal–base catalyst for 
C2–H bond activation of the N-unprotected indole.  Efforts are ongoing to synthesize, isolate, and 






Table 13: Control experiments towards the elucidation of the catalytically active species. 
 
 
Entry catalyst components[a] yield (%)[b] Selectivity 
 C2:C3 [C3:bis(C3)][b] 
Significance of copper(I) 
1 CuCl + NaBF4 + Li2CO3 27 23:1 (1:>99) 
2 CuCl2 + NaBF4 + Li2CO3 47 3.8:1 (1:>99) 
3 CuBF4 + Li2CO3 67 24:1 (1:>99) 
4 LiBF4 + Cu2CO3 10 20:1 (1:>99) 
 
Significance of lithium  
5 CuBF4 + Na2CO3 51 7.0:1 (1:>99) 
6 CuBF4 + K2CO3 65 4.0:1 (1:>99) 
7 CuBF4 + Cs2CO3 61 2.0:1 (1:>99) 
8 Cu2CO3 NR – 
 
Significance of carbonate  
9 CuBF4 + LiBF4 58 1:2.0 (1:>99) 
[a] Catalyst components prestirred for 1 h at 30 oC prior to use.  [b] Both NMR yield and regioselectivity were determined by 1H 







1.7.2 Examination of a Potential Radical Reaction Pathway 
When considering plausible mechanistic pathways for the C2 functionalisation of the N-unprotected 
indole core, a radical mechanism may seem conceivable based on the reagents and catalyst 
components used.  In addition to the proposed ionic mechanism99 for Grubbs’ silylation of N-
heterocycles, a radical pathway has been also described.100 Thus, we examined the use of three 
commercially available radicals –galvinoxy (129), TEMPO (130), and 3-carbamoyl-PROXYL (131)– as 
additives in our standard transformation; however, the imine was used directly here (Scheme 16). Their 
use resulted only in a minor erosion to the normal selectivity observed.  Thus, while the use of stable 
radicals may give some hint that the reaction does not proceed via a radical pathway, it is not conclusive.  
Indeed, in situ-formed radicals may have reacted preferentially with the substrates as these were 
present in higher concentration.  Also, the free radicals may have served as ligands to metal species in 
solution.  Experiments may have to be carried out again in a different setting (different free radicals, 
higher concentration etc.), and potentially to isolate adducts with these free radicals incorporated. 
 




[a] The yield and the  regioselectivity were determined by 1H NMR spectroscopic analysis of an aliquot of the reaction mixture after 
addition of an internal standard DBE (0.25 M) in mesitylene. Catalyst components were prestirred for 1 h at 25 oC.   
 
With the aim to test the “radical” hypothesis from a different aspect, cyclopropyl carbaldehyde –as a 
radical clock101 substrate– was used under under standard conditions.  This reaction afforded product 
133 selectively in quantitative yield based on the internal standard (dibenzyl ether); however, its 
isolation proved treacherous.  Ring-opened products could not be detected in the 1H NMR 










Scheme 17: Use of cyclopropyl carbaldehyde as a radical clock substrate.a 
 
 
[a] The yield and the regioselectivity were determined by 1H NMR spectroscopic analysis of an aliquot of the reaction mixture after 
addition of an internal standard DBE (0.25 M) in mesitylene. 
 
The studies by Blackmond et al. towards reaction progress kinetic analysis has aided in the identification 
of reaction mechanisms for several different reactions.102-104  For example the use of kinetic analysis 
has been applied to the study of several palladium catalaysed transformations.  The benefit of the 
approach being the generation of a wealth of valuable data from a minimum of experiments102.  This 
approach105 was applied to the present C2-selective indole Mannich-type coupling (Chart 1).   
 
The reaction was run at several different concentrations of the imine 22 keeping the same excess of 
this reagent in all experiments. This allows the influence of several effects to be observed. Using NMR 
the concentration of starting material and product was monitored. The concentration of 22 was plotted 
with respect to the reaction time.  This plot was then “time adjusted”; the lower concentrations were 
overlaid at the time point when they met the highest concentration. Between these reactions the 
concentration of the substrate is the same but in two cases the reaction has been on for longer allowing 
products to form and catalsyts to potentially decompose.  Since the reaction was effectively at the same 
time the plots should overlay assuming that there is no product inhibition or catalyst deactivation.  
Despite the substrate concentration being the same at these points, the reaction rate was notably 
different.  These data highlight the influence of product interaction and catalyst inhibition on the kinetics. 

























Chart 1: Further mechanistic control experiments. 
 
In order to see if the products inhibited the reaction, the isolated products 23 and 24 were added to the 
catalyst pre-stirring prior to starting the reaction.  In order to avoid saturation of the catalyst only one 
equivalent of imine 22 was added.  For both the 23 and 24 additive there was an enhancement in the 
reaction rate suggesting a ligand-stabilizing influence of the corresponding substrate.  The addition of 
1.5 equivalents of imine 22 afforded a significant enhancement of the C2 regioselectivity.  These data 
show promise for the addition of a chiral ligand to the system in view of asymmetric catalysis.  While 
several different ligand classes were screend no ee was observed.  This was demonstrated earlier with 
the slow addition experimets.  While the same excess and additive experiments provided nice data with 
regards to catalyst deactivation and/or product inhibition, more data was required before a reliable 
































Chart 2: Influence of additives on the reaction rate. 
 
Deuterium labelling experiments were performed using indole deuterated at C3 and C2, respectively.  
There have been several reports of indole C2 functionalisation via a C3-to-C2 migration.106 By using a 
C3-deuterated indole we would expect a decrease in the level of deuteration at C3 via an exchange 
process.  The synthesis of this substrate takes advantage of the enamine to use a deuterated DCl 
catalyst in D2O to equilibrate to the C3-deuterated product.  For the use of the C3-deuterated indole 
under the normal reaction conditions, a scrambling of the deuterium label was not observed (Scheme 
17).  This result may suggest that such migration did not occur in our reaction system.  For the use of 
the C2-deuterated indole, the monitoring with time of the labelled substrate vs. “normal” indole gave a 
small primary kinetic isotope effect (KIE) of 1.54 (Scheme 18). This result may suggest that the C2–H 
bond activation corresponds to the rate-determining step.  Future expeeiments may include monitoring 
the C3-deutereated indole vs “normal” substrate to see if any minor isotope effect exists.  Current work 
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Scheme 18: Deuterium labelling experiments: use of indole deuterated at C3. 
 
 
[a] Catalyst components were prestirred for 1 h at 30 oC. [b] The yield and the geometric selectivity were determined by 1H NMR 
spectroscopic analysis of an aliquot of the reaction mixture after addition of an internal standard DBE (0.25 M) in mesitylene. 
 
Scheme 19: Deuterium labelling experiments: use of indole deuterated at C2.  
 
[a] Catalyst components were prestirred for 1 h at 30 oC. [b] The yield and the geometric selectivity were determined by 1H NMR 
spectroscopic analysis of an aliquot of the reaction mixture after addition of an internal standard DBE (0.25 M) in mesitylene. 
Several different mechanisms can be proposed for this activation. While electrophilic aromatic 
substitution can proceed via the C2 possition (Scheme 20, A) the unfavourable dearomatisation 144 vs 
the enamine reactivity through C3 suggests this is unlikely. A more likely scenario is reaction through 
the enamine to C3 146 followed by migration 147 (Scheme 20, B). Via this mechanism it would be 
expected that deuteration at C3 would lead to scrambling at this position. As this was not observed 











Scheme 20: Plausible mechanisms of C2 alkylation.  
 
 
Based on these experiments, a C2–H bond activation pathway can be proposed for this C2-selective 
indole–Mannich-type coupling (Scheme 21).  The formation of a heterobimetallic carbonate (Cu/Li) 148 
has been suggested.  This species may be apt –through coordination to the metal sites– for initial 
deprotonative N–H bond activation of indole; the resulting metallated enamide would then react at the 
N-terminus with the imine (1 equiv) to form an N-lithiated N,N-hemiaminal 150; this intermediate 
corresponds to a lithium amide species, which receives support from the proximal aromatic methoxy 
group (bidentate coordination).  Such a metal–base should be reactive enough to activate the adjacent 
C2–H bond of indole (deprotonation).  The in situ-generated C-metallated N,N-hemiaminal 151 would 
then add to another molecule of the imine (second equivalent; C–C bond formation).  The product thus 
formed would undergo collapse of the hemiaminal moiety to regenerate the original N–H bond of the 
indole core.  This mechanism would correspond to a traceless protecting/directing group approach.  












1.8 Conclusions and Future Work 
A rare C2 functionalisation of N-unprotected indoles has been reported.  This Mannich-type reaction 
was discovered by serendipity and optimized further.  Good to excellent C2-selectivities were achieved, 
and a mild catalyst system allowed a range of functional groups to be retained through the 
transformation.  The reaction was tolerant of several reactive functional groups, e.g. aldehydes, 
bromides etc.  In an attempt to expand the substrate scope, aldehydes were used without success.  
This “negative” result opened the possibility of a three-component reaction.  Using o-anisidine this 
transformation proceeded smoothly.  Mechanistic investigations suggested the formation of a 
heterobimetallic carbonate through double anion metathesis, and a deprotonative C2–H bond activation 
by an intermediary lithiated N,N-hemiaminal, which may serve as a traceless protecting/directing group.   
Scheme 22: C2 Specific Mannich Reaction.  
 
Future work will focus on further exploring the mechanism of this three-component reaction system.  






2 Catalysis with a carbodicarbene 
2.1 Carbenes [Carbon(II)] vs. Carbones [Carbon(0)] 
Carbenes, particularly N-heterocyclic carbenes (NHCs), have been established arguably among the 
most common Lewis base catalysts and ligands (Scheme 23; right).107  These species represent carbon 
in its formal oxidation state (II); they possess a vacant p orbital and a lone pair of electrons in an sp2 
orbital.  In contrast, so-called carbones are carbon species with the central atom in a formal oxidation 
state (0); thus, while such compounds are neutral they possess two lone pairs of electrons and no 
vacant orbital at carbon (Scheme 23; left).108  Among the first examples reported in the late 1960s are 
so-called carbodiphosphoranes (CDPs).  Their strongly basic nature has been demonstrated in their 
extraordinary first proton affinity (280 kJmol–1; vs. 250 kJmol–1 for carbenes), and moreover a high 
second proton affinity of 186 kJmol–1 indicating a substantial dibasic character.109  A variety of carbones 
have been reported; according to the substituents at the central carbon atom the following classes may 
be distinguished: allenes or heterocumulenes, 110-117 carbodicarbenes118-128 and CDPs129-137. 






3.2 Synthesis of a Carbodiphosphorane 
The first reported synthesis of hexaphenylcarbodiphosphorane (152) was achieved through reaction of 
dibromomethane with an excess of triphenylphosphine forming an intermediary bis(phosphonium) 
bromide salt that was deprotonated using potassium metal (Scheme 24).138  Other bases used include 
K–HMDS139 and Na–NH2.140 
 




After this initial low-yielding route, a new method was developed by Appel et al. (Scheme 25).141  The 
sequence included double nucleophilic substitution on CCl4 using an excess of triphenylphosphine, and 
subsequent dechlorination by tris(dimethylamino)phosphine. 
 







2.3 Stoichiometric Reactivity of a Carbodiphosphorane 
Hexaphenylcarbodiphosphorane, abbreviated in the following by CDP, has been explored in a variety 
of contexts.  Its addition to an equimolar amount of TMSOTf afforded the corresponding silyl-complex 
160 as an air-sensitive complex which was unstable in solution (Scheme 26).  Subsequent reaction of 
the latter with triflic acid afforded –after elimination of the TMS moiety– the bis(protonated) CDP 
complex rather than the (presumably) unstable protonated silyl-complex; this “decomposition” was 
indicated by 31P NMR spectroscopy (26.2 ppm –> 20.0 ppm).142 
Scheme 26: Stoichiometric reactivity of a carbodiphosphorane towards a silicon Lewis acid. 
 
In the presence of a stoichiometric amount of TMSOTf, CDP was also shown to react with a 
chlorophosphine through nucleophilic substitution (Scheme 27).  Addition to the phosphonium center 
forms novel halo and pseudohalophosphonium dications 163.143  Oxidation of this complex with 
tertbutylperoxide affords the unstable trication 164 which was stabilised by triflation of the phosphine 
oxide forming 165. A similar synthetic strategy is utilized for C‒F activation using transient phosphonium 
dications.144 




CDP was also reported to react with specific acyclic ketones to give cyclized145 and/or acyclic 
compounds (Scheme 28).146  Initial conjugate addition to the ,-unsaturated ketone, followed by 
cyclisation and extrusion of triphenylphosphine oxide, resulted in the generation of a strained 






Scheme 28: Wittig-type reactivity of a carbodiphosphorane towards acyclic ketones.  
 
 
Noteworthy in this “reactivity” context are the distinct properties of NHCs and CDPs (Scheme 29).  While 
both carbon nucleophiles undergo an identical initial vinylogous conjugate addition to 
tetrakis(trifluoromethyl)cyclopentadienone.  Unlike carbenes CDPs and alkyl phosphines undergo a 
thermodynamic rearrangement while isonitriles undergo a second addition forming iminosubstituted 
dihydrofuran rings 184.147 







In addition, CDP’s reactivity with alcohols,148,149 hydroxylamines,150 and small molecules such as 
CO2151,152  has been investigated (Scheme 30).  In the same line, CDPs have been part of frustrated 
Lewis pairs (FLPs) to activate molecular hydrogen, terminal alkynes, boranes, and silanes.153,154   







2.4 Stoichiometric CDP–Metal complexes 
Various CDP–metal complexes were synthesised in a variety of contexts.  Fürstner et al.110 and Gandon 
et al.155 reported various gold and gallium complexes with several distinct carbon(0) species.  In a similar 
context, Stephan et al. synthesised iron complexes that displayed the CDP’s ability to stabilise a rare 
three-coordinate iron geometry (Scheme 31).138  These complexes were further exploited as synthons 
for low-oxidation state compounds. Complex 191 when reacted with two equivilents of benzyl Grignard 
formed the highly air-sensitive complex 193.  Displacement of one chloride from complex 191 using 
LiHMDS formed a complex uncharacterizable by X-ray diffraction.   Dechlorination with TMSOTf 
afforded 194 of which X-ray quality crystals could be grown for characterisation. Attempts to form a two 
coordinate iron species from 191, 193, 194 have been unsuccessful.  
 




The CDP’s ability to stabilise reactive metal centres was further demonstrated through reaction with 
GeCl2 (Scheme 32).156 Abstraction of a chloride from the mono germyanyl complex forms a highly 
reactive [GeCl]+ species stabilised by CDP.  On extension of the protocol to tin rather than an expected 
[SnCl]+ a dimeric form was isolated.  
 






Several other CDP–metal complexes have been synthesised under similar reaction conditions.  For 
instance, complexes of a 1:1 stoichiometry between the CDP ligand and the corresponding metal salt 
have been reported for several transition metal salts, including copper,157 silver and gold,158,159 zinc and 
cadmium,160 aluminum and indium,161 manganese162 as well as beryllium.163  It is noted that the reaction 
of 0.5 equiv of CDP with the corresponding metal salt (Cu, Au, Ag) triggered the formation of various 
2:1 complexes.164  Additionaly CDP/carbonyl complexes were formed with tungsten165 and rhenium.166 
Although CDPs bear two lone pairs of electrons at the central carbon atom their full accessibility was 
initially doubtful.  However, in 1976 Schmidbaur et al. reported the coordination of the CDP’s central 
carbon atom to two gold centers, thus representing the first proof of the full availability of all four 
electrons at carbon (Scheme 33; top).167  In 2009, the first complexation of both lone pairs to a main 
group element was uncovered (Scheme 33; bottom);168 diborane was reacted with CDP to generate the 
corresponding double adduct that appeared to be hydride-bridged in dimethoxyethane (DME). 
Scheme 33: Formation of diaurated and bis(borane) complexes of a CDP. 
 
Such double (homo)complexations of a CDP was extended to a double (hetero)complexation using a 
non-symmetric pyridyl-tethered CDP (Scheme 34).  Initially, after anion metathesis between AuCl(PPh3) 
and NaSbF6, the CDP was complexed by Au(I).  Subsequently, copper(I) chloride was shown to be 
complexed by the second lone pair of electrons at carbon; such complexation may be facilitated by an 
ortho-pyridyl’s N–Cu interaction.  While no characteristic application was reported for this 



















2.5 Catalytic Use of a Carbon(0) Species in Organic Synthesis  
To the best of our knowledge, the use of carbon(0) compounds as catalysts has been limited to two 
sporadic examples.  The first one was a catalytic hydroamination of terminal dienes facilitated by a Rh–
CDC complex (Scheme 35).169,170  Here, a good functional group tolerance was obtained at low catalyst 
loadings, with primary and secondary amines as well as a broad variety of dienes among successful 
substrates. 
Scheme 35: Rh–CDP-catalysed hydroamination of dienes.  
 
Unlike carbenes where a diverse range of electronic properties can be tuned a more limited range of 
carbon (0) compounds are available.171  This may explain the underutilisation of carbon (0) compounds 
in catalysis. Pd–CDC complexes have been used to catalyse both Heck and Suzuki–Miyaura cross-
coupling reactions.172,173 
The first use of a carbon(0) species in organocatalysis was reported by Ong et al. for the N-methylation 
of aliphatic and aromatic primary as well as secondary amines using CO2 (1 atm) and a borane as 
reagents (Scheme 36).174 
Scheme 36: CDC-catalysed N‒methylation of amines with carbon dioxide and a borane.174 
 
 
While the reductive amination by Ong demonstrated the CDC’s potential for use in catalysis, CDPs 
have not been reported as organocatalysts to date.  CDP’s have been proposed as intermidiates in the 
reduction of CO2.  
It was observed that triethyl phosphine under an atmosphere of CO2 led to a very slow formation of CO 
(overall reduction).  The addition of a catalytic amount of a Lewis acid, ZnBr2, and diiodomethane 
resulted in a substantial rate acceleration (Scheme 37).175 Mechanistic investigations led to the isolation 




It was believed that the I2 complex could be deprotonated by additional phosphine forming a CDP 220 
in situ.  This could then react with CO2 as has been reported with other CDPs forming adduct 222175.  
Thermolysis of this adduct generates the phosphaketene 224 which was believed to reform the CDP 
with extrusion of CO.  While this postulation seems reasonable the 31P NMR shift of +28.0 ppm seems 
unlikely when compared to other CDPs. This value is quite close to the values reported for the TMS 
adduct with CDP (vide supra) suggesting a possible CDP adduct rather than an actual CDP.  While the 
formation of the ketene is shown conclusively through x-ray crystallography the NMR signals ascribed 
to a proposed CDP intermediate seem unlikely.  Attempts to prepare a pure sample of the 
carbodiphosphorane for use in catalysis were unsuccessful. 







2.6 Catalytic Activation of Alkyl Nitriles 
Shibasaki et al. reported the cooperative catalytic activation of acetonitrile by a ruthenium complex and 
DBU for the subsequent nucleophilic addition to aldehydes (Scheme 38).176  Under the mild conditions 
ester functionalities remained intact and enolisable aldehydes were tolerated.  In addition, imines 
proved to be successful electrophiles. 
 




After this seminal work, additional research into the nucleophilic addition to aldehydes has been carried 
out using various metal complexes.177-184  Additionally, isatins,185 imines,186,187 and esters188 have been 
used as electrophiles.  These approaches rely on lowering the pKa value of acetonitrile through Lewis 
acid activation.  In a similar context, Brønsted base catalysis was reported for the activation of alkyl 
nitriles in view of an asymmetric conjugate addition to Michael amides (Scheme 38).189  Here, K–HMDS 
was combined with an enantiomerically enriched crown ether 237 to generate an effective chiral catalyst 
system.  While several substituted alkyl nitriles displayed good reactivity, the substrate scope regarding 
heteroaromatics and -substituted α,β-unsaturated amides 236 was found to be poor.  Importantly, the 
simplest alkyl nitrile, acetonitrile, was not tolerated under the mild reaction conditions forming a complex 
mixture.  Such drawbacks may be related to the presence of the metal cation, which may trigger a 
polymerisation of the Michael acceptor rather than a C–C bond formation between the two substrates.  
In turn, while metal catalysis may be not suitable for the use of acetonitrile, metal-free organocatalysis 
may be an option to overcome such an issue. 
 







In order to test this hypothesis, N,N-dimethylacrylamide was reacted in acetonitrile at ambient 
temperature overnight using 5 mol% loading of CDP (Scheme 40).  Gratifyingly, the corresponding 
conjugate adduct 242 was formed in 79% yield; a potential 1,2-addition was not observed. 
 






2.7 Aims  
Based on the preliminary work carried out by Hanno Kossen, the goal of this project was to truly develop 
an unprecedented CDP catalysis, and to show the significance with respect to other organocatalysts as 
well as metal-centred catalysts.  Also, in Kobayashi‘s study the substrate scope proved to be limited.  
In turn, the development of a general procedure applicable to a wide range of alkyl nitriles was another 
worthwhile goal; additional substrates were proposed to test the robustness of the intended 
transformation (Scheme 41). 
 




Furthermore, the examination of the potential mechanisms of such unprecedented catalytic use of a 
CDP was an important aim; two plausible pathways could be imagined (Scheme 42).  The postulated 
Lewis base pathway would involve conjugate addition to the Michael acceptor followed by deprotonation 
of acetonitrile by the in situ-generated amide-enolate (top).  Alternatively, a Brønsted base pathway 
would be conceivable through direct deprotonation of acetonitrile followed by the conjugate addition of 
the resulting carbanion to the Michael acceptor. 
 








2.8 Solvent screen  
Table 14: Solvent screen for the 1, 4 addition reaction.  
 
entry solvent dielectric 
constant 
(ε) 
yield (%) mass balance 
(%) 
1 DMF 38.2 NR[a] 97 
2 Neat 37.5 Quant. 101 
3 NMP 32 NR[a] 70 
4 PhCN 26 NR[a] 98 
5 TCE 10.4 NR[a] 93 
6 THF 7.5 NR[a] 94 
7 TBME 2.6 NR[a] 96 
8 toluene 2.4 NR[a] 97 
9 dioxane 2.3 NR[a] 99 
10 tBuCN - NR[a] 98 
[a] No reaction only starting material recovered.  
While the use of acetonitrile neat worked very effectively it would be desirable for other expensive 
nitriles if other solvents could be used.  Various polarity solvents were investigated though no reaction 
was observed in all cases; despite good solubility.  Generally good mass balances were observed 
except for the cyclic lactam NMP.  The lack of reactivity in solvents such as TCE was unsurprising; and 
visible decomposition and decolouration of the solution was observed.  Other nitrile solvents such as 





2.9 Control Experiments 
In order to stress the significance of the observed catalytic use of CDP, other base catalysts were 
examined.  Kobayashi reported an undesirable reactivity by using KHMDS in the presence of a crown 
ether ligand; such issue may be triggered by the presence of a metal cation.  Thus, other potential 
metal–amide catalysts were screened at 1 mol% loading (Table 15).  Here again, very poor reactivity 
and mass balance were observed with a variety of metal–amide species.  On the other hand, the 
catalytic use of CDP provided the intended conjugate addition product in 99% yield. 
 




entry Catalyst yield (%)[b] mass balance  
1 LTMP 14% 14% 
2 LDA NR[b] 85% 
3 LHMDS NR[b] 2% 
4 NaHMDS 23% 23% 
5 Zn(HMDS)2 NR[b] 77% 
6 Sn(HMDS)2 1% 71% 









[a] Reactions were carried out in duplicate and an average reported. The yield and mass balance were determined by 1H NMR 
spectroscopic analysis of an aliquot of the reaction mixture after addition of an internal standard DBE (0.25 M) in mesitylene. [b] 
No reaction only starting material recovered.  
 
Next, a variety of metal–alkoxides were screened because such compounds were shown to catalyse 
the deprotonation of pro-nucleophiles with challenging pKa values.99,100,190  Also, the propensity of these 
compounds to form stabilised radicals191,192 that may possibly abstract the -hydrogen of an alkyl nitrile, 
cannot be neglected.  Similar to the results with amides, a variety of metal–alkoxides gave essentially 




























entry Catalyst yield (%)[a] mass balance  
1 LiOtBu NR[b] 0% 
2 NaOtBu NR[b] 43% 
3 KOtBu NR[b] 0% 
4 Mg(OEt)2 NR[b] 84% 
5 Ca(OMe)2 NR[b] 60% 
6 Sr(OiPr)2 NR[b] 83% 
7 Ba(OiPr)2 NR[b] 83% 
8 Fe(OEt)3 NR[b] 100% 









[a] The yield and mass balance were determined by 1H NMR spectroscopic analysis of an aliquot of the reaction mixture after 
addition of an internal standard DBE (0.25 M) in mesitylene. Reactions were carried out in duplicate and an average reported.  [b] 
No reaction only starting material recovered.  
 
These results confirmed to some extent Kobayashi’s observation and our hypothesis regarding the 
issue with metal traces in such sensitive acrylamide substrates.  While the goal to report an 
unprecedented CDP catalysis was paramount, the significance would be diminished if the reaction could 
be accomplished using more commonly used organobases.  In turn, a variety of common 
organobases193-195 were screened (Scheme 43).  Gratifyingly, the reaction with amines, guanidines, 
amidines and phosphines gave no reaction under the mild conditions. 
 





[a] Reactions were carried out in duplicate and an average reported. The yield and mass balance were determined by 1H NMR 
spectroscopic analysis of an aliquot of the reaction mixture after addition of an internal standard DBE (0.25 M) in mesitylene. [b] 





In addition, various N-heterocyclic carbenes bearing N-aryl groups were found to not give any reactivity 
in the model transformation (Scheme 44); here the mass balances proved to be very good.  These data 
may highlight the fact that carbones are more basic and/or nucleophilic than carbenes. 
 
Scheme 44: Control experiments with “aromatic” N-heterocyclic carbenes (vs. CDP).a 
 
 
[a] Reactions were carried out in duplicate and an average reported. The yield and mass balance were determined by 1H NMR 
spectroscopic analysis of an aliquot of the reaction mixture after addition of an internal standard DBE (0.25 M) in mesitylene. [b] 
No reaction only starting material recovered.  
 
In the same line, “aliphatic” NHCs were examined in order to further compare carbenes with the CDP 
(Scheme 45).  While a reaction was not observed at all with triazolium- and thiazolium-based NHCs as 
well as an acyclic (alkyl)amino carbene, a very modest reactivity was observed with a few ordinary N-
alkyl carbenes.  In order to ensure that the deprotonation of the corresponding precursor salts was 
successful, an identical pre-stirred solution of the in situ-formed carbene 177 was reacted with BEt3 and 
analysed by 11B NMR spectroscopy (generation of a boron–ate complex). A shift in 11B NMR from 80 










[a] The yield and mass balance were determined by 1H NMR spectroscopic analysis of an aliquot of the reaction mixture after 
addition of an internal standard DBE (0.25 M) in mesitylene. Reactions were carried out in duplicate and an average reported. 
[b] No reaction only starting material recovered.   
  
A vast amount of research has been published regarding the use of metal-centred superbases in 
organic synthesis.196  Typically, these bases may represent a combination of an alkyl lithium species 
and a metal alkoxide through exchange,197-201 e.g. the Schlosser-type LICKOR bases.  More recently 
however, metal-free organic superbases have been synthesised and made commercially available.  
Phosphazene or Schwesinger202-204 and Verkade205-207 bases are N- and P-centred strong bases, 
respectively.  These species do have extremely high pKa values as demonstrated in Scheme 46.  Most 
of the superbases examined were as proficient at enabling the model transformation as CDP.  However, 
compared to the earlier base screenings, the observed reactivity was generally higher.  As for 
phosphazene bases, increasing the basicity up to P4-tBu resulted in an increased reactivity going from 
P1 to P2 to P4.  Similarly, Verkade’s “iPr” base was also a successful catalyst while lower reactivity was 
observed for its derivatives.  While some of these bases gave modest to good reactivity, none were as 
competent as CDP.  These data validated our initial goal of using a CDP in an organocatalytic context 










[a] The yield and mass balance were determined by 1H NMR spectroscopic analysis of an aliquot of the reaction mixture after 
addition of an internal standard DBE (0.25 M) in mesitylene. Reactions were carried out in duplicate and an average reported.    
[b] No reaction only starting material recovered.  
 
A wide range of ,-unsaturated amides were prepared to investigate the applicability and tolerance of 
the catalytic conjugate addition using acetonitrile.  In addition to the commercially available N,N-
dimethyl acrylamide, the corresponding Weinreb amide was synthesized; among others (see SI).  Next, 
the scope for the catalytic use of CDP was examined regarding the various ,-unsaturated amides 
(Scheme 47).  α-Substitution was tolerated with both methyl and phenyl groups giving good NMR yields.  
The use of the β-substituted crotyl amide as well as β-substituted heteroaromatic amides required 
heating to 80 oC, while the β-substituted cinnamyl amide reacted at 40 oC.  For the α,β-disubstituted 
cyclohexene-derived amide a mixture of diasteroisomers was obtained.  Cyclic Michael systems such 











[a] Reactions were carried out according to General Procedure V.  [b] NR = no reaction: a reaction was not observed; only starting 
materials recovered.  [c] Reaction temperature: 80 oC. 
 
In addition to acetonitrile, other aliphatic nitriles were examined in this catalytic conjugate addition 
(Scheme 48).  Gratifyingly, these pro-nucleophies were all activated using a catalytic amount of CDP.  
In addition, trimethylsilyl acetonitrile as well as -methylbenzyl cyanide reacted well; both substrates 




While it was hoped that chlorinated and brominated acetonitrile would be tolerated under the standard 
conditions with N,N-dimethyl acrylamide, a productive reaction was not observed by 1H NMR 
spectroscopic analysis of a reaction aliquot; in principle, such failure could be ascribed to the ability of 
the CDP to dehalogenate the nitrile, however, such by-product was not detectable (31P NMR 
spectroscopy).  The reaction using mono-fluorinated acetonitrile was possible for a few selected 
substrates, but as it was formed with low diastereoselectivity it was not isolated.  The use of methoxy- 
and phenoxy-substituted acetonitrile failed to give any reaction product despite forcing conditions to 80 
oC.  Where substituted amides were used the formation of diastereoisomers generally occurred with 
low selectivity.  However, the use of several substrates allowed a certain level of diastereocontrol.  For 
instance, the use of the -benzothiophene-substituted Michael amide, the diastereoselectivity of 5:1 (at 
40 oC) could be improved to 10:1 (30 oC); further experiments to achieve higher level of 
disstereoselection are on-going.  Finally, it is noted that alkyne-derived Michael amides failed to give 
any reactivity with any of the nitriles investigated.  
 





[a] The yield and mass balance were determined by 1H NMR spectroscopic analysis of an aliquot of the reaction mixture after 
addition of an internal standard DBE (0.25 M) in mesitylene.   [b] No reaction only starting material recovered.  [c] Reactions were 





2.10 Possible Activation Pathways by CDP 
Being both a powerful Lewis base and Brønsted base, CDP may catalyse the reaction in two different 
ways.  First, the CDP –as a Lewis base (nucleophile)– may add in a conjugate fashion to the Michael 
acceptor forming a zwitterionic amide-derived enolate, which should be apt to deprotonate acetonitrile.  
Thereby, the acetonitrile-anion (nucleophile) and the phosphonium-substituted amide (electrophile) 
would be formed.  A simple nucleophilic substitution would (re)generate both product and CDP catalyst 
(C–C bond formation).  Second, the CDP –as a Brønsted base– may directly deprotonate acetonitrile 
to form the acetonitrile-anion (nucleophile).  The latter woud undergo conjugate addition to the Michael 
acceptor (electrophile; C–C bond formation).  Here, the generated amide-derived enolate may be 
protonated by CDP–H+ (catalysis) or the next molecule of acetonitrile (initiation), so to provide turnover 
of the reaction.  While determining the exact reaction pathway may be challenging, a partial 
investigation seemed possible through 31P NMR spectroscopy. 
 




1H NMR decoupled spectroscopy of the CDP starting material displayed a sharp singlet at –4.1 ppm.  
In order to investigate the formation of reaction intermediates (by nucleophilic addition or deprotonation) 
variable-temperature experiments were carried out using dimethylacrylamide and various alkyl nitriles.  
Reacting the CDP with MeCN (1 equiv) in benzene-d6 led to the formation of a small signal at +20.4 
ppm.  This signal displays a similar in chemical shift to the product of the “addition of water” to CDP, 
thus suggesting a protonated CDP species.  Variation of the temperature had very little influence on the 










The use of other aliphatic nitriles, namely propionitrile and isobutyronitrile gave lower and significantly 
lower concentrations of the +20.4 peak, respectively.  When the CDP and dimethylacrylamide were 
combined, the use of variable-temperature 1H and 31P NMR spectroscopy showed only a signal at –4.1 
ppm, which was not influenced by the temperature.  This result may suggest that the CDP first 
deprotonates the acetonitrile rather than adding as a nucleophile to the Michael amide.  However, 
further experiments are required to fully elucidate the mode of action. 
 
Chart 4: 31P NMR spectroscopic analysis of CDP with each reagent: (a) acetonitrile, (b) N,N-dimethyl 
acryl amide.  
 


















2.11 Conclusions and Future Work 
The first catalytic use of a CDP was developed in organic synthesis, in the context of catalytic conjugate 
additions of aliphatic nitriles to ,-unsaturated amides (Scheme 48).  The catalyst proved to be very 
active in neat nitriles, though poorly in other solvents.  In the context of substrate scope and functional 
group tolerance, a reasonable range of substitution motifs and functionalities was developed, including 
a variety of heterocyclic fragments.  In case of substituted Michael acceptors and/or aliphatic nitriles, 
low diastereoselectivites were observed in most cases although encouraging signs started to appear in 
a few specific cases (with dr ~ 10:1).  The activation pathway for this catalytic use of CDP has been 
only investigated in a very preliminary form that does not allow any definite conclusion at this stage. 
However it would appear that initial deprotonation of the acetonitrile by the CDP followed by 1, 4 addition 
to the unsaturated amides is the most likely candidate. Whether the CDP acts catalytically or initiates 
the formation of the amide enolate is unknown.  
 




Future work on this project could focus on the use of different phosphine fragments to be incorporated 
in the CDP core as such alteration may substantially influence the catalytic activity.  Such modification 
may be of particular interest in view of asymmetric catalysis triggered by an enantiomerically enriched 
CDP; the latter may be accessible through incorporation of an enantiomerically enriched phosphine into 





3.0 Experimental  
 3.1 General Experimental   
Reaction Setup: All reactions were carried out under inert atmospheres using N2 in a 
MBraun glovebox; otherwise reactions were carried out under dry Ar using balloons.  Unless 
otherwise stated, chemicals were purchased from Sigma, Alfa, Acros or Fischer and used 
without further purification.  Toluene, diethyl ether and THF were distilled over Na with 
benzophenone indicator and stored over 4 Å molecular sieves.  All other solvents were dried 
and purified in a solvent purification system using Grubbs method208 and stored over 4 Å 
molecular sieves.  Sieves were activated at 300 oC for 72 h under high vacuum.  Solvent 
dryness was confirmed using coulometric Carl-Fischer apparatus.  Catalytic reactions were 
run at either 25, 30, 40, 60 or 80 oC in constant temperature sand baths with a stirring rate of 
400 rpm.  7 cm screw seal vials were used as catalytic reaction vessels and were further 
sealed with Teflon and parafilm.   All reactions were stirred magnetically.  All glassware was 
stored for a minimum one hour in a hot (80 oC) oven and cooled under inert gas.  For lower 
than ambient temperature standard cooling baths were used.  
NMR spectroscopy: 1H NMR spectra were recorded on Bruker AVA400 (400 MHz) 
with BBFO+ probe, Bruker AVA500 (500 MHz) with DCH cryo-probe, Bruker PRO500 (500 
MHz) with Prodigy cryo-probe, or Bruker AVA600 (600 MHz) with TCI cryo-probe 
spectrometers.  Chemical shifts (δ) are quoted in parts per million (ppm) downfield of 
tetramethylsilane, using TMS as an internal standard (Si(CH3)4, δ = 0.00 ppm).  In the absence 
of TMS, residual solvent in deuterated solvents were used as an internal standard (CDCl3, δ 
= 7.26 ppm or C6D6, δ = 7.16 ppm).  Abbreviations used in the description of resonances are: 
s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet) and br (broad).  Coupling constants 
(J) are quoted to the nearest 0.1 Hz.  13C NMR spectra were recorded on Bruker AVA500 (125 
MHz), or Bruker AVA600 (150 MHz) spectrometers.  Chemical shifts (δ) are quoted in parts 
per million (ppm) downfield of tetramethylsilane as an internal standard (Si(CH3)4, δ = 0.00 
ppm).  In the absence of TMS, residual deuterated solvent was used as an internal standard 
(CDCl3, δ = 77.0 ppm or C6D6, δ = 128.4 ppm.  Chemical shifts (δ) are quoted in parts per 
million (ppm) downfield of lithium chloride without internal standard.  11B NMR spectra were 
recorded on Bruker AVA400 (128 MHz) or Bruker PRO500 (160 MHz) spectrometers.  
Chemical shifts (δ) are quoted in parts per million (ppm) downfield of trifluoroborate 
diethyletherate without internal standard.  19F NMR spectra were recorded on Bruker AVA400 
(376 MHz) or Bruker PRO500 (470 MHz) spectrometers.  Chemical shifts (δ) are quoted in 
parts per million (ppm) downfield of trichlorofluoromethane without internal standard. Chemical 
shifts (δ) are quoted in parts per million (ppm) downfield of sodium chloride without internal 




(202 MHz) spectrometers.  Chemical shifts (δ) are quoted in parts per million (ppm) downfield 
of phosphoric acid without internal standard. 
Mass Spectrometry: Mass Spectrometry was provided by the Edinburgh University 
School of chemistry and performed on either a Bruker ESI Micro-Tof or a ThermoElectron 
MAT 900 sector.  
IR Spectroscopy: Infra-red spectra were recorded on a Shimadzu IRAffinity-1 
instrument on isolated samples using the attenuated total reflectance sampling technique 
provided in the School of Chemistry, The University of Edinburgh. 
Chromatography: Analytical thin-layer chromatography (TLC) was performed using 
Merck Silica gel 60 F254 plates.  The plates were visualised using either UV light, anisaldehyde 
stain, KMnO4 or iodine stain.  Flash column chromatography was performed using Merck 
Geduran P60 43-60 µm silica gel using winchester grade solvents: Petroleum ether (VWR); 
diethyl ether (Aldrich); hexane (Aldrich); dichloromethane (Fischer); and ethyl acetate (VWR).  
High performance liquid chromatography (HPLC) was performed on a Shimadzu LC-20AT 
with a SPD-20A detector on 4.6 x 250 mm columns from Diacel using winchester HPLC grade 
solvents which were degassed by ultrasonication.   Preparative thin-layer Chromatography 
(PTLC) was carried out on self-prepared plates prepared from Wakogel B-5F (particle size 45 
μm) from WAKO.  
Melting points: Melting points were carried out using Gallenkamp melting point 
apparatus and are uncorrected.   
Commercially available indoles: 4-Methyl indole: Fluorochem (>97%), 5-Methyl 
indole: Sigma Aldrich (99%), 6-Methyl indole Sigma Aldrich (97%), 4-Aza indole: Fluorochem 
(>97), 5-Azaindole: Alfa Aesar (98%), 6-Azaindole:  Fluorochem (>97%), 7-Azaindole: Sigma 
Aldrich (98%), 3-Chloro-7-azaindole: Sigma Aldrich (97%), 4-Chloro-7-azaindole: Sigma 
Aldrich (97%), Tryptamine: Sigma Aldrich (98%), 5-Cyanoindole: Sigma Aldrich (99%), 4-
Hydroxyindole: Alfa Aesar (98%), 5-Methoxyindole: Sigma Aldrich (99%), 5-Methoxy-6-
azaindole: Sigma Aldrich (96%), 6-Fluoro-7-methylindole: Sigma Aldrich (97%),  5-Bromo-7-
azaindole: Sigma Aldrich (96%), 5-Trifluoromethylindole: Sigma Aldrich (97%), 4-Cyano-7-
azaindole: Fluorochem (>97%), 5-Aminoindole: Fluorochem (>97%).   
Commercially available nitriles: Acetonitrile: Acros (>99%), Propionitrile: Acros 
(99%), Isobutyronitrile: Sigma Aldrich (99%), Butyronitrile: Acros (99%), α-
methylbenzylcyanide: Alfa (98%), Trimethylacetonitrile: Sigma (98%), Fluoroactonitrile: Sigma 




cyanide: Sigma Aldrich (98%), Methoxyacetonitrile: Sigma Aldrich (>98%), 












3.2 General Procedures 
Base screening of indole coupling (general procedure I) 
In a nitrogen glove box, a dry screw-capped vial with a magnetic stirrer bar was charged with 
metal–base (0.01 mmol, 10 mol%), indole (11.7 mg, 0.10 mmol, 1.00 equiv), 22 (18.1 mg, 0.10 
mmol, 1.00 equiv) and THF (0.5 ml).  The reaction mixture was stirred at 30 oC for 16 h.  The 
internal standard, dibenzyl ether, was added prior to 1H NMR analysis of an aliquot of the 
reaction mixture.  For reactions which gave no reaction the mixture was heated to 80 oC for 
63 h and 1H NMR analysis repeated.  
Lewis acid addition to the catalytic system (general procedure II) 
In a nitrogen glove box, a dry screw-capped vial with a magnetic stirrer bar was charged with 
metal base (0.01 mmol, 10 mol%), Lewis acid co-catalyst (0.01 mmol, 10 mol%), indole (11.7 
mg, 0.10 mmol, 1.00 equiv), 22 (18.1 mg, 0.10 mmol, 1.00 equiv) and THF (0.5 ml).  The 
reaction mixture was stirred at 30 oC for 16 h.  The internal standard, dibenzyl ether, was 
added prior to 1H NMR analysis of an aliquot of the reaction mixture.   
Amine protecting groups for the 3-component reaction (general procedure III) 
In a dry screw-capped vial with a magnetic stirrer bar was charged with Li2CO3 (1.50 mg, 0.02 
mmol, 5 mol%), CuCl (2.00 mg, 0.02 mmol, 5 mol%), NaBF4 (2.20 mg, 0.02 mmol, 5 mol%) 
and 2-MeTHF (200 μL) and stirred at 30 oC for 1 h.  Indole (46.8 mg, 0.40 mmol, 1.00 equiv) 
was added followed by a solution of benzaldehyde (84.9 mg, 0.80 mmol, 2.00 equiv), and 
amine (0.80 mmol, 2.00 equiv) in 2-MeTHF (200 μL). The reaction mixture was stirred at 30 
oC for 24 h.  The internal standard, dibenzyl ether, was added prior to 1H NMR analysis of an 
aliquot of the reaction mixture. 
Substrate scope for the 3-component reaction (general procedure IV) 
In a dry screw-capped vial with a magnetic stirrer bar was charged with Li2CO3 (1.50 mg, 0.02 
mmol, 10 mol%), CuCl (2.00 mg, 0.02 mmol, 10 mol%), NaBF4 (2.20 mg, 0.02 mmol, 10 mol%) 
and 2-MeTHF (100 μL) and stirred at 30 oC for 1 h.  Indole (46.8 mg, 0.40 mmol, 1 equiv) was 
added followed by a solution of aldehyde (0.80 mmol, 2.00 equiv), and o-anisidine (49.2 mg, 
0.80 mmol, 2.00 equiv) in 2-MeTHF (100 μL). The reaction mixture was stirred at 30 oC for 24 
h.  The internal standard, dibenzyl ether, was added prior to 1H NMR analysis of an aliquot of 






Deuterium labelling and monitoring (general procedure V) 
In a dry screw-capped vial with a magnetic stirrer bar was charged with Li2CO3 (1.50 mg, 0.02 
mmol, 10 mol%), CuCl (2.00 mg, 0.02 mmol, 10 mol%), NaBF4 (2.20 mg, 0.02 mmol, 10 mol%) 
and 2-MeTHF (200 μL) and stirred at 30 oC for 1 h.  d-Indole (46.8 mg, 0.40 mmol, 1 equiv) 
was added followed by 17 (72.5 mg, 0.40 mmol, 1 equiv) in 2-MeTHF (200 μL). The reaction 










To a round bottom flask under an atmosphere of argon was added indole (2.00 g, 17.0 mmol, 
1.00 equiv), NaOH (20 ml, 50% aq), toluene (30 ml) and water (15 ml).  TBAB (0.64 g, 2.00 
mmol, 0.12 equiv) was added followed by benzene sulfonyl chloride (3.00 g 17.0 mmol, 1.00 
equiv) and the mixture stirred vigorously for 14 h.  The reaction mixture was extracted with 
diethyl ether (3 x 30 ml) and dried over MgSO4.  The solvent was removed under reduced 
pressure to afford an amorphous solid which was recrystallised from ethanol and dried in 
vacuo to afford the titled compound.  
Colourless solid  
Yield: 2.10 g (48%). 
Mp: 78.2–79.3 oC (Lit.: 78–79 oC).211 
1H NMR (500 MHz, CDCl3): δ = 8.02 (d, J = 8.4 Hz, 1H), 7.91 (d, J = 7.3 Hz, 2H), 7.59 (d, J = 
3.6 Hz, 1H), 7.56–7.53 (m, 2H), 7.47–7.44 (t, J = 7.9 Hz, 2H), 7.34 (t, J = 7.3 Hz, 1H), 7.25 (t, 
J = 7.9 Hz, 1H), 6.69 (d, J = 3.6 Hz, 1H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 137.9, 134.5, 133.5, 130.4, 128.9 (2C), 126.4 (2C), 126.0, 
124.3, 123.1, 121.1, 113.2, 108.9 ppm.   





To a solution of indole (351 mg, 3.00 mmol, 1.00 equiv) in DMF (10 ml) was added portion 
wise NaH (86.4 mg, 3.60 mmol, 1.20 equiv). After 1 h 2-chloropyrimidine (412 mg, 3.60 mmol, 
1.20 equiv) was added. Stirring was continued for 18 h after which water (15 ml) was added 
and extracted with ethyl acetate (3 x 15 ml). The combined organic layer was dried over 




dissolved in THF, dried over molecular sieves (4 Å), filtered and the solvent removed under 
reduced pressure.  
Colourless solid  
Yield: 350 mg (60%). 
Mp: 84.5–85.3 oC (Lit.: 85–86 oC).212 
1H NMR (500 MHz, CDCl3): δ 8.85 (dq, J = 8.4, 0.9 Hz, 1H), 8.73 (d, J = 4.8 Hz, 2H), 8.31 (d, 
J = 3.7 Hz, 1H), 7.69–7.61 (m, 1H), 7.38 (ddd, J = 8.4, 7.1, 1.3 Hz, 1H), 7.31–7.22 (m, 1H), 
7.07 (t, J = 4.8 Hz, 1H), 6.74 (dd, J = 3.7, 0.8 Hz, 1H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 158.1 (2C), 157.9, 135.4, 131.4, 125.8, 123.7, 122.1, 120.8, 
116.3, 116.1, 106.9 ppm.   




To a dispersion of NaH (288 mg, 12.0 mmol, 1.20 equiv) in THF (20 ml) at 0 oC was added 
indole (1.17 g, 10.0 mmol, 1.00 equiv) dissolved in THF (10 ml) and the mixture stirred for 1 
h.  Benzyl bromide (1.79 ml, 15.0 mmol, 1.50 equiv) was added dropwise and the solution 
stirred for 4 h.  The reaction was quenched with ammonium chloride (10 ml) and the solution 
extracted with ethyl acetate (3 x 20 ml).  The combined organic fractions were washed with 
brine (20 ml) and dried over magnesium sulfate and the solvent removed in vacuo.  The solid 
was purified by column chromatography eluting 20% ethyl acetate in hexane.   
Pale pink solid  
Yield: 1.82 g (88%).  
Mp: 42.5–43.0 oC (Lit.: 42–43 oC).213 
1H NMR (500 MHz, CDCl3): δ = 7.71 (d, J = 7.5 Hz, 1H), 7.36–7.31 (m, 3H), 7.31–7.27 (m, 
2H), 7.22 (t, J = 7.5 Hz, 1H), 7.18–7.13 (m, 4H), 6.60 (d, J = 3.0 Hz, 1H), 5.36 (s, 2H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 137.6, 136.4, 128.8 (2C), 128.7, 128.3, 127.6, 126.8 (2C), 
121.7, 121.0, 119.6, 109.7, 101.7, 50.1 ppm.   











Indole (293 mg, 2.50 mmol, 1.00 equiv) was dissolved in DCM (5 ml). To the solution DMAP 
(61.1 mg, 0.50 mmol, 0.20 equiv) and NEt3 (758 mg, 7.50 mmol, 3.00 equiv) was added and 
the resultant mixture stirred for 1 h at ambient temperature.  Di-tert-butyl dicarbonate (600 mg, 
2.75 mmol, 1.10 equiv) was added and the reaction stirred for 3 h at ambient after which the 
reaction was quenched with water (10 ml) and extracted with DCM (3 x 5 ml).  The combined 
organic extracts were dried over anhydrous magnesium sulfate and the solvent removed 
under reduced pressure; drying in vacuo afforded the crude product as a colourless liquid 
which was suitably pure.  
Colourless liquid 
Yield: 530 mg (97%) 
1H NMR (500 MHz, CDCl3): δ = 8.17 (d, J = 8.3 Hz, 1H), 7.62 (d, J = 3.7 Hz, 1H), 7.58 (ddd, J 
= 7.8, 1.3, 0.8 Hz, 1H), 7.37–7.30 (m, 1H), 7.25 (ddd, J = 7.8, 7.2, 1.3 Hz, 1H), 6.59 (dd, J = 
3.7, 0.8 Hz, 1H), 1.70 (s, 9H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 149.8, 135.2, 130.6, 125.9, 124.2, 122.6, 120.9, 115.2, 107.3, 






To a solution of indole (1.20 g, 10.2 mmol, 1.00 equiv) in DCM (100 ml) at ambient temperature 
was added tetrabutylhydrogen sulfate (340 mg, 10.4 mmol, 1.02 equiv) and sodium hydroxide 
2.00 g, 51.0 mmol, 5.00 equiv) and the mixture stirred for 0.5 h.  Acetyl chloride (2.37 g, 30.6 
mmol, 3 equiv) was added and the mixture stirred at ambient for 2 h afterwhich water (20 ml) 
was added cautiously.  The organic layer was separated and the aqueous extracted with DCM 
(3 x 20 ml).  The combined organic extracts were dried over anhydrous magnesium sulfate, 
filtered and the solvent removed under reduced pressure affording the crude compound as an 




dissolved in THF and dried over 4 Å molecular sieves for 18 h.  The solution was then filtered 
and the solvent removed under reduced pressure and finally dried in vacuo.  
Colourless oil. 
Yield: 780.0 mg (48%). 
1H NMR (500 MHz, CDCl3): δ = 8.44 (s, 1H), 7.56 (d, J = 7.8 Hz, 1H), 7.42–7.37 (m, 1H), 7.34 
(t, J = 8.4 Hz, 1H), 7.27 (dd, J = 7.8, 1.0 Hz, 1H), 6.63 (d, J = 3.8 Hz, 1H), 2.63 (s, 3H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 168.3, 135.2, 130.1, 124.9, 124.8, 123.4, 120.5, 116.2, 108.9, 
23.7 ppm.   
IR (neat):  = 3051, 1697, 1450, 1319, 1207, 932, 746 cm–1.   








A solution of Sodium 1-Acetylindoline-2-sulfonate hemihydrate (12.0 g, 44.0 mmol, 1.00 equiv) 
in water (55 ml) was cooled to 0 oC and bromine (7.75 g, 48.5 mmol, 1.10 equiv) was added 
cautiously dropwise.  The mixture was stirred for 1 h then warmed to ambient temperature and 
stirred for an additional hour.  Sodium bisulfite (75 ml, sat aq.) was added followed by NaOH 
(7.50 g, 187.5 mmol, 4.30 equiv) and the mixture refluxed overnight.  The mixture was cooled 
and the solid formed filtered under vacuum to afford a brown solid. Recrystalisation from ether 
yielded a tan solid which was dried over molecular sieves (4 Å) in THF at room temperature 
for 18 h in a glovebox.  After filtration, the solvent was removed in vacuo, and the liquid dried 
in high vacuum before use in catalysis.   
Tan solid  
Yield: 3.20 g (37%). 
Mp: 91.5–92.0 oC (Lit.: 90–92 oC). 
1H NMR (500 MHz, CDCl3): δ = 8.13 (br s, 1H), 7.77–7.76 (m, 1H), 7.28–7.26 (m, 1H), 7.26–
7.25 (m, 1H), 7.19 (t, J = 3.1 Hz, 1H), 6.49 (ddd, J = 3.1, 2.1, 0.8 Hz, 1H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 134.1, 129.3, 125.1, 124.6, 122.9, 112.7, 112.1, 102.0 ppm.   




To 4-bromo-2-nitrotoluene (2.00 g, 9.20 mmol, 1.00 equiv) was added anhydrous DMF (40 
ml), N, N dimethylformamide dimethylacetal (1.60 ml, 11.2 mmol, 1.20 equiv) and pyrrolidine 
(1.00 ml, 11.2 mmol, 1.20 equiv).  The mixture was heated at reflux until tlc indicated 
consumption of the starting material.  The mixture was cooled to 0 oC before addition of 
ammonium acetate (40 ml, 4M) and TiCl3 (43.0 ml, 15% in 10% HCl). The mixture was stirred 
for 1 h.  The grey slurry was gradually brought to ambient temperature and NaOH (4M) was 
added to bring the solution to pH 9.  The solution was extracted with diethyl ether (3 x 100 ml) 
and the combined organic extracts were washed with brine (100 ml) and dried over 




hexanes yielded a tan solid which was dried over molecular sieves (4 Å) in THF at room 
temperature for 18 h in a glovebox.  After filtration, the solvent was removed in vacuo, and the 
liquid dried in high vacuum before use in catalysis.   
Tan solid  
Yield: 1.25 g (70%). 
Mp: 92.6–93.2 oC (Lit.: 92–93 oC).218 
1H NMR (500 MHz, CDCl3): δ = 8.13 (br s, 1H), 7.56–7.55 (m, 1H), 7.50 (d, J = 8.4 Hz, 1H), 
7.22 (dd, J = 8.4, 1.7 Hz, 1H), 7.19 (dd, J = 3.2, 2.4 Hz, 1H), 6.53 (ddd, J = 3.2, 2.1, 0.9 Hz, 
1H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 136.6, 126.7, 124.7, 123.2, 121.9, 115.5, 113.9, 102.9 ppm.   
IR (neat):  = 3393, 1605, 1335, 1093, 891, 806, 729 cm–1.   
 
Allyl Bromide (322) 219  
 
KOH (19.6 g, 350 mmol, 1.30 equiv) was dissolved in ethanol (110 ml).  To the flask was 
attached a still head, condenser and receiver flask and a pressure equalising dropping funnel.   
The solution was brought to 40 oC and 1, 2 dibromoethane (49.9 g, 22.7 ml, 266 mmol, 1.00 
equiv) was added steadily dropwise.  After addition was complete the solution was heated for 
a further 1 h collecting the distillate at -78 oC.  The allyl bromide was distilled a further time.  
Colourless liquid 
Yield: 10.10 g (36%). 
1H NMR (500 MHz, CDCl3): δ = 6.47 (dd, J = 7.9, 7.2 Hz, 1H), 6.01 (dd, J = 7.2, 1.9 Hz, 1H), 
5.88 (dd, J = 7.9, 1.9 Hz, 1H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 121.88, 113.97 ppm.   
 
Vinyl magnesium bromide220 
 
THF (60 ml) was added to magnesium turnings (3.30 g, 135 mmol, 1.28 equiv) and the flask 
placed under argon and cooled to 0 oC.  Iodine (1 crystal) was added followed by vinyl bromide 
(11.4 g, 106 mmol, 1.00 equiv) in THF (40 ml).  The flask was stirred for 2 h and the Grignard 









To a solution of o-nitrotoluene (4.11 g, 30.0 mmol, 1.00 equiv) in THF (100 ml) cooled to -40 
oC was added vinyl magnesium bromide (100 ml, 1.00 M, 100 mmol, 3.30 equiv).  The solution 
was allowed to warm to ambient and stirred for 15 h.  Ammonium chloride (50 ml, sat. aq.) 
was added and the mixture extracted with ether (3 x 100 ml).  The combined organic fractions 
were dried over magnesium sulfate, filtered, and the solvent removed under reduced pressure.  
The solid obtained was purified by flash column chromatography eluting EtOAc: hexane 
(1:10).  
Colourless solid 
Yield: 1.20 g (34%). 
Mp: 77.3–77.9 oC 
1H NMR (500 MHz, CDCl3): δ = 8.09 (br s, 1H), 7.54 (d, J = 7.7 Hz, 1H), 7.25 (t, J = 2.8 Hz, 
1H), 7.08 (t, J = 7.7 Hz, 1H), 7.03–7.04 (m, 1H), 6.60 (dd J = 2.8 Hz, 1H), 2.54 (s, 3H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 135.4, 127.4, 123.8, 122.5, 120.2, 120.0, 118.5, 103.2, 16.7 
ppm.   









N-benzenesulfonylindole (3.00 g, 12 mmol, 1.00 equiv) was stirred at -78 oC in THF (60 ml).  
nBuLi (9.6 ml, 24 mmol, 2.00 equiv, 2.5 M) was added and the solution warmed to ambient 
and stirred for 2 h.  The solution was recooled to -78 oC and D2O (3 ml) was added and the 
mixture stirred at ambient for 30 min.  Solid potassium carbonate (1 g) and MTBE (100 ml) 
added and the mixture filtered and dried under reduced pressure.  The formed amorphous 
solid was crystallised twice from MTBE.  
Colourless solid. 
Yield: 1.57 g (51%). 
1H NMR (500 MHz, CDCl3): δ = 8.00 (dq, J = 8.4, 0.8 Hz, 1H), 7.88 (dd, J = 8.3, 1.0 Hz, 1H), 
7.57–7.49 (m, 2H), 7.48–7.39 (m, 2H), 7.34–7.27 (m, 1H), 7.25–7.20 (m, 1H), 6.66 (t, J = 0.7 
Hz, 1H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 137.9, 134.5, 133.5, 130.5, 129.0, 128.9, 126.5, 126.0 (t, J = 
25.9 Hz), 124.4, 123.1, 121.1, 113.2, 108.8 ppm.   
2H NMR (77 MHz, CDCl3): δ = 7.92, 7.60 ppm 





2-Deuterio-1-(2-deuteriophenyl)sulfonyl-indole (1.00 g, 3.86 mmol, 1.00 equiv) was dissolved 
in methanol (11 ml) and NaOH (14 ml, 2M) added and the mixture refluxed for 16 h.  The 
solvent was removed in vacuo and the solid extracted with MTBE (3 x 20 ml) dried over 
magnesium sulfate, filtered, and the solvent removed under reduced pressure.  The solid was 
recrystalised twice from hexanes.  
Colourless solid. 
Yield: 400 mg (88%). 




1H NMR (500 MHz, CDCl3): δ = 8.22 (s, 1H), 7.65 (dq, J = 7.9, 0.9 Hz, 1H), 7.40 (dq, J = 7.7, 
0.9 Hz, 1H), 7.23–7.17 (m, 1H), 7.12 (ddd, J = 8.2, 7.1, 1.0 Hz, 1H), 6.59–6.54 (m, 1H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 135.8, 127.9, 123.8 (t, J = 28.0 Hz), 122.0, 120.7, 119.8, 
111.0, 102.7 ppm.   




Indole (2.00 g, 17.0 mmol, 1.00 equiv) was suspended in DCl (0.01 M, 20 ml) and stirred at 
60 oC for 3 h.  The reaction was cooled and extracted with MTBE (3 x 20 ml) and the combined 
organic layers dried over magnesium sulfate, filtered, and the solvent removed under reduced 
pressure affording a tar.  The tar was redissolved in MTBE (20 ml) and H2O (10 ml) added 
and stirred for 0.5 h.  The organic layer was separated and the aqueous further extracted with 
MTBE (2 x 20 ml). The combined organic layers were dried over magnesium sulfate, filtered, 
and dried to a tar which was recrystalised from hexanes.  
Colourless solid. 
Yield: 1.57 g (78%). 
Mp: 51.0–51.5 oC  
1H NMR (500 MHz, CDCl3): δ = 8.23 (s, 1H), 7.65 (dq, J = 7.9, 0.9 Hz, 1H), 7.41 (dt, J = 8.1, 
0.9 Hz, 1H), 7.23–7.21 (m, 1H), 7.20–7.17 (m, 1H), 7.12 (dd, J = 7.9, 0.9 Hz, 1H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 135.4, 127.6, 123.8, 121.7 (d, J = 1.4 Hz), 120.5, 119.5, 
110.7, 102.3 (d, J = 22.7 Hz) ppm.   





3.2.4 Other starting materials 
N-Phenyl-Benzaldimine (22)225 
 
In an oven dried flask under an argon atmosphere, aniline (4.66 g, 50.0 mmol, 1.00 equiv) and 
benzaldehyde (5.30 g, 10.0 mmol, 1.00 equiv) were combined.  Ethanol (25 mL) and 
magnesium sulfate (10 g) were added and the mixture stirred for 15 h.  The mixture was then 
filtered, and the solvent removed under reduced pressure to give the crude imine, which was 
recrystallized twice from refluxing ethanol to yield the pure aldimine.  The compounds were 
then further dried over 4 Å MS in THF, dried in vacuo and ground before use.  
Pale yellow solid 
Yield: 8.20 g (90%). 
Mp: 52.0–52.3 oC (Lit.: 51–52 oC). 
1H NMR (500 MHz, CDCl3): δ = 8.50 (s 1H), 7.96 (dd, J = 6.5, 3.1 Hz, 2H), 7.51–7.44 (m, 3H), 
7.40–7.36 (m, 2H), 7.24–7.18 (m, 3H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 160.5, 152.1, 136.2, 131.5, 129.2 (2C), 128.9 (2C), 128.8 
(2C), 126.0, 120.9 (2C) ppm. 
IR (neat):  = 3061, 2889, 1624, 1192, 754, 690 cm–1.   






In an oven dried flask under an argon atmosphere, p-anisidine (6.16 g, 50.0 mmol, 1.00 equiv) 
and benzaldehyde (5.30 g, 10.0 mmol, 1.00 equiv) were combined.  Ethanol (25 mL) and 
magnesium sulfate (10 g) were added and the mixture stirred for 15 h.  The mixture was then 
filtered, and the solvent removed under reduced pressure to give the crude imine, which was 
recrystallized twice from refluxing ethanol to yield the pure aldimine.  The compounds were 
then further dried over 4 Å MS in THF, dried in vacuo and ground before use.  
Pale pink solid  
Yield: 6.25 g (59%). 




1H NMR (500 MHz, CDCl3): δ = 8.48 (s, 1H), 7.90–7.88 (m, 2H), 7.47–7.46 (m, 3H), 7.26–7.23 
(m, 2H), 6.94–6.92. (m, 2H), 3.83 (s, 3H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 158.4, 158.3, 144.9, 136.5, 131.0, 128.7 (2C), 128.6 (2C), 
122.2 (2C), 114.7 (2C), 55.5 ppm.   
IR (neat):  = 2955, 1622, 1502, 1244, 1030, 833, 687 cm–1.   




In an oven dried flask under an argon atmosphere, p-toluenesulfonylamide (8.56 g, 50.0 mmol, 
1.00 equiv) and benzaldehyde (5.30 g, 10.0 mmol, 1.00 equiv) were combined.  Ethanol (25 
mL) and magnesium sulfate (10 g) were added and the mixture stirred for 15 h.  The mixture 
was then filtered, and the solvent removed under reduced pressure to give the crude imine, 
which was recrystallized twice from refluxing ethanol to yield the pure aldimine.  The 
compounds were then further dried over 4 Å MS in THF, dried in vacuo and ground before 
use.  
Colourless solid 
Yield: 7.30 g (56%). 
Mp: 113.5–114.0 oC (Lit.: 112–114 oC). 
1H NMR (500 MHz, CDCl3): δ = 9.03 (s, 1H), 7.93 (d, J = 8.5 Hz, 2H), 7.89 (d, J = 8.5 Hz, 2H), 
7.62 (t, J = 7.5 Hz, 1H), 7.49 (t, J = 7.5 Hz, 2H), 7.35 (d, J = 7.5 Hz, 2H), 2.44 (s, 3H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 170.1, 144.6, 135.1, 134.9, 132.4, 131.3 (2C), 129.8 (2C), 
129.2 (2C), 128.1 (2C), 21.7 ppm.   
IR (neat):  = 3071, 1595, 1318, 1153, 1086, 781, 638 cm–1.   




To a solution of pyrrole-2-carboxaldehyde (951 mg, 10.0 mmol, 1.00 equiv) in DCM (50 ml) 




mmol, 0.05 equiv), and triethylamine (1.01 g, 10.0 mmol, 1.00 equiv).  The reaction was stirred 
for 1 h at ambient temperature.  The solution was washed with water (10 ml) followed by HCl 
(3 x 10 ml, 20%).  The organic layer was separated and washed with brine (25 ml) dried over 
magnesium sulfate and the solvent removed in vacuo.   
Pale brown liquid 
Yield: 1.90 g (97%). 
1H NMR (500 MHz, CDCl3): δ = 10.23 (s, 1H), 7.65–7.61 (m, 1H), 7.39–7.35 (m, 1H), 6.59–
6.54 (m, 1H), 1.62 (s, 9H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 184.8, 147.1, 131.9, 124.8, 123.0, 113.8, 84.1, 22.8 (3C) 
ppm.   



















3.2.5 Products of the indole coupling.  




25 was prepared according to general procedure II using indole (23.4 mg, 0.20 mmol, 1.00 
equiv), phenyl imine (36.2 mg, 0.20 mmol, 1.00 equiv) in the presence of KHMDS (4.00 mg, 
0.01 mmol, 10 mol%) and CuOTf•tol (10.90 mg, 0.01 mmol, 10 mol%) inTHF (200 µL, 1 M), 
at 30 oC for 15 h.  25 was purified by PTLC on silica gel (EtOAc/NEt3/PE = 9:1:90; eluted twice) 
Pale pink solid. 
Mp: 68.5‒70.0 oC 
Yield: 21.5 mg, (36%). 
1H NMR (500 MHz, CDCl3): δ = 8.02 (s, 1H), 7.63–7.60 (m, 1H), 7.57–7.51 (m, 2H), 7.44–7.34 
(m, 4H), 7.27–7.22 (m, 1H), 7.17–7.11 (m, 3H), 6.85–6.76 (m, 1H), 6.73–6.70 (m, 1H), 6.63 
(s, 1H), 6.62 (s, 1H), 5.86 (s, 1H) 4.40 (br s, 1H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 143.9, 136.5, 128.3 (2C), 128.0 (2C), 127.1, 126.1 (2C), 
126.0, 123.4, 121.7 (2C), 119.8 (2C), 119.4, 119.2 (2C), 110.9, 110.7, 40.0 ppm. 
IR (neat):  = 3406, 3080, 1599, 1454, 1314, 1093, 870, 733 cm–1. 
HRMS (ESI): calculated for C21H18N2+ = [M+]: m/z = 298.1465, found: m/z = 298.1478.   
 
3, 3’-bisindolyl(phenyl)methane(24) 228 
 
 
24 was prepared according to general procedure II using indole (23.4 mg, 0.20 mmol, 1.00 
equiv), phenyl imine (36.2 mg, 0.20 mmol, 1.00 equiv) in the presence of KHMDS (4.00 mg, 
0.01 mmol, 10 mol%) and CuOTf•tol (10.90 mg, 0.01 mmol, 10 mol%) inTHF (200 µL, 1 M), 
at 30 oC for 15 h.  24 was purified by PTLC on silica gel (EtOAc/NEt3/PE = 9:1:90; eluted twice) 
Pink solid. 
Yield: 25.0 mg, (38%). 
1H NMR (500 MHz, CDCl3): δ = 7.90 (s, 2H), 7.43 (dq, J = 7.9, 0.9 Hz, 2H), 7.41–7.36 (m, 3H), 
7.34–7.28 (m, 3H), 7.27–7.22 (m, 1H), 7.20 (ddd, J = 8.2, 7.0, 1.2 Hz, 2H), 7.04 (ddd, J = 8.0, 




13C NMR (125 MHz, CDCl3): δ = 147.9, 142.9, 136.8, 129.3 (2C), 128.7 (2C), 127.4 (2C), 126.2 
(2C), 123.6, 122.5 (2C), 120.0, 119.5 (2C), 119.0, 117.5, 115.3, 113.5, 111.6, 55.9 ppm. 
IR (neat):  = 3406, 3055, 2918, 1599, 1491, 1454, 1416, 1240, 1091, 792 cm–1. 





71 was prepared according to general procedure IV using indole (23.4 mg, 0.20 mmol, 1.00 
equiv), o-anisidine (49.3 mg, 0.40 mmol, 2.00 equiv) and benzaldehyde (42.9 mg, 0.40 mmol, 
2.00 equiv), in the presence of Li2CO3 (1.50 mg, 0.01 mmol, 5 mol%), CuCl (1.90 mg, 0.01 
mmol, 5 mol%), NaBF4 (2.20 mg, 0.01 mmol, 5 mol%) as the catalyst components, in 2-MeTHF 
(200 µL, 1 M), at 30 oC for 15 h.  71 was purified by PTLC on silica gel (EtOAc/NEt3/PE = 
9:1:90; eluted twice). 
Colourless solid. 
Yield: 61.4 mg, (92%). 
Mp: 133‒134 oC 
1H NMR (500 MHz, CDCl3): δ = 8.01 (br s, 1H), 7.63 (d, J = 8.9 Hz, 1H), 7.54 (d, J = 7.1 Hz, 
1H), 7.42–7.35 (m, 2H), 7.33–7.27 (m, 2H), 7.24 (ddd, J = 8.2, 7.1, 1.2 Hz, 1H), 7.13 (ddd, J 
= 8.0, 7.1, 1.0 Hz, 1H), 6.88–6.83 (m, 2H), 6.82 (d, J = 1.4 Hz, 1H), 6.79 (td, J = 7.7, 1.4 Hz, 
1H), 6.69 (td, J = 7.7, 1.6 Hz, 1H), 6.56 (dd, J = 7.9, 1.5 Hz, 1H), 5.85 (s, 1H), 4.99 (s, 1H), 
3.84 (s, 3H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 146.78, 142.88, 137.64, 136.64, 128.50 (2C), 127.33 (2C), 
127.08, 126.19, 123.30, 122.32, 121.18, 119.75, 119.54, 119.21, 116.45, 111.21, 111.10, 
109.35, 55.61, 55.42 ppm. 
IR (neat):  = 3381, 3059, 1599, 1506, 1221, 1123, 1028, 731 cm–1. 




2-((2-methoxyphenyl)-4-fluorobenzylidene) indole (74) 
 
74 was prepared according to general procedure IV using indole (23.4 mg, 0.20 mmol, 1.00 
equiv), o-anisidine (49.3 mg, 0.40 mmol, 2.00 equiv) and p-fluorobenzaldehyde (49.6 mg, 0.40 
mmol, 2.00 equiv), in the presence of Li2CO3 (1.50 mg, 0.01 mmol, 5 mol%), CuCl (1.90 mg, 
0.01 mmol, 5 mol%), NaBF4 (2.20 mg, 0.01 mmol, 5 mol%) as the catalyst components, in 2-
MeTHF (200 µL, 1 M), at 30 oC for 15 h.  74 was purified by PTLC on silica gel (EtOAc/NEt3/PE 
= 9:1:90; eluted thrice). 
Tan solid  
Yield: 60.3 mg, (88%). 
Mp: 89‒90 oC 
1H NMR (500 MHz, CDCl3): δ = 8.02 (br s, 1H), 7.59 (d, J = 8.0, 0.9 Hz, 1H), 7.56–7.46 (m, 
2H), 7.40 (dt, J = 8.2, 0.8 Hz, 1H), 7.24 (ddt, J = 8.1, 7.1, 1.1 Hz, 1H), 7.12 ddd (J = 8.0, 7.1, 
1.0 Hz, 1H), 7.07–7.02 (m, 2H), 6.84–6.75 (m, 3H), 6.70 (td, J = 7.7, 1.6 Hz, 1H), 6.52 (dd, J 
= 7.9, 1.4 Hz, 1H), 5.83 (s, 1H), 4.96 (br s, 1H), 3.84 (s, 3H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 163.0 (d, J = 244.8 Hz), 146.8, 138.6, 137.4, 136.7, 128.8 (d, 
J = 8.0 Hz, 2C), 123.2, 124.4, 121.2, 119.8, 119.5, 119.1, 118.5, 116.7, 115.3 (d, J = 21.4 Hz, 
2C), 111.2, 111.1, 109.4, 55.4, 55.0 ppm. 
19F NMR (470 MHz, CDCl3): δ = -116.0 (ap. tt, J = 8.7, 5.3 Hz) ppm. 
IR (neat):  = 3431, 3379, 2927, 2360, 1600, 1504, 1221, 1123, 736 cm-1 
HRMS (EI): calculated for C22H19FNO2Na+ = [M+Na+]: m/z = 369.1374, found: m/z = 369.1363. 
 
2-((2-methoxyphenyl)-4-chlorobenzylidene) indole (75) 
 
 
75 was prepared according to general procedure IV using indole (23.4 mg, 0.20 mmol, 1.00 
equiv), o-anisidine (49.3 mg, 0.40 mmol, 2.00 equiv) and p-chlorobenzaldehyde (56.2 mg, 
0.40 mmol, 2.00 equiv), in the presence of Li2CO3 (1.50 mg, 0.01 mmol, 5 mol%), CuCl (1.90 




in 2-MeTHF (200 µL, 1 M), at 30 oC for 62 h.  75 was purified by PTLC on silica gel (EtOAc/PE 
= 10:90; eluted thrice). 
Colourless solid. 
Yield: 56.4 mg, (78%). 
1H NMR (500 MHz, CDCl3): δ = 8.03 (s, 1H), 7.57 (d, J = 8.0 Hz, 1H), 7.46–7.42 (m, 2H), 7.37 
(d, J = 8.2 Hz, 1H), 7.31–7.28 (m, 2H), 7.21 (td, J = 7.6, 1.1 Hz, 1H), 7.09 (ddd, J = 8.0, 7.1, 
0.9 Hz, 1H), 6.81–6.78 (m, 2H), 6.75 (td, J = 7.7, 1.4 Hz, 1H), 6.69–6.64 (m, 1H), 6.46 (dd, J 
= 7.8, 1.5 Hz, 1H), 5.78 (s, 1H), 4.92 (br s, 1H), 3.80 (s, 3H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 146.8, 141.5, 137.4, 136.6, 132.7, 128.7 (4C), 126.0, 123.3, 
122.5, 121.2, 119.9, 119.4, 118.8, 116.8, 111.3, 111.1, 109.4, 55.4, 55.0 ppm. 
IR (neat):  = 3412, 2916, 2361, 1601, 1508, 1221, 907, 731 cm–1. 
HRMS (ESI): calculated for C22H19ClN2ONa+ = [M+]: m/z = 385.1078, found: m/z = 385.1097.   
 
2-((2-methoxyphenyl)-4-bromobenzylidene) indole (76) 
 
 
76 was prepared according to general procedure IV using indole (23.4 mg, 0.20 mmol, 1.00 
equiv), o-anisidine (49.3 mg, 0.40 mmol, 2.00 equiv) and p-bromobenzaldehyde (74.0 mg, 
0.40 mmol, 2.00 equiv), in the presence of Li2CO3 (1.50 mg, 0.01 mmol, 5 mol%), CuCl (1.90 
mg, 0.01 mmol, 5 mol%), NaBF4 (2.20 mg, 0.01 mmol, 5 mol%) as the catalyst components, 
in 2-MeTHF (200 µL, 1 M), at 30 oC for 15 h.  76 was purified by PTLC on silica gel (EtOAc 
/PE = 20:80; eluted thrice). 
Colourless solid. 
Yield: 66.8 mg, (82%). 
1H NMR (500 MHz, CDCl3): δ = 8.05 (s, 1H), 7.60 (dq, J = 8.0, 1.0 Hz, 1H), 7.52–7.45 (m, 2H), 
7.45–7.37 (m, 3H), 7.24 (ddd, J = 8.3, 7.1, 1.2 Hz, 1H), 7.12 (ddd, J = 8.0, 7.0, 1.0 Hz, 1H), 
6.86–6.74 (m, 3H), 6.69 (td, J = 7.7, 1.6 Hz, 1H), 6.49 (dd, J = 7.9, 1.5 Hz, 1H), 5.79 (s, 1H), 
4.95 (s, 1H), 3.83 (s, 3H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 192.4, 146.8, 142.3, 140.1, 137.3, 129.7, 128.8 (2C), 127.4, 
127.3, 126.1, 125.3, 124.9, 122.4, 121.2, 121.1, 116.9, 111.9, 111.2, 109.4, 55.5, 55.4 ppm. 
IR (neat):  = 3412, 2926, 2363, 1599, 1508, 1223, 1009, 737 cm–1. 
HRMS (ESI): calculated for C22H19BrN2ONa+ = [M+Na+]: m/z = 429.0573, found: m/z = 








77 was prepared according to general procedure IV using indole (23.4 mg, 0.20 mmol, 1.00 
equiv), o-anisidine (49.3 mg, 0.40 mmol, 2.00 equiv) and p-trifluoromethylbenzaldehyde (69.6 
mg, 0.40 mmol, 2.00 equiv), in the presence of Li2CO3 (1.50 mg, 0.01 mmol, 5 mol%), CuCl 
(1.90 mg, 0.01 mmol, 5 mol%), NaBF4 (2.20 mg, 0.01 mmol, 5 mol%) as the catalyst 
components, in 2-MeTHF (200 µL, 1 M), at 30 oC for 15 h.  77 was purified by PTLC on silica 
gel (EtOAc/PE = 1:5; eluted twice). 
Colourless solid. 
Yield: 59.2 mg, (75%). 
1H NMR (500 MHz, CDCl3): δ = 8.03 (br s, 1H), 7.65–7.61 (m, 2H), 7.61–7.56 (m, 3H), 7.39–
7.36 (m, 1H), 7.24–7.20 (m, 1H), 7.11 (ddd, J = 8.0, 7.1, 0.9 Hz, 1H), 6.81–6.74 (m, 3H), 6.68 
(td, J = 7.6, 1.6 Hz, 1H), 6.43 (dd, J = 7.8, 1.5 Hz, 1H), 5.86 (s, 1H), 4.97 (br s, 1H), 3.81 (s, 
3H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 146.9, 142.4, 138.0, 137.4, 128.4 (2C), 127.4, 127.3 (2C), 
125.5, 125.4 (q, J = 271.0 Hz), 125.0, 122.3 (q, J = 31.8 Hz), 121.1, 120.2, 119.2 (q, J = 3.5 
Hz), 117.3 (q, J = 4.3 Hz), 116.9, 111.5, 111.3, 109.5, 55.6, 55.4 ppm. 
19F NMR (470 MHz, CDCl3): δ = -62.29 ppm 
IR (neat):  = 3410, 2916, 1600, 1508, 1323, 1123, 739 cm–1. 
HRMS (ESI): calculated for C23H19F3N2ONa+ = [M+Na+]: m/z = 419.1342, found: m/z = 
419.1349.   
 
2-((2-methoxyphenyl)-2-methylbenzylidene) indole (72) 
 
 
72 was prepared according to general procedure IV using indole (23.4 mg, 0.20 mmol, 1.00 
equiv), o-anisidine (49.3 mg, 0.40 mmol, 2.00 equiv) and o-tolualdehyde (48.1 mg, 0.40 mmol, 
2.00 equiv), in the presence of Li2CO3 (1.50 mg, 0.01 mmol, 5 mol%), CuCl (1.90 mg, 0.01 




(200 µL, 1 M), at 30 oC for 15 h.  72 was purified by PTLC on silica gel (EtOAc/PE = 20:80; 
eluted twice). 
Tan solid. 
Yield: 60.5 mg, (88%). 
1H NMR (500 MHz, CDCl3): δ = 8.01 (s, 1H), 7.62 (dd, J = 8.0, 1.0 Hz, 1H), 7.60–7.55 (m, 1H), 
7.40 (dt, J = 8.2, 0.9 Hz, 1H), 7.28–7.18 (m, 4H), 7.13 (ddd, J = 8.0, 7.1, 1.0 Hz, 1H), 6.88–
6.80 (m, 2H), 6.72 (dd, J = 2.5, 0.9 Hz, 1H), 6.67 (td, J = 7.7, 1.6 Hz, 1H), 6.43 (dd, J = 7.9, 
1.5 Hz, 1H), 5.99 (s, 1H), 4.91 (s, 1H), 3.84 (s, 3H), 2.37 (d, J = 0.6 Hz, 3H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 146.7, 140.4, 137.6, 136.7, 135.8, 130.5, 126.9, 126.6, 126.5, 
126.2, 123.8, 122.3, 121.2, 119.7, 119.4, 118.0, 116.3, 111.2, 110.7, 109.4, 55.4, 52.0, 19.1 
ppm. 
IR (neat):  = 3410, 3059, 2916, 1599, 1506, 1456, 1221, 1026, 735 cm–1. 
HRMS (ESI): calculated for C23H22N2ONa+ = [M+Na+]: m/z = 365.1624, found: m/z = 365.1600.   
 




73 was prepared according to general procedure IV using indole (23.4 mg, 0.20 mmol, 1.00 
equiv), o-anisidine (49.3 mg, 0.40 mmol, 2.00 equiv) and p-methylbenzaldehyde (48.0 mg, 
0.40 mmol, 2.00 equiv), in the presence of Li2CO3 (1.50 mg, 0.01 mmol, 5 mol%), CuCl (1.90 
mg, 0.01 mmol, 5 mol%), NaBF4 (2.20 mg, 0.01 mmol, 5 mol%) as the catalyst components, 
in 2-MeTHF (200 µL, 1 M), at 30 oC for 15 h.  73 was purified by PTLC on silica gel (EtOAc/PE 
= 10:90; eluted twice). 
Colourless solid. 
Yield: 48.4 mg, (71%). 
1H NMR (500 MHz, CDCl3): δ = 7.98 (br s, 1H), 7.58 (d, J = 7.9 Hz, 1H), 7.40–7.32 (m, 3H), 
7.19 (t, J = 8.0 Hz, 1H), 7.13 (d, J = 7.9 Hz, 2H), 7.10–7.05 (m, 1H), 6.84 (s, 1H), 6.81–6.70 
(m, 2H), 6.63 (td, J = 7.7, 1.6 Hz, 1H), 6.52 (dd, J = 7.9, 1.6 Hz, 1H), 5.79 (s, 1H), 4.92 (br s, 
1H), 3.80 (s, 3H), 2.33 (s, 3H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 146.7, 139.9, 137.7, 136.7, 136.6, 129.2 (2C), 127.2 (2C), 
126.2, 123.2, 122.3, 121.2, 119.7, 119.6, 119.3, 116.3, 111.2, 111.1, 109.3, 55.4, 29.7, 21.1 
ppm. 
IR (neat):  = 3412, 2916, 2849, 1599, 1508, 1221, 907, 738 cm–1. 








87 was prepared according to general procedure IV using indole (23.4 mg, 0.20 mmol, 1.00 
equiv), o-anisidine (49.3 mg, 0.40 mmol, 2.00 equiv) and tert-butylaldehyde (34.4 mg, 0.40 
mmol, 2.00 equiv), in the presence of Li2CO3 (1.50 mg, 0.01 mmol, 5 mol%), CuCl (1.90 mg, 
0.01 mmol, 5 mol%), NaBF4 (2.20 mg, 0.01 mmol, 5 mol%) as the catalyst components, in 2-
MeTHF (200 µL, 1 M), at 30 oC for 15 h.  87 was purified by PTLC on silica gel (EtOAc/PE = 
10:90; eluted twice). 
Colourless oil. 
Yield: 41.2 mg, (67%). 
1H NMR (500 MHz, CDCl3): δ = 8.03 (br s, 1H), 7.78 (d, J = 7.7 Hz, 1H), 7.36 (d, J = 7.4 Hz, 
1H), 7.23–7.12 (m, 2H), 7.10 (d, J = 2.4 Hz, 1H), 6.89–6.77 (m, 1H), 6.61 (t, J = 7.6 Hz, 1H), 
6.57–6.48 (m, 1H), 6.33 (d, J = 9.4 Hz, 1H), 4.44 (s, 1H), 3.91 (s, 3H), 3.90 (br s, 1H), 1.11 (s, 
9H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 146.8, 138.2, 128.0, 122.9, 121.5, 121.3 (2C), 119.8, 
119.3 (2C), 117.1, 115.6 (2C), 111.1, 110.6, 109.1, 59.9, 55.4, 36.0, 29.7, 27.2 ppm. 
IR (neat):  = 3416, 2916, 2849, 1614, 1506, 1223, 908, 735 cm–1. 











106 was prepared according to general procedure IV using 6-methylindole (26.2 mg, 0.20 
mmol, 1.00 equiv), o-anisidine (49.3 mg, 0.40 mmol, 2.00 equiv) and benzaldehyde (42.2 mg, 
0.40 mmol, 2.00 equiv), in the presence of Li2CO3 (1.50 mg, 0.01 mmol, 5 mol%), CuCl (1.90 
mg, 0.01 mmol, 5 mol%), NaBF4 (2.20 mg, 0.01 mmol, 5 mol%) as the catalyst components, 
in 2-MeTHF (200 µL, 1 M), at 30 oC for 22 h.  106 was purified by PTLC on silica gel (EtOAc/PE 
= 1:90; eluted twice). 
Colourless solid. 
Yield: 58.8 mg (81%). 
1H NMR (500 MHz, CDCl3): δ = 7.87 (br s, 1H), 7.49 (d, J = 7.2 Hz, 2H), 7.46 (d, J = 8.0 Hz, 
1H), 7.35–7.30 (m, 2H), 7.26–7.23 (m, 1H), 7.16 (s, 1H), 6.92 (dd, J = 8.1, 1.0 Hz, 1H), 6.79–
6.71 (m, 3H), 6.66–6.61 (m, 1H), 6.50 (dd, J = 7.8, 1.5 Hz, 1H), 5.78 (s, 1H), 4.94 (br s, 1H), 
3.80 (s, 3H), 2.45 (s, 3H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 146.8, 142.9, 137.7, 137.1, 132.2, 128.4 (2C), 127.3 (2C), 
127.0, 124.0, 122.6, 121.5, 121.1, 119.2, 119.1, 116.3, 111.1, 111.1, 109.3, 55.6, 55.4, 21.7 
ppm. 
IR (neat):  = 3414, 2916, 2849, 2359, 1601, 1508, 1223, 907, 729 cm–1. 






108 was prepared according to general procedure IV using 6-fluoroindole (27.0 mg, 0.20 
mmol, 1.00 equiv), o-anisidine (49.3 mg, 0.40 mmol, 2.00 equiv) and benzaldehyde (42.9 mg, 
0.40 mmol, 2.00 equiv), in the presence of Li2CO3 (1.50 mg, 0.01 mmol, 5 mol%), CuCl (1.90 




in 2-MeTHF (200 µL, 1 M), at 30 oC for 24 h.  108 was purified by PTLC on silica gel 
(EtOAc/NEt3/PE = 9:1:90; eluted thrice). 
Light brown solid. 
Yield: 53.2 mg (77%). 
1H NMR (500 MHz, CDCl3): δ = 7.99 (br s, 1H), 7.55–7.48 (m, 3H), 7.41–7.34 (m, 2H), 7.33–
7.29 (m, 1H), 7.05 (dd, J = 9.5, 2.2 Hz, 1H), 6.88 (ddd, J = 9.6, 8.8, 2.3 Hz, 1H), 6.85–6.78 
(m, 2H), 6.73–6.69 (m, 1H), 6.56 (dd, J = 7.8, 1.5 Hz, 1H), 5.83 (d, J = 4.1 Hz, 1H), 4.97 (br s, 
1H), 3.85 (s, 3H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 160.1 (d, J = 237.9 Hz), 146.8, 142.7, 137.5, 136.6 (d, J = 
12.5 Hz), 128.6 (2C), 127.3 (2C), 127.2, 123.5 (d, J = 3.5 Hz), 122.8, 121.2, 120.3 (d, J = 10.0 
Hz), 119.3, 116.6, 111.1, 109.4, 108.5 (d, J = 24.4 Hz), 97.5 (d, J = 25.9 Hz), 55.6, 55.5 ppm. 
19F NMR (470 MHz, CDCl3): δ = -120.70 ppm 
IR (neat):  = 3412, 3063, 2916, 1599, 1508, 1242, 906, 733 cm–1. 






109 was prepared according to general procedure IV using 5-bromoindole (39.2 mg, 0.20 
mmol, 1.00 equiv), o-anisidine (49.3 mg, 0.40 mmol, 2.00 equiv) and benzaldehyde (42.5 mg, 
0.40 mmol, 2.00 equiv), in the presence of Li2CO3 (1.50 mg, 0.01 mmol, 5 mol%), CuCl (1.90 
mg, 0.01 mmol, 5 mol%), NaBF4 (2.20 mg, 0.01 mmol, 5 mol%) as the catalyst components, 
in 2-MeTHF (200 µL, 1 M), at 30 oC for 15 h.  109 was purified by PTLC on silica gel 
(EtOAc/NEt3/PE = 9:1:90; eluted thrice). 
Pale brown solid 
Yield: 51.2 mg (63%). 
Mp: 163–165 oC 
1H NMR (500 MHz, CDCl3): δ = 8.01 (br s, 1H), 7.74 (d, J = 1.9 Hz, 1H), 7.51–7.47 (m, 2H), 
7.37–7.35 (m, 2H), 7.33–7.28 (m, 2H), 7.21 (dd, J = 8.6, 0.4 Hz, 1H), 6.85–6.80 (m, 2H), 6.79–
6.75 (m, 1H), 6.72–6.67 (m, 1H), 6.53 (dd, J = 7.9, 1.5 Hz, 1H), 5.78 (s, 1H), 4.92 (br s, 1H), 
3.86 (s, 3H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 146.9, 142.5, 137.5, 135.3, 128.7 (2C), 127.9, 127.3, 127.3 
(2C), 125.3, 124.5, 122.1, 121.2, 118.9, 116.8, 113.1, 112.7, 111.3, 109.5, 55.5, 55.4 ppm. 




HRMS (ESI): calculated for C22H19ON2BrNa+ = [M+Na+]: m/z = 429.0570, found: m/z = 






117 was prepared according to general procedure IV using 5-nitroindole (32.4 mg, 0.20 mmol, 
1.00 equiv), o-anisidine (49.3 mg, 0.40 mmol, 2.00 equiv) and benzaldehyde (42.4 mg, 0.40 
mmol, 2.00 equiv), in the presence of Li2CO3 (1.50 mg, 0.01 mmol, 5 mol%), CuCl (1.90 mg, 
0.01 mmol, 5 mol%), NaBF4 (2.20 mg, 0.01 mmol, 5 mol%) as the catalyst components, in 2-
MeTHF (200 µL, 1 M), at 30 oC for 39 h.  117 was purified by PTLC on silica gel (EtOAc/PE = 
20:90; eluted twice). 
Pale yellow solid. 
Yield: 55.0 mg (74%). 
Mp: 139‒140 oC 
1H NMR (500 MHz, CDCl3): δ = 8.53 (d, J = 2.2 Hz, 1H), 8.43 (br s, 1H), 8.10 (dd, J = 9.0, 2.1 
Hz, 1H), 7.50–7.45 (m, 2H), 7.39–7.33 (m, 3H), 7.31–7.27 (m, 1H), 7.07–7.04 (m, 1H), 6.83–
6.78 (m, 1H), 6.77–6.72 (m, 1H), 6.71–6.66 (m, 1H), 6.51 (dd, J = 7.8, 1.5 Hz, 1H), 5.84 (s, 
1H), 4.90 (s, 1H), 3.83 (s, 3H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 146.9, 142.1, 141.9, 139.7, 137.2, 128.8 (2C), 127.6, 127.3 
(2C), 126.2, 125.5, 121.6, 121.2, 118.1, 117.1, 116.9, 111.3, 111.3, 109.5, 55.6, 55.5 ppm. 
IR (neat):  = 3381.2, 2916, 2849, 1601, 1508, 1329, 1221, 1026, 733 cm–1. 
HRMS (ESI): calculated for C22H19O3N3Na+ = [M+Na+]: m/z = 396.1319, found: m/z = 






114 was prepared according to general procedure IV using 5-cyanoindole (28.4 mg, 0.20 
mmol, 1.00 equiv), o-anisidine (49.3 mg, 0.40 mmol, 2.00 equiv) and benzaldehyde (42.9 mg, 




mg, 0.01 mmol, 5 mol%), NaBF4 (2.20 mg, 0.01 mmol, 5 mol%) as the catalyst components, 
in 2-MeTHF (200 µL, 1 M), at 30 oC for 15 h.  114 was purified by PTLC on silica gel (EtOAc/PE 
= 1:9; eluted twice). 
Colourless solid 
Yield: 62.5 mg (89%). 
1H NMR (500 MHz, CDCl3): δ = 8.44 (br s, 1H), 7.94–7.88 (m, 1H), 7.48–7.42 (m, 2H), 7.42–
7.37 (m, 2H), 7.34 (t, J = 7.4 Hz, 2H), 7.30–7.26 (m, 1H), 6.98 (dd, J = 2.4, 0.8 Hz,1H), 6.80 
(dd, J = 7.9, 1.4 Hz,1H), 6.77–6.72 (m, 1H), 6.68 (td, J = 7.7, 1.7 Hz, 1H), 6.50 (dd, J = 7.7, 
1.5 Hz, 1H), 5.78 (d, J = 4.7 Hz, 1H), 4.87 (d, J = 4.8 Hz, 1H), 3.82 (m, 3H) ppm.  
13C NMR (125 MHz, CDCl3): δ 146.8, 142.1, 138.4, 137.2, 128.8 (2C), 127.6, 127.3 (2C), 
125.9, 125.4, 125.3, 125.3, 121.2, 120.6, 120.1, 117.1, 112.1, 111.2, 109.5, 103.0, 55.6, 55.5 
ppm.   
IR (neat):  = 3331, 2916, 2849, 2220, 1514, 1275, 1227, 908, 731 cm–1.   






112 was prepared according to general procedure IV using 5-trifluoromethylindole (37.0 mg, 
0.20 mmol, 1.00 equiv), o-anisidine (49.3 mg, 0.40 mmol, 2.00 equiv) and benzaldehyde (42.4 
mg, 0.40 mmol, 2.00 equiv), in the presence of Li2CO3 (1.50 mg, 0.01 mmol, 5 mol%), CuCl 
(1.90 mg, 0.01 mmol, 5 mol%), NaBF4 (2.20 mg, 0.01 mmol, 5 mol%) as the catalyst 
components, in 2-MeTHF (200 µL, 1 M), at 30 oC for 43 h.  112 was purified by PTLC on silica 
gel (EtOAc/PE = 1:5; eluted thrice). 
Colourless oil. 
Yield: 64.8 mg (82%). 
1H NMR (500 MHz, CDCl3): δ = 8.19 (br s, 1H), 7.87 (s, 1H), 7.52–7.46 (m, 2H), 7.44–7.41 (m, 
2H), 7.38–7.33 (m, 2H), 7.31–7.26 (m, 1H), 6.93 (dd, J = 2.4, 0.9 Hz, 1H), 6.80 (dd, J = 7.9, 
1.3 Hz, 1H), 6.74 (ap. td, J = 7.6, 1.4 Hz, 1H), 6.67 (ap. td, J = 7.6, 1.6 Hz, 1H), 6.51 (dd, J = 
7.9, 1.5 Hz, 1H), 5.82 (s, 1H), 4.93 (br s, 1H), 3.82 (s, 3H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 146.9, 142.4, 138.0, 137.4, 128.7 (2C), 127.4, 127.3 (2C), 
125.6 (q, J = 271.8 Hz), 125.5, 125.0, 122.1 (q, J = 31.9 Hz, 2C), 121.1, 120.2, 119.1 (q, J = 
3.3 Hz), 117.3 (q, J = 4.0 Hz), 116.9, 111.5, 111.3, 109.4, 55.6, 55.4 ppm. 




IR (neat):  = 3408, 2916, 2849, 1601, 1508, 1326, 1221, 1113, 736.8 cm–1. 






118 was prepared according to general procedure IV using 6-fluoro-7-methylindole (29.8 mg, 
0.20 mmol, 1.00 equiv), o-anisidine (49.3 mg, 0.40 mmol, 2.00 equiv) and benzaldehyde (42.4 
mg, 0.40 mmol, 2.00 equiv), in the presence of Li2CO3 (1.50 mg, 0.01 mmol, 5 mol%), CuCl 
(1.90 mg, 0.01 mmol, 5 mol%), NaBF4 (2.20 mg, 0.01 mmol, 5 mol%) as the catalyst 
components, in 2-MeTHF (200 µL, 1 M), at 30 oC for 15 h.  118 was purified by PTLC on silica 
gel (EtOAc/PE = 1:5; eluted twice). 
Pale tan solid. 
Yield: 63.7 mg (88%). 
1H NMR (500 MHz, CDCl3): δ = 7.86 (br s, 1H), 7.49–7.45 (m, 2H), 7.35–7.29 (m, 3H), 7.27–
7.24 (m, 1H), 6.84–6.07 (m, 4H), 6.65 (td, J = 7.7, 1.6 Hz, 1H), 6.50 (dd, J = 7.9, 1.5 Hz, 1H), 
5.76 (s, 1H), 4.90 (br s, 1H), 3.80 (s, 3H), 2.35 (s, 3H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 157.7 (d, J = 236.4 Hz), 146.7, 142.7, 137.6, 136.7 (d, J = 
9.5 Hz), 128.5, 127.3, 127.1, 123.2 (d, J = 3.0 Hz), 122.1, 119.8, 118.5, 117.4 (d, J = 10.0 Hz), 
116.5, 115.0, 111.1, 110.5, 109.3, 108.6 (d, J = 25.4 Hz), 106.4 (d, J = 21.9 Hz), 55.6, 55.4, 
8.8 (d, J = 4.5 Hz) ppm. 
19F NMR (470 MHz, CDCl3): δ = ‒62.50 ppm. 
IR (neat):  = 3418, 2916, 2849, 1601, 1504, 1221, 907, 729 cm–1. 
HRMS (ESI): calculated for C23H21ON2FNa+ = [M+Na+]: m/z = 383.1527, found: m/z = 










111 was prepared according to general procedure IV using 5-iodoindole (48.6 mg, 0.20 mmol, 
1.00 equiv), o-anisidine (49.3 mg, 0.40 mmol, 2.00 equiv) and benzaldehyde (42.5 mg, 0.40 
mmol, 2.00 equiv), in the presence of Li2CO3 (1.50 mg, 0.01 mmol, 5 mol%), CuCl (1.90 mg, 
0.01 mmol, 5 mol%), NaBF4 (2.20 mg, 0.01 mmol, 5 mol%) as the catalyst components, in 2-
MeTHF (200 µL, 1 M), at 30 oC for 15 h.  111 was purified by PTLC on silica gel 
(EtOAc/NEt3/PE = 9:1:90; eluted thrice) 
Brown solid  
Yield: 64.4 mg (71%). 
1H NMR (500 MHz, CDCl3): δ = 8.03 (br s, 1H), 7.97–7.94 (m, 1H), 7.50–7.46 (m, 3H), 7.39–
7.35 (m, 2H), 7.33–7.30 (m, 1H), 7.15 (d, J = 8.5 Hz, 1H), 6.84 (dd, J = 7.8, 1.4 Hz, 1H), 6.80–
6.75 (m, 2H), 6.74–6.68 (m, 1H), 6.53 (dd, J = 7.8, 1.5 Hz, 1H), 5.78 (d, J = 4.2 Hz, 1H), 4.93 
(d, J = 4.3 Hz, 1H), 3.87 (s, 3H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 146.9, 142.5, 137.5, 135.7, 130.8, 128.7, 128.6 (2C), 128.3, 
127.3 (2C), 127.3, 124.1, 121.2, 118.6, 116.8, 113.2, 111.3, 109.5, 83.4, 55.5 ppm. 
IR (neat):  = 3416, 2928, 2245, 1506, 1221, 1026, 905, 726 cm–1. 
HRMS (ESI): calculated for C22H19ON2INa+ = [M+Na+]: m/z = 477.0434, found: m/z = 






115 was prepared according to general procedure IV using 5-formylindole (29.0 mg, 0.20 
mmol, 1.00 equiv), o-anisidine (49.3 mg, 0.40 mmol, 2.00 equiv) and benzaldehyde (42.4 mg, 
0.40 mmol, 2.00 equiv), in the presence of Li2CO3 (1.50 mg, 0.01 mmol, 5 mol%), CuCl (1.90 
mg, 0.01 mmol, 5 mol%), NaBF4 (2.20 mg, 0.01 mmol, 5 mol%) as the catalyst components, 
in 2-MeTHF (200 µL, 1 M), at 30 oC for 15 h.  115 was purified by PTLC on silica gel (EtOAc/ 





Yield: 61.2 mg (86%). 
1H NMR (500 MHz, CDCl3): δ = 9.99 (s, 1H), 8.42–8.29 (m, 1H), 8.24–8.08 (m, 1H), 7.81 (dd, 
J = 8.5, 1.6 Hz, 1H), 7.55–7.50 (m, 2H), 7.47 (dt, J = 8.5, 0.7 Hz, 1H), 7.41–7.35 (m, 2H), 7.32 
(d, J = 7.3 Hz, 1H), 6.99 (dd, J = 2.5, 1.0 Hz, 1H), 6.83 (dd, J = 7.9, 1.4 Hz, 1H), 6.78 (td, J = 
7.6, 1.4 Hz, 1H), 6.70 (td, J = 7.7, 1.6 Hz, 1H), 6.55 (dd, J = 7.8, 1.6 Hz, 1H), 5.90 (s, 1H), 
4.97 (s, 1H), 3.85 (s, 3H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 192.4, 146.8, 142.3, 140.1, 137.3, 129.7, 128.7 (2C), 127.4, 
127.3 (2C), 126.1, 125.3, 124.9, 122.4, 121.2, 121.1, 116.9, 111.9, 111.2, 109.4, 55.5, 55.4 
ppm. 
IR (neat):  = 3383, 2916, 2359, 1670, 1508, 1175, 733 cm–1. 
HRMS (ESI): calculated for C23H20N2O2Na+ = [M+Na+]: m/z = 379.1417, found: m/z = 







3.3 Conjugate addition with CDP  
3.3.1 General Procedures 
Solvent screening – conjugate addition (general procedure I) 
In a nitrogen glove box, a dry screw-capped vial with a magnetic stirrer bar was charged with CDP (2.10 
mg, 4.00 mol, 1.00 mol%), Michael acceptor (39.6 mg, 400 mol, 1.00 equiv), solvent (750 L) and 
MeCN (45.0 L, 2.00 equiv).  The reaction mixture was stirred at 40 oC for 3 h.  The internal standard, 
dibenzyl ether, was added prior to 1H NMR spectroscopic analysis of an aliquot of the reaction mixture.  
Base screening – conjugate addition (general procedure II) 
In a nitrogen glove box, a dry screw-capped vial with a magnetic stirrer bar was charged with base (4.00 
mol, 1 mol%), dimethylacrylamide (39.6 mg, 400 mmol, 1.00 equiv), MeCN (800 μL).  The reaction 
mixture was stirred at 40 oC for 3 h.  The internal standard, dibenzyl ether, was added prior to 1H NMR 
spectroscopic analysis of an aliquot of the reaction mixture.  
Alkyl carbene control experiments – conjugate addition (general procedure III) 
In a nitrogen glove box, a dry screw-capped vial with a magnetic stirrer bar was charged with KHMDS 
(1.60 mg, 8.00 mol, 1.00 mol%), carbene salt (12.0 mol, 1.20 mol%) and MeCN (400 L) and stirred 
at 40 oC for 24 h. Dimethylacrylamide (39.6 mg, 400 mol, 1.00 equiv), and MeCN (400 L) were added 
and the solution stirred at 40 oC for 3 h.  The internal standard, dibenzyl ether, was added prior to 1H 
NMR analysis of an aliquot of the reaction mixture.  
Aryl carbene control experiments – conjugate addition (general procedure IV) 
In a nitrogen glove box, a dry screw-capped vial with a magnetic stirrer bar was charged with KHMDS 
(1.60 mg, 8.00 mol, 1.00 mol%), carbene salt (12.0 mol, 1.20 mol%) and MeCN (400 L) and stirred 
at 40 oC for 1 h. Dimethylacrylamide (39.6 mg, 400 mol, 1.00 equiv), and MeCN (400 L) were added 
and the solution stirred at 40 oC for 3 h.  The internal standard, dibenzyl ether, was added prior to 1H 
NMR analysis of an aliquot of the reaction mixture.  
Substrate screen – conjugate addition (general procedure V) 
In a nitrogen glove box, a dry screw-capped vial with a magnetic stirrer bar was charged with CDP (2.20 
mg, 5.00 μmol, 10.0 mol%), amide (100 or 50 mol, 1.00 equiv), and alkyl nitrile (100-200 L).  The 
reaction mixture was stirred at the specified temperature for the specified time.  The internal standard, 
dibenzyl ether, was added prior to 1H NMR analysis of an aliquot of the reaction mixture.  For reactions 





3.3.1 Preparation of catalysts 
 
1-Chloro-methylenebis(triphenylphosphonium) chloride (158)141  
 
To a solution of triphenylphosphine (26.2 g, 100 mmol, 1.50 equiv) in DCM (50 mL) 
tetrachloromethane (6.43 mL, 66.7 mmol) was added dropwise at room temperature.  The 
mixture was stirred for 26 h upon which the solution changed colour from yellow to brown and 
a white precipitate formed.  1,2-epoxybutane (5.80 mL, 66.7 mmol, 1.00 equiv) was added 
while ensuring that the temperature did not rise above 20 °C.  The white precipitate dissolved 
and ether (50 mL) was added dropwise until a precipitate formed. The product was crystallised 
at 0 °C and was then filtered, washed with DCM (2 x 2 mL) and Et2O (2 x 2 mL) and 
recrystallised from DCM and Et2O. 
Colourless solid  
Yield: 12.4 g (31%). 
1H NMR (500 MHz, CDCl3): δ = 7.68–7.61 (m, 6H), 7.61–7.53 (m, 12H), 7.53–7.43 (m, 12H) 
ppm.  
13C NMR (125 MHz, CDCl3): δ = 134.0 (6C), 133.8 (t, J = 5.0 Hz, 12C), 129.7 (t, J = 6.2 Hz, 
12C), 123.2 (d, J = 94.3 Hz, 6C), 123.1 (dd, J = 76.0, 74.5 Hz) ppm.   
31P NMR (220 MHz, CDCl3): δ = 25.8 ppm.   




In a nitrogen filled glovebox 1-chloro-methylenebis(triphenylphosphonium) chloride (1.60 g, 
2.64 mmol, 1.00 equiv) was suspended in benzene (6 mL) and tris(dimethylamino) phosphine 
(0.43 g, 2.64 mmol, 1.00 equiv) added.  The mixture was stirred for 24 h at 25 oC.  The solution 
was heated and held at reflux for 5 min before being filtered through a G4 sintered frit.  The 
hot solution was cooled slowly and crystallised spontaneously.  The crystals were filtered and 
washed with benzene (1 mL).  After a second recrystallization from benzene the crystals were 
crushed and dried in vacuo.  The compound was stored in a nitrogen glovebox.   
Yellow solid  
Yield: 1.05 g (75%). 
Mp: 214 – 215 oC 




13C NMR (125 MHz, CDCl3): δ = 137.9 (pent, J = 48.3 Hz), 132.3 (t, J = 5.4 Hz, 6C), 129.1 
(12C), 128.3 (12C), 128.1 (6C) ppm.   
31P NMR (220 MHz, CDCl3): δ = ‒4.1 ppm.   
IR (neat):  = 1464, 1431, 1094, 752, 691 cm–1.   
HRMS (EI): calculated for C37H30P2+ = [M+]: m/z = 536.1739, found: m/z = 536.1739.  
 
N,N'-bis(2,4,6-trimethylphenyl)ethanediimine (328) 229 
 
To an oven dried flask was added 1,3,5-trimethylaniline (31.9 mL, 169 mmol, 2.00 equiv) 
methanol (85 mL) and the solution was stirred for 5 min.  Glyoxal (9.7 mL, 84.6 mmol, 40% in 
water, 1.00 equiv) was added followed by formic acid (0.2 ml).  After 10 min a yellow solid 
precipitated.  Additional methanol was added (85 mL) to facilitate stirring.  The mixture was 
left stirring for 24 hours at room temperature.  The suspension was filtered under vacuum and 
the precipitate was washed with methanol (3 x 20 mL).  The volatiles were removed in vacuo 
to afford product 328.  
Yellow solid  
Yield: 23.5 g (76%). 
Melting point: 214–215 oC 
1H NMR (500 MHz, CDCl3): δ = 8.31 (s, 2H), 6.94 (s, 4H), 2.23 (s, 6H), 2.19 (s, 12H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 163.5 (4C), 147.4 (2C), 134.2 (2C), 129.0 (4C), 126.5 (2C), 
20.8 (2C), 18.2 (4C) ppm.   
 
2,6-bis(mesityl)imidazolium chloride (176-BF4)230 
 
Under an atmosphere of argon N,N'-bis(2,4,6-trimethylphenyl)ethanediimine (17.2 g, 58.5 
mmol, 1.00 equiv), was dissolved in ethyl acetate (120 mL).  Paraformaldehyde (1.92 g, 64.0 
mmol, 1.10 equiv), and HCl (4 M in dioxane, 177 mmol, 3.00 equiv) were added and stirred at 
25 oC for 20 h.  The colourless precipitate was filtered and the ethyl acetate solution was dried 




water (170 ml) and tetrafluroboric acid (4.04 mL, 28.2 mmol, 1.1 equiv) was added.  Extraction 
with DCM (200 mL) drying over magnesium sulfate and drying in vacuo afforded a pale brown 
solid.  This solid was dissolved in the minimum amount of DCM and precipitated with Et2O.  
After filtration the product was dried in vacuo.  
Yield: 6.9 g (68%) 
1H NMR (500 MHz, CDCl3): δ = 8.92 (s, 1H), 7.58 (s, 2H), 7.07 (s, 4H), 2.38 (s, 6H), 2.15 (s, 
12H) ppm. 
13C NMR (500 MHz, CDCl3): δ = 138.9, 137.0 (2C), 135.2 (4C), 128.9 (4C), 128.0 (2C), 120.3 
(2C), 20.7 (2C), 17.8 (4C) ppm. 
11B NMR (160 MHz, CDCl3): δ = -1.25 ppm. 




Under an atmosphere of argon 1,3-bis(mesityl)imidazolium chloride (2.00 g, 5.00 mmol, 1.00 
equiv) was dissolved in THF (20 mL) and sodium hydride (240 mg, 10.0 mmol, 2.00 equiv) 
added followed by a catalytic quantity of KOtBu (~20 mg).  The mixture was stirred for 15 h 
filtered through a G4 sintered frit and concentrated to half the original volume.  Pentane (10 
mL) was precipitating a colourless solid which was collected by suction filtration.  The solid 
was dried in vacuo and stored under argon at -20 oC.  
Yield: 1.25 g (82%) 
1H NMR (500 MHz, CDCl3): δ = 6.81 (s, 4H), 6.48 (s, 2H), 2.16 (s, 18H) ppm. 
13C NMR (500 MHz, CDCl3): δ = 138.9, 137.0 (2C), 135.2 (4C), 128.9 (2C), 120.3 (4C), 20.7 
(2C), 17.8 (6C) ppm. 













To a solution of 2, 6 diisopropylaniline (7.09 g, 40.0 mmol, 2.00 equiv) in methanol (50 ml) 
was added glyoxal (20 mmol, 40% aq), 1.00 equiv).  Formic acid (3 drops) was added and the 
solution stirred for 5 h.  The bright yellow precipitate formed was filtered and washed with 
methanol (3 x 50 ml) and dried in vacuo to constant weight.  
Yield: 6.80 g (90%) 
1H NMR (500 MHz, CDCl3): δ = 8.13 (s, 2H), 7.24–7.17 (m, 6H), 2.97 (sept, J = 6.9 Hz, 4H), 
1.24 (d, J = 6.9 Hz, 24H) ppm. 
13C NMR (500 MHz, CDCl3): δ = 163.1 (2C), 148.0 (2C), 136.7 (4C), 125.1 (2C), 123.2 (4C), 
28.1 (4C), 23.4 (8C) ppm. 
 
2,6-bis(diisopropylphenyl)imidazolium chloride (177-Cl)  
 
To a stirred solution of 329 (6.8 g, 18.0 mmol, 1 equiv) in ethyl acetate (160 ml) was added 
paraformaldehyde (560 mg, 18.7 mmol, 1.04 equiv) followed by trimethylsilyl chloride (2.4 ml, 
19 mmol, 1.05 equiv) under an argon atmosphere. The solution was heated to 70 oC and 
maintained at this temperature for 3 h. The mixture was cooled to ambient whereupon the 
product crystallises from solution. The solid was filtered and washed with ethyl acetate (3 x 
100 ml) and dried in vacuo.   
Yield: 6.60 g (87%) 
1H NMR (500 MHz, CDCl3): δ = 10.14 (s, 1H), 8.15 (s, 2H), 7.59 (t, J = 7.8 Hz, 2H), 7.36 (d, J 
= 7.8 Hz, 4H), 2.47 (sept, J = 6.8 Hz, 4H), 1.31 (d, J = 6.8 Hz, 12H), 1.26 (d, J = 6.8 Hz, 12H) 
ppm. 
13C NMR (500 MHz, CDCl3): δ = 163.1 (2C), 148.0 (2C), 136.7 (4C), 125.1 (2C), 123.2 (4C), 







2,6-bis(diisopropylphenyl)imidazolium tetrafluoroborate (177-BF4)  
 
To a stirred solution of 177-Cl (6.60 g, 17.00 mmol, 1 equiv) in water (250 ml) was added HBF4 
(4.30 g, 18.7 mmol, 1.10 equiv, 38% aq) and the mixture was stirred at ambient for 30 minutes.  
DCM (50 ml) was added and the organic layer separated.  Diethyl ether (~50 ml) was added 
to precipitate a colourless solid which was filtered under vacuum and washed with diethyl ether 
(2 x 20 ml).  The colourless solid was dried under in vacuo.    
Yield: 6.60 g (87%) 
1H NMR (500 MHz, CDCl3): δ = 10.14 (s, 1H), 8.15 (s, 2H), 7.59 (t, J = 7.8 Hz, 2H), 7.36 (d, J 
= 7.8 Hz, 4H), 2.47 (sept, J = 6.8 Hz, 4H), 1.31 (d, J = 6.8 Hz, 12H), 1.26 (d, J = 6.8 Hz, 12H) 
ppm. 
13C NMR (500 MHz, CDCl3): δ = 163.1 (2C), 148.0 (2C), 136.7 (4C), 125.1 (2C), 123.2 (4C), 
28.1 (4C), 23.4 (8C) ppm. 
11B NMR (160 MHz, CDCl3): δ = -1.25 ppm. 




Under an atmosphere of argon 1,3-bis(diisopropyl)imidazolium chloride (2.55 g, 5.00 mmol, 
1.00 equiv) was dissolved in THF (20 mL) and sodium hydride (240 mg, 10.0 mmol, 2.00 
equiv) added followed by a catalytic quantity of KOtBu (~20 mg).  The mixture was stirred for 
15 h filtered through a G4 sintered frit and concentrated to half the original volume.  Pentane 
(10 mL) was precipitating a colourless solid which was collected by suction filtration.  The solid 
was dried in vacuo and stored under argon at -20 oC.  
Yield: 1.41 g (73%) 
1H NMR (500 MHz, CDCl3): δ = 7.29 (t, J = 7.3 Hz, 2H), 7.18 (d, J = 7.3 Hz, 4H), 6.62 (s, 2H), 
2.96 (sept, J = 6.9 Hz, 4H), 1.28 (d, J = 6.9 Hz, 12H), 1.19 (d, J = 6.9 Hz, 12H) ppm. 
13C NMR (500 MHz, CDCl3): δ = 146.0 (4C), 138.7, 128.8 (2C), 128.1 (2C), 123. 4 (4C), 121.3 













3.3.2 Unsubstituted amide starting materials  
N, N Diphenylacrylamide (330)231 
 
To a solution of acryloyl chloride (2.00 g, 22.1 mmol, 1.00 equiv) in DCM (20 mL) was added 
diphenylamine (3.40 g, 22.1 mmol, 1.00 equiv) dissolved in DCM (10 mL) cautiously.  The 
brown solution was stirred for 14 h and water (20 ml) added.  The organic layer was separated 
and the aqueous washed with DCM (2 x 25 ml) and dried over magnesium sulfate.  Removal 
of the solvent in vacuo afforded a tar which was refluxed in methanol (10 ml) and cooled to -
20 oC whereupon the titled compound crystalised as colourless needle crystals, which were 
dried over molecular sieves (4 Å) in THF at room temperature for 18 h in a glovebox.  After 
filtration, the solvent was removed in vacuo, and the liquid dried in high vacuum before use in 
catalysis.   
Colourless solid  
Yield: 650 mg (15%). 
Mp: 78–79 oC  
1H NMR (500 MHz, CDCl3): δ = 7.46–7.32 (m, 4H), 7.28–7.14 (m, 6H), 6.47 (dd, J = 16.8, 1.9 
Hz, 1H), 6.19 (dd, J = 16.8, 10.3 Hz, 1H), 5.62 (dd, J = 10.3, 1.9 Hz, 1H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 165.7, 142.5 (2C), 129.6 (4C), 129.3 (2C), 128.5, 128.4 (4C), 
126.9 ppm.   
IR (neat):  = 3096, 1663, 1491, 1406, 1261, 993, 766, 697 cm–1.   





To a stirred solution of acryloyl chloride (2.00 ml, 24.8 mmol, 1.00 equiv) in DCM (20 
ml) at ambient temperature under an argon atmosphere was added N, O-
dimethylhydroxylamine hydrochloride (2.90 g, 29.8 mmol, 1.20 equiv) and sodium 
bicarbonate (5.20 g, 62.0 mmol, 2.50 equiv) and the suspension stirred for 3 h.  To the 
solution was added HCl (20 ml, 1M) and the organic layer separated and washed with 




organic fractions were dried over MgSO4, filtered, and the solvents were removed in 
vacuo.  Distillation under reduced pressure afforded 331 as a colourless solution, 
which was dried over molecular sieves (4 Å) in THF at room temperature for 18 h in a 
glovebox.  After filtration, the solvent was removed in vacuo, and the liquid dried in 
high vacuum before use in catalysis.   
Colourless liquid 
Yield: 2.10 g (74%). 
Bp: 62–64 oC (20 mbar) 
1H NMR (500 MHz, CDCl3): δ = 6.73 (dd, J = 17.1, 10.4 Hz, 1H), 6.43 (dd, J = 17.1, 2.0 Hz, 
1H), 5.75 (dd, J = 10.4, 2.0 Hz, 1H), 3.71 (s, 3H), 3.26 (s, 3H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 166.5, 129.0, 126.0, 61.8, 32.3 ppm.   
IR (neat):  = 2968, 2940, 1655, 1620, 1419, 1179, 995, 787 cm–1.   










To a solution of methacryloyl chloride (1.61 g, 15.0 mmol, 1.50 equiv), diphenylamine (1.69 g, 
10.0 mmol , 1.00 equiv) in toluene (15 ml).  The crude was recrystalised using diethyl ether 
yielding a colourless solid which was dried over molecular sieves (4 Å) in THF at room 
temperature for 18 h in a glovebox.  After filtration, the solvent was removed in vacuo, and the 
solid ground and dried in high vacuum before use in catalysis. 
Colourless solid. 
Yield: 1.60 mg (50%). 
Mp: 102–103 oC (Lit.: 102–103 oC).234 
1H NMR (500 MHz, CDCl3): δ = 7.38–7.29 (m, 4H), 7.25–7.19 (m, 2H), 7.19–7.12 (m, 4H), 
5.23 (s, 1H), 5.17 (s, 1H), 1.84 (s, 3H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 171.86, 143.52, 141.22, 129.1 (4C), 127.2 (4C), 126.5 (2C), 
120.9 (2C), 19.9 ppm. 
IR (neat):  = 3067, 2945, 1655, 1589, 1489, 1339, 1229, 945, 71 cm–1. 
HRMS (EI): calculated for C16H15NO+ = [M+]: m/z = 237.1148, found: m/z =237.1158.   
 
2-Phenylacrylic acid ethyl ester (333)235 
 
 
To a solution of ethyl phenylacetate (3.20 ml, 20.0 mmol, 1.00 equiv) in DMF (90 ml) was 
added potassium carbonate (2.80 g, 20.0 mmol, 1.00 equiv) and formaldehyde (2.30 ml, 28.4 
mmol, 1.42 equiv, 37% aq) and the solution heated to 110 oC for 3 h.  The solution was cooled 
to ambient and water (200 ml) was added and the solution extracted with diethylether (3 x 100 
ml).  The combined organic fractions were washed with HCl (3 x 100 ml, 6M) and dried over 
magnesium sulfate and the solvent dried in vacuo yielding a pale yellow solid which was used 





Yield: 1.84 g (54%).  
1H NMR (500 MHz, CDCl3): δ = 7.46–7.42 (m, 2H), 7.39–7.34 (m, 3H), 6.37 (d, J = 1.3 Hz, 
1H), 5.91 (d, J = 1.3 Hz, 1H), 4.32 (q, J = 7.2 Hz, 2H), 1.36 (t, J = 7.2 Hz, 3H) ppm.  
 
2-Phenylacrylic acid (334)236 
 
 
2-Formyl ethyl phenylacetate (1.76 g, 10.0 mmol, 1.00 equiv) was refluxed in in lye 
(20 ml, 1 M aq) for 13 h.  The solution was washed with diethylether (2 x 20 ml) and 
acidified with HCl (20 ml, 3M aq).  The aqueous solution was extracted with 
diethylether (2 x 40 ml) dried over magnesium sulfate and the solvent removed in 
vacuo affording the titled compound.  
Waxy colourless solid. 
Yield: 800 mg (56%).  
1H NMR (500 MHz, CDCl3): δ = 7.50–7.43 (m, 2H), 7.42–7.35 (m, 3H), 6.57 (s, 1H), 6.05 (s, 
1H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 171.3, 140.5, 136.1, 129.3, 128.4 (2C), 128.4, 128.2 (2C) 
ppm.   





3.3.4 β-substitued Michael amides  
 
(E)-N, N-Dimethyl-3-phenylacrylamide (355)237 
 
 
To a stirred solution of trans-cinnamic acid (1.48 g, 10.0 mmol, 1.00 equiv) in DCM (25 ml) at 
ambient temperature under an argon atmosphere was added thionyl chloride (2.38 g, 20.0 
mmol, 2.00 equiv) and the solution stirred for 4 h.  The solvent and excess thionyl chloride 
was removed in vacuo affording a colourless solid which was dissolved in toluene (20 ml).  
Dimethylammonium chloride (735 mg, 9.00 mmol, 0.90) was added followed by pyridine (1.57 
g, 20.0 mmol, 2.00 equiv) and the reaction stirred for 15 h.  Water (20 ml) was added and the 
mixture was extracted with DCM (3 x 20 ml) and washed with NaHCO3 (20 ml, sat. aq.).  The 
combined organic fractions were dried over MgSO4, filtered, and the solvents were removed 
in vacuo.  Recrystallisation from methanol afforded 355 as a colourless solid, which was dried 
over molecular sieves (4 Å) in THF at room temperature for 18 h in a glovebox.  After filtration, 
the solvent was removed in vacuo, and the solid ground and dried in high vacuum before use 
in catalysis.   
Colourless solid  
Yield: 1.25 g (71%).  
Mp: 94–95 oC (Lit.: 94–96 oC).238 
1H NMR (500 MHz, CDCl3): δ = 7.67 (d, J = 15.4 Hz, 1H), 7.53 (d, J = 7.3 Hz, 2H), 7.43–7.30 
(m, 3H), 6.89 (d, J = 15.4 Hz, 1H), 3.17 (s, 3H), 3.07 (s, 3H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 166.7, 142.3, 135.4, 129.5, 128.8 (2C), 127.8 (2C), 117.5, 
37.4, 35.9 ppm.   
IR (neat):  = 3078, 2930, 2359, 1651, 1599, 1396, 1140, 995, 767 cm–1.   




To a solution of cinamoyl chloride (1.12 g, 6.70 mmol, 1.00 equiv) in DCM (10 ml) was added 




bought to reflux and maintained for 4 h.  Water (10 ml) was added and the biphasic mixture 
extracted with ethyl acetate (3 x 10 ml).  The combined organic fractions were dried over 
MgSO4 and the solvent removed under reduced pressure affording the crude product.  
Recrystallisation from isopropanol afforded the titled compound as colourless prismatic 
crystals which were dried over molecular sieves in diethylether.  Ether was removed under 
reduced pressure and the solid ground and further dried in vacuo before use. 
Colourless solid  
Yield: 1.38 g, (69%). 
Melting point: 153–154 oC 
1H NMR (500 MHz, CDCl3): δ = 7.80 (d, J = 15.5 Hz, 1H), 7.43–7.37 (m, 6H), 7.32–7.28 (m, 
9H), 6.51 (d, J = 15.5 Hz, 1H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 166.2, 142.8, 142.6 (2C), 135.1, 129.7, 129.3 (4C), 128.8 
(2C), 128.0 (2C), 126.9 (br, 6C), 119.8 ppm. 
IR (neat): 3662, 3005, 2937, 2864, 1658, 1487, 1448, 1352, 1255, 761, 569 cm-1 
HRMS (EI): calculated for C21H17O1N + = [M+]: m/z = 299.1301, found: m/z = 299.1304. 
 
(E)-N, N-diphenyl-2-butenamide (337)240 
 
 
To a stirred solution of trans-crotonic acid (3.44 g, 40.0 mmol, 1.00 equiv) in DCM (30 ml) at 
ambient temperature under an argon atmosphere was added thionyl chloride (4.76 g, 40.0 
mmol, 1.00 equiv) and the solution stirred for 15 h.  Diphenyl amide (6.09 g, 36.0 mmol, 0.90 
equiv) was added followed by triethylamine (5.02 ml, 36.0 mmol, 0.90 equiv) dropwise and the 
mixture stirred for an additional 6 h.  The solution was washed with K2CO3 (3 x 20 ml sat. aq.) 
followed by brine (20 ml).  The combined organic fractions were dried over MgSO4, filtered, 
and the solvents were removed in vacuo.  Recrystalisation from ethanol afforded 292 as tan 
prismatic crystals, which were dried over molecular sieves (4 Å) in THF at room temperature 
for 18 h in a glovebox.  After filtration, the solvent was removed in vacuo, and the liquid dried 
in high vacuum before use in catalysis.   
Tan solid  
Yield: 1.70 g (18%). 




1H NMR (500 MHz, CDCl3): δ = 7.40–7.31 (m, 4H), 7.28–7.20 (m, 6H), 7.03 (dq, J = 15.1, 6.9 
Hz, 1H), 5.87 (dq, J = 15.1, 1.7 Hz, 1H), 1.79 (dd, J = 6.9, 1.7 Hz, 3H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 166.1, 142.9 (2C), 142.4 (4C), 129.2 (2C), 127.7, 126.7, 123.9 
(4C), 18.1 ppm.   
IR (neat):  = 3059, 2357, 1665, 1489, 1344, 1251, 637 cm–1.   





To a stirred solution of chloroacetylchloride (16.9 g, 150 mmol, 1.00 equiv) in toluene (200 ml) 
at ambient temperature under an argon atmosphere was added diphenylamine (25.4 g, 150 
mmol, 1.00 equiv).  The mixture was heated at 90 oC for 14 h after which the solvent was 
removed in vacuo. The oil formed was purified by column chromatography eluting DCM 
affording a pale liquid which solidified on standing.    
Colourless waxy solid 
Yield: 24.5 g (67%). 
1H NMR (500 MHz, CDCl3): δ = 7.54–7.38 (m, 4H), 7.38–7.20 (m, 6H), 4.05 (s, 2H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 166.2, 144.9 (2C), 129.2 (br 4C), 128.6 (br 4C), 126.1 (2C), 
42.7 ppm.   






To a stirred solution of 338 (24.5 g, 100 mmol, 1.00 equiv) in DMF (160 ml) at ambient 
temperature under an argon atmosphere was added triethylphosphite (25.7 ml, 150 mmol, 
1.50 equiv) and sodium iodide (1.50 g, 10.0 mmol, 0.10 equiv).  The mixture was heated at 
110 oC for 14 h and the solvent was removed in vacuo.  The tar was dissolved in ethyl acetate 
(200 ml) and activated charcoal (~2 spatulas) was added and stirred for 10 minutes before 
filtering through celite.  HCl (50 ml, 6M) was added and the organic layer separated and 
washed with additional HCl (2 x 50 ml, 6M).  The organic layer was dried over magnesium 




Colourless waxy solid 
Yield: 20.5 g (59%). 
1H NMR (500 MHz, CDCl3): δ = 7.49–7.16 (m, 10H), 4.23–4.15 (m, 4H), 3.07 (s, 1H), 3.02 (s, 
1H), 4.05 (s, 2H), 1.35 (t, J = 7.1 Hz, 6H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 165.2, 142.6 (d, J = 55.9 Hz), 129.9 (2C), 129.0 (2C), 128.8 
(2C), 128.2, 126.6 (2C), 62.6 (d, J = 6.5 Hz, 2C), 34.4 (d, J = 136.6 Hz), 16.4 (d, J = 6.5 Hz, 
2C) ppm.   
   
31P NMR (202 MHz, CDCl3): δ = 21.0 ppm 
IR (neat):  = 2980, 2924, 1655, 1491, 1348, 1246, 1020, 962, 694 cm–1.   
 
Trans-N,N-diphenyl-3-(thiophen-2-yl) acrylamide (340)243 
 
To a stirred solution of trans-2-thiopheneacrylic acid (1.54 g, 10.0 mmol, 1.00 equiv) in DCM 
(25 ml) at ambient temperature under an argon atmosphere was added thionyl chloride (2.38 
g, 20.0 mmol, 2.00 equiv) and the solution stirred for 4 h.  The solvent and excess thionyl 
chloride was removed in vacuo affording a tan solid which was dissolved in toluene (20 ml).  
Diphenylamine (1.69 g, 10.0 mmol, 1.00 equiv) was added followed by triethylamine (1.01 g, 
10.0 mmol, 1.00 equiv) and the reaction stirred for 15 h.  Water (20 ml) was added and the 
mixture was extracted with DCM (3 x 20 ml) and washed with brine (20 ml).  The combined 
organic fractions were dried over MgSO4, filtered, and the solvents were removed in vacuo.  
Recrystallisation from methanol afforded 340 as a colourless solid, which was dried over 
molecular sieves (4 Å) in THF at room temperature for 18 h in a glovebox.  After filtration, the 
solvent was removed in vacuo, and the solid ground and dried in high vacuum before use in 
catalysis.   
Colourless solid  
Yield: 2.90 g (95%). 
Mp: 158–160 oC  
1H NMR (500 MHz, CDCl3): δ = 7.86 (d, J = 15.2 Hz, 1H), 7.45–7.33 (m, 4H), 7.32–7.21 (m, 
7H), 7.16 (d, J = 3.5 Hz, 1H), 6.99 (dd, J = 4.9, 3.5 Hz, 1H), 6.27 (d, J = 15.2 Hz, 1H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 166.0, 142.8, 140.4, 135.2 (4C), 130.2 (4C), 129.3, 128.0 
(2C), 127.7 (2C), 126.9, 118.8 (2C) ppm.   
IR (neat):  = 3026, 1661, 1609, 1489, 1319, 1250, 995, 833, 754, 729 cm–1.   




(E)-N,N-diphenyl-3-(fur-2-yl) acrylamide (341)243 
 
To a stirred solution of trans-2-furylacrylic acid (1.38 g, 10.0 mmol, 1.00 equiv) in DCM (25 ml) 
at ambient temperature under an argon atmosphere was added thionyl chloride (2.38 g, 20.0 
mmol, 2.00 equiv) and the solution stirred for 4 h.  The solvent and excess thionyl chloride 
was removed in vacuo affording a tan solid which was dissolved in toluene (20 ml).  
Diphenylamine (1.69 g, 10.0 mmol, 1.00 equiv) was added followed by triethylamine (1.01 g, 
10.0 mmol, 1.00 equiv) and the reaction stirred for 15 h.  Water (20 ml) was added and the 
mixture was extracted with DCM (3 x 20 ml) and washed with brine (20 ml).  The combined 
organic fractions were dried over MgSO4, filtered, and the solvents were removed in vacuo.  
Recrystallisation from methanol afforded 341 as a colourless solid, which was dried over 
molecular sieves (4 Å) in THF at room temperature for 18 h in a glovebox.  After filtration, the 
solvent was removed in vacuo, and the solid ground and dried in high vacuum before use in 
catalysis.   
Colourless solid  
Yield: 2.64 g (91%). 
Mp: 179–180 oC (Lit.: 181.5 oC). 
1H NMR (500 MHz, CDCl3): δ = 7.53 (d, J = 15.3 Hz, 1H), 7.45–7.32 (m, 5H), 7.31–7.19 (m, 
6H), 6.53 (d, J = 3.3 Hz, 1H), 6.40 (dd, J = 3.3, 1.9 Hz, 1H), 6.37 (d, J = 15.3 Hz, 1H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 166.2, 151.6, 144.2 (4C), 142.8, 129.4 (4C), 129.2, 126.8, 
117.4 (2C), 114.2 (2C), 112.14 (2C) ppm.   
IR (neat):  = 3111, 1655, 1609, 1487, 1350, 1267, 708, 615 cm–1.   




To a stirred suspension of trans-3-(3-pyridyl)acrylic acid (1.00 g, 6.70 mmol, 1.00 equiv) in 
DCM (6 mL) at 0 oC under an argon atmosphere was added triethylamine (1.10 ml, 8.04 mmol, 




was warmed to ambient and stirred for 17 h.  The solvent was removed in vacuo and the solid 
redissolved in DCM (20 ml).  Diphenylamine (1.36 g, 8.04 mmol, 1.20 equiv) was added in 3 
portions over 15 minutes and stirred at ambient for 6 h.  The solvent was removed in vacuo 
and the crude solid purified by column chromatography eluting 10% EtOAc:Hexanes (rf = 0.1) 
yielding a pale yellow solid which was dried over molecular sieves (4 Å) in diethyl ether at 
room temperature for 18 h in a glovebox.  After filtration, the solvent was removed in vacuo, 
and the solid ground and dried in high vacuum before use in catalysis. 
Pale yellow solid. 
Yield: 750 mg (40%). 
Mp: 131–132 oC. 
1H NMR (500 MHz, CDCl3): δ = 8.61 (d, J = 2.1 Hz, 1H), 8.53 (dd, J = 4.8, 1.6 Hz, 1H), 7.74 
(d, J = 15.6 Hz, 1H), 7.61 (dt, J = 8.0, 1.6 Hz, 1H), 7.47–7.35 (m, 4H), 7.34–7.28 (m, 4H), 
7.28–7.26 (m, 2H), 7.24 (dd, J = 8.0, 4.8, Hz, 1H), 6.55 (d, J = 15.6 Hz, 1H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 165.5, 150.4, 149.4 (2C), 142.6, 138.9 (2C), 134.4 (4C), 
130.9, 129.4, 126.9, 126.5, 123.6 (2C), 121.9 (2C) ppm. 
IR (neat):  = 3053, 3030, 1659, 1614, 1487, 1344, 1252, 982, 754, 692 cm–1. 
HRMS (EI): calculated for C20H16N2O+ = [M+]: m/z = 300.1257, found: m/z =300.1268.   
 
(E)- N, N-diphenyl-3-pyridin4-yl-acrylamide (343) 
 
To a stirred slurry of sodium hydride (144 mg, 6.00 mmol, 1.20 equiv) in THF (20 ml) at 0 oC  
was added phosphonate 339 (1.74 g, 5.00 mmol, 1.00 equiv) in THF (10 ml).  The mixture 
was stirred for 1 h and 4-pyridyl carboxaldehyde (502 mg, 4.70 mmol, 0.95 equiv) in THF (10 
ml) was added.  The mixture was stirred for 15 h then ammonium chloride (10 ml, sat. aq.) 
and DCM (10 ml) was added and the organic layer separated, washed with brine (25 ml) dried 
over magnesium sulfate and the solvent removed in vacuo.  Recrystalisation from ethanol 
afforded 343 as colourless needle crystals, which were dried over molecular sieves (4 Å) in 
THF at room temperature for 18 h in a glovebox.  After filtration, the solvent was removed in 
vacuo, and the liquid dried in high vacuum before use in catalysis.   
Colourless solid  
Yield: 1.10 g (78%). 




1H NMR (500 MHz, CDCl3): δ = 8.58 (d, J = 6.1 Hz, 2H), 7.69 (d, J = 15.5 Hz, 1H), 7.52–7.35 
(m, 5H), 7.32–7.30 (m, 3H), 7.30–7.28 (m, 2H), 7.20 (d, J = 6.1 Hz, 2H), 6.65 (d, J = 15.5 Hz, 
1H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 165.2, 150.5 (4C), 142.4 (2C), 142.3, 139.6 (2C), 129.3 (2C), 
126.5 (2C), 124.3 (2C), 121.8 (4C), ppm.   
IR (neat):  = 3057, 1657, 1489, 1344, 1250, 991, 709 cm–1.   
HRMS (EI): calculated for C20H16ON2+ = [M+]: m/z = 300.1257, found: m/z = 300.1234.   
 
(E)-N, N-Diphenyl-3-[1-(Toluene-4-sulfonyl)-pyrrole-2-yl]prop-2-enamide (344) 
 
To a stirred slurry of sodium hydride (79.5 mg, 3.46 mmol, 1.20 equiv) in THF (10 ml) at -20 
oC under an argon atmosphere was added phosphonate 339 (1.00 g, 2.88 mmol, 1.00 equiv) 
and the solution stirred for 1 h.  The solution was warmed to 0 oC and 1-(4-tolylsulfonyl)pyrrole-
2-carboxaldehyde (683 mg, 2.74 mmol, 0.95 equiv) was added in THF (5 ml) and the solution 
warmed to ambient and stirred for 12 h.  Ammonium chloride (10 ml, sat. aq.) was added and 
the mixture was extracted with DCM (3 x 20 ml) and washed with brine (20 ml).  The combined 
organic fractions were dried over MgSO4, filtered, and the solvents were removed in vacuo.  
Recrystallisation from diethyl ether afforded 344 as a tan solid, which was dried over molecular 
sieves (4 Å) in THF at room temperature for 18 h in a glovebox.  After filtration, the solvent 
was removed in vacuo, and the solid ground and dried in high vacuum before use in catalysis.   
Colourless solid  
Yield: 620 mg (51%). 
Mp: 184–185 oC. 
1H NMR (500 MHz, CDCl3): δ = 8.10 (d, J = 15.3 Hz, 1H), 7.77 (dt, J = 8.4, 2.0 Hz, 2H), 7.43 
(dd, J = 3.2, 1.6 Hz, 1H), 7.38–7.32 (m, 4H), 7.30 (d, J = 8.4 Hz, 2H), 7.29–7.19 (m, 6H), 6.37–
6.33 (m, 1H), 6.22–6.20 (m, 1H), 6.19 (d, J = 15.3 Hz, 1H), 2.41 (s, 3H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 165.8, 145.3, 142.7 (2C), 135.7, 131.3, 130.2 (4C), 130.0, 
129.2, 127.5, 127.3 (4C), 126.8, 125.2 (2C), 119.4 (2C), 114.9 (2C), 112.1, 21.7 ppm.   
IR (neat):  = 3136, 3119, 2365, 1653, 1587, 1364, 1179, 671, 582 cm–1.   







1-Tosylindole-3-carboxaldehyde (345) 245 
 
 
To a solution of indole-3-carboxaldehyde (2.18 g, 15.0 mmol, 1.00 equiv) in DCM (30 ml) was 
added NEt3 (4.20 ml, 30.0 mmol, 2.00 equiv) and the mixture cooled to 0 oC.  Tosyl chloride 
(3.16 g, 16.6 mmol, 1.10 equiv) was added and the mixture stirred at ambient for 16 h.  The 
solution was washed with HCl (10% aq 3 x 20 ml), followed by brine (50 ml) and dried over 
sodium sulfate.  After filtration the solvent was removed under reduced pressure affording the 
titled compound.   
Dark red solid  
Yield 2.90 g (67%) 
1H NMR (500 MHz, CDCl3): δ = 10.11 (s, 1H), 8.28–8.25 (m, 2H), 7.97 (d, J = 8.3 Hz, 1H), 
7.87 (d, J = 8.3 Hz, 2H), 7.45–7.36 (m, 2H), 7.33–7.28 (m, 2H), 2.39 (s, 3H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 185.4, 146.2, 136.3, 135.3, 134.4, 130.3 (2C), 127.3 (2C), 
126.3, 126.3, 125.1, 122.6, 122.3, 113.3, 21.7 ppm.   
IR (neat):  = 3132, 2849, 1663, 1368, 1161, 1126, 968, 758, 658 cm–1.   
 




To a stirred slurry of sodium hydride (79.5 mg, 3.46 mmol, 1.20 equiv) in THF (10 ml) at -20 
oC under an argon atmosphere was added phosphonate 339 (1.00 g, 2.88 mmol, 1.00 equiv) 
and the solution stirred for 1 h.  The solution was warmed to 0 oC and 1-(4-tolylsulfonyl)indole-
3-carboxaldehyde (818 mg, 2.74 mmol, 0.95 equiv) was added in THF ( 5 ml) and the solution 
warmed to ambient and stirred for 12 h. Ammonium chloride (10 ml, sat. aq.) was added and 
the mixture was extracted with DCM (3 x 20 ml) and washed with brine (20 ml).  The combined 
organic fractions were dried over MgSO4, filtered, and the solvents were removed in vacuo.  




sieves (4 Å) in THF at room temperature for 18 h in a glovebox.  After filtration, the solvent 
was removed in vacuo, and the solid ground and dried in high vacuum before use in catalysis.   
Tan solid  
Yield: 580 mg (43%). 
Mp: 190–191 oC  
1H NMR (500 MHz, CDCl3): δ = 7.96 (d, J = 8.4 Hz, 1H), 7.85 (d, J = 15.6 Hz, 1H), 7.75 (d, J 
= 8.4 Hz, 2H), 7.72 (s, 1H), 7.51–7.35 (m, 4H), 7.35–7.24 (m, 8H), 7.22 (d, J = 8.1 Hz, 2H), 
7.22 (t, J = 7.5 Hz, 1H), 6.57 (d, J = 15.6 Hz, 1H), 2.33 (s, 3H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 166.2, 145.4, 142.8 (2C), 135.6, 134.8, 133.5 (2C), 130.0 
(4C), 129.3, 128.3, 127.9, 126.9 (4C), 125.3 (2C), 123.9 (2C), 120.3 (2C), 120.2 (2C), 118.9, 
113.8, 21.6 ppm.   
IR (neat):  = 3138, 3061, 2359, 1661, 1359, 1173, 1130, 980, 681 cm–1.   
HRMS (EI): calculated for C30H24O3N232S+ = [M+]: m/z = 492.1502, found: m/z = 492.1505.  
 
Carbonyl dipyrrole (347)246 
 
To a solution of pyrrole (4.40 ml, 64.4 mmol, 3.00 equiv) was added 1, 1’ carbonyldiimidazole 
(3.47 g, 21.4 mmol, 1.00 equiv) and the suspension heated to 130 oC and stirred under 
nitrogen for 90 minutes before cooling. The black solution was dried in vacuo to a black tar.  
The residue was dissolved in EtOAc (50 ml), activated carbon (1 spatula) added and the 
mixture heated to reflux for 5 minutes before filtering through celite and washed with EtOAc 
(3 x 100 ml).  The filtrate was washed with HCL (2 x 50 ml, 1 M) and brine (50 ml).  The 
combined organic fractions were dried over MgSO4, filtered, and the solvents were removed 
in vacuo.  
Tan solid.  
Yield: 1.98 g (56%). 
1H NMR (500 MHz, CDCl3): δ = 7.33 (t, J = 2.4 Hz, 4H), 6.39 (t, J = 2.4 Hz, 4H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 148.0, 122.0 (4C), 113.3 (4C) ppm.   










To a solution of methyltriphenylphosphonium bromide (12.9 g, 36.0 mmol, 3.00 equiv) in THF 
(36 ml) at 0 oC was added nBuLi (22.5 ml, 36.0 mmol, 3.00 equiv, 1.6 M) and the mixture stirred 
for 1 h.  After cooling to -78 oC carbonyldipyrrole (1.92 g, 12.0 mmol, 1.00 equiv) in THF (18 
ml) was added and the solution warmed to ambient over 15 h.  Water (50 ml) was added and 
the mixture extracted with a mix of ethyl acetate/DCM (5:1) (3 x 100 ml) and the combined 
organic fractions dried over magnesium sulfate and the solvent removed.  
Colourless solid 
Yield: 1.40 g (56%). 
1H NMR (500 MHz, CDCl3): δ = 7.78–7.67 (m, 6H), 7.64–7.57 (m, 3H), 7.55–7.47 (m, 6H), 
7.38 (t, J = 2.3 Hz, 2H), 6.21 (t, J = 2.3 Hz, 2H), 3.75 (d, J = 19.0 Hz, 1H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 165.6 (d, J = 10.0 Hz), 133.2 (d, J = 10.5 Hz, 6C), 132.2 (3C), 
131.9 (2C), 128.9 (d, J = 12.4 Hz, 6C) 126.75 (d, J = 92.3 Hz), 118.6 (2C), 109.5 (3C) ppm.   




To a stirred solution of pyrrolylmethylenetriphenylphosphorane (1.39 g, 6.50 mmol, 1.30 equiv) 
in toluene (15 ml) at ambient temperature under an argon atmosphere was added 
benzaldehyde (508 ml, 5.00 mmol, 1.00 equiv) and the mixture heated to reflux and stirred for 
48 h.  To the solution was added water (20 ml) and the organic layer separated and washed 
with brine (10 ml).  The combined organic fractions were dried over MgSO4, filtered, and the 
solvents were removed in vacuo.  Recrystalisation from methanol yielded a colourless solid 
which was dried over molecular sieves (4 Å) in THF at room temperature for 18 h in a glovebox.  
After filtration, the solvent was removed in vacuo, and the liquid dried in high vacuum before 
use in catalysis.   
Colourless solid 




Mp: 110–110.5 oC  
1H NMR (500 MHz, CDCl3): δ = 8.03 (d, J = 15.5 Hz, 1H), 7.69–7.63 (m, 2H), 7.50 (t, J = 2.4 
Hz, 2H), 7.48–7.47 (m, 3H), 7.18 (d, J = 15.5 Hz, 1H), 6.39 (d, J = 2.7 Hz, 2H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 163.0, 147.6 (2C), 134.3, 131.0, 129.1 (2C), 128.5 (2C), 
119.3, 115.8, 113.4 (2C) ppm.   
IR (neat):  = 3142, 1688, 1622, 1346, 1125, 738 cm–1.   
HRMS (EI): calculated for C13H11ON+ = [M+]: m/z = 197.0835, found: m/z = 197.0839.   
 
4-Fluorocinnamic acid-N, N-diphenylamide (350) 
 
 
To a stirred slurry of sodium hydride (144 mg, 6.00 mmol, 1.20 equiv) in THF (20 ml) at 0 oC 
was added phosphonate 339 (1.74 g, 5.00 mmol, 1.05 equiv) in THF (10 ml).  The mixture 
was stirred for 1 h and 4-fluorobenzaldehyde (596 mg, 4.70 mmol, 1.00 equiv) in THF (10 ml) 
was added.  The mixture was stirred for 15 h then ammonium chloride (10 ml, sat. aq.) and 
DCM (10 ml) was added and the organic layer separated, washed with brine (25 ml) dried over 
magnesium sulfate and the solvent removed in vacuo.  Recrystalisation from ethanol afforded 
350 as colourless needle crystals, which were dried over molecular sieves (4 Å) in THF at 
room temperature for 18 h in a glovebox.  After filtration, the solvent was removed in vacuo, 
and the liquid dried in high vacuum before use in catalysis.   
Colourless solid  
Yield: 1.05 g (70%). 
Mp: 180–181 oC  
1H NMR (500 MHz, CDCl3): δ = 7.72 (d, J = 15.5 Hz, 1H), 7.49–7.35 (m, 4H), 7.35–7.30 (m, 
3H) 7.30–7.21 (m, 5H), 6.99 (t, J = 8.6 Hz, 2H), 6.39 (d, J = 15.5 Hz, 1H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 166.0, 164.6, 162.6 (d, J = 250.5 Hz), 142.8 (2C), 141.4 (2C), 
131.4 (d, J = 3.5 Hz), 129.8 (2C), 129.7 (2C), 129.3 (2C), 126.9, 119.5 (d, J = 2.0 Hz, 2C), 
115.9 (2C), 115.8 (2C) ppm.   
19F NMR (470 MHz, CDCl3): δ = -110.50 ppm. 
IR (neat):  = 3067, 1661, 1487, 1354, 829, 696 cm–1.   





4-Bromocinnamic acid-N, N-diphenylamide (351) 
 
 
To a stirred slurry of sodium hydride (144 mg, 6.00 mmol, 1.28 equiv) in THF (20 ml) at 0 oC 
was added phosphonate 339 (1.74 g, 5.00 mmol, 1.06 equiv) in THF (10 ml).  The mixture 
was stirred for 1 h and 4-chlorobenzaldehyde (675 mg, 4.70 mmol, 1.00 equiv) in THF (10 ml) 
was added.  The mixture was stirred for 15 h then ammonium chloride (10 ml, sat. aq.) and 
DCM (10 ml) was added and the organic layer separated, washed with brine (25 ml) dried over 
magnesium sulfate and the solvent removed in vacuo.  Recrystalisation from ethanol afforded 
351 as colourless needle crystals, which were dried over molecular sieves (4 Å) in THF at 
room temperature for 18 h in a glovebox.  After filtration, the solvent was removed in vacuo, 
and the liquid dried in high vacuum before use in catalysis.   
Colourless solid  
Yield: 1.22 g (67%). 
Mp: 174–175 oC  
1H NMR (500 MHz, CDCl3): δ = 7.69 (d, J = 15.5 Hz, 1H), 7.43 (d, J = 8.5 Hz, 2H), 7.41– 7.34 
(m, 4H), 7.33–7.24 (m, 6H), 7.20 (d, J = 8.5 Hz, 2H), 6.46 (d, J = 15.5 Hz, 1H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 165.9, 142.7, 141.2 (2C), 134.0 (2C), 132.0 (4C), 129.4 (4C), 
127.0, 123.9 (2C), 120.5 (2C) ppm.   
IR (neat):  = 3707, 2967, 1659, 1487, 1346, 1007, 704 cm–1.   
HRMS (EI): calculated for C21H16ON79Br+ = [M+]: m/z = 377.0410, found: m/z = 377.0411.   
 
4-Methoxycinnamic acid-N, N-diphenylamide (352)239 
 
 
To a stirred solution of 4-methoxycinnamic acid (3.56 g, 20.0 mmol, 1.00 equiv) in 
DCM (20 ml) at ambient temperature under an argon atmosphere was added thionyl 
chloride (4.80 g, 40.0 mmol, 2.00 equiv) and the mixture stirred for 3 h at reflux.  The 
solvent and excess thionyl chloride were removed in vacuo and the solid redissolved 




equiv) and the mixture stirred for 15 h.  The solvent was removed in vacuo and the 
solid recrystalised from ethanol to afford a pale yellow solid which was dried over 
molecular sieves (4 Å) in THF at room temperature for 18 h in a glovebox.  After 
filtration, the solvent was removed in vacuo, and the solid dried in high vacuum before 
use in catalysis.   
Pale yellow solid 
Yield: 1.8 g (55%). 
Mp: 132–133 oC (Lit.: 94–96 oC). 
1H NMR (500 MHz, CDCl3): δ = 7.73 (d, J = 15.5 Hz, 1H), 7.44–7.33 (m, 4H), 7.32–7.20 (m, 
8H), 6.82 (d, J = 8.8 Hz, 2H), 6.35 (d, J = 15.5 Hz, 1H), 3.79 (s, 3H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 166.5, 161.0, 143.0 (2C), 142.3 (2C), 129.6 (4C), 129.2, 127.9 
(2C), 127.6, 126.7, 117.4 (2C), 114.2 (4C), 55.3 ppm.   
IR (neat):  = 3009, 2381, 1653, 1593, 1489, 1240, 1153, 992, 755 cm–1.   




4-Bromostyrene (3.00 g, 16.2 mmol, 1.00 equiv) was dissolved in THF (60 ml) and cooled to 
-78 oC.  nBuLi (7.2 ml, 18.0 mmol, 1.13 equiv, 1.6 M) was added dropwise and the reaction 
stirred for 2 h at -78 oC before DMF (1.40 ml, 18.0 mmol, 1.13 equiv) was added and the 
reaction stirred for a further 14 h.  Ethyl acetate (25 ml) and ammonium chloride (25 ml, sat. 
aq.) was added and the organic layer separated.  The mixture was extracted with ethyl acetate 
(2 x 25 ml) and the combined organic extracts dried over magnesium sulfate and the solvent 
removed in vacuo which was used without further purification. 
Pale yellow liquid. 
Yield: 2.00 g (93%).  
1H NMR (500 MHz, CDCl3): δ = 10.01 (s, 1H), 7.87 (d, J = 8.2 Hz, 2H), 7.57 (d, J = 8.2 Hz, 











4-Vinylcinnamic acid-N, N-diphenylamide (354) 
 
 
To a stirred slurry of sodium hydride (227 mg, 9.48 mmol, 1.20 equiv) in THF (20 ml) at 0 oC 
was added phosphonate 339 (2.70 g, 7.90 mmol, 1.05 equiv) in THF (10 ml).  The mixture 
was stirred for 1 h and 4-vinylbenzaldehyde (1.00 g, 7.57 mmol, 1.00 equiv) in THF (10 ml) 
was added.  The mixture was stirred for 15 h then ammonium chloride (10 ml, sat. aq.) and 
DCM (10 ml) was added and the organic layer separated, washed with brine (25 ml) dried over 
magnesium sulfate and the solvent removed in vacuo.  Recrystalisation from ethanol afforded 
354 as colourless needle crystals, which were dried over molecular sieves (4 Å) in THF at 
room temperature for 18 h in a glovebox.  After filtration, the solvent was removed in vacuo, 
and the liquid dried in high vacuum before use in catalysis.   
Colourless solid  
Yield: 450 mg (18%). 
Mp: 143–144 oC  
1H NMR (500 MHz, CDCl3): δ = 7.74 (d, J = 15.5 Hz, 1H), 7.41–7.36 (m, 4H), 7.36–7.28 (m, 
5H), 7.29–7.25 (m, 5H), 6.68 (dd, J = 17.6, 10.9 Hz, 1H), 6.47 (d, J = 15.5 Hz, 1H), 5.76 (dd, 
J = 17.6, 0.8 Hz, 1H), 5.28 (dd, J = 17.6, 0.8 Hz, 1H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 166.2, 142.8 (2C), 142.1 (2C), 139.0, 136.2 (2C), 134.6, 
129.3, 128.2 (4C), 127.1, 126.6 (4C), 119.6 (2C), 114.9 (2C) ppm.   
IR (neat):  = 3096, 1663, 1491, 1261, 766, 697 cm–1.   
HRMS (EI): calculated for C23H19ON+ = [M+]: m/z = 325.1461, found: m/z = 325.1469.  
 
4-Methoxybenzocinnamic acid-N, N-diphenylamide (355) 
 
 
To a stirred slurry of sodium hydride (144 mg, 6.00 mmol, 1.20 equiv) in THF (20 ml) at 0 oC 
was added phosphonate 339 (1.74 g, 5.00 mmol, 1.00 equiv) in THF (10 ml).  The mixture 




ml) was added.  The mixture was stirred for 15 h then ammonium chloride (10 ml, sat. aq.) 
and DCM (10 ml) was added and the organic layer separated, washed with brine (25 ml) dried 
over magnesium sulfate and the solvent removed in vacuo.  Recrystalisation from ethanol 
afforded 355 as colourless needle crystals, which were dried over molecular sieves (4 Å) in 
THF at room temperature for 18 h in a glovebox.  After filtration, the solvent was removed in 
vacuo, and the liquid dried in high vacuum before use in catalysis.   
Colourless solid  
Yield: 1.38 g (82%). 
Mp: 174–175 oC  
1H NMR (500 MHz, CDCl3): δ = 8.58 (d, J = 6.1 Hz, 2H), 7.69 (d, J = 15.5 Hz, 1H), 7.52–7.35 
(m, 5H), 7.32–7.30 (m, 3H), 7.30–7.28 (m, 2H), 7.20 (d, J = 6.1 Hz, 2H), 6.65 (d, J = 15.5 Hz, 
1H) 4.15 (s, 3H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 166.5, 165.7, 142.6, 141.2 (2C), 139.4 (2C), 130.9 (2C), 130.0 
(4C), 129.4 (2C), 127.8 (4C), 126.7, 122.2 (2C), 52.2 ppm.   
IR (neat):  = 3024, 1707, 1653, 1362, 1279, 1016, 698 cm–1.   
HRMS (EI): calculated for C23H19O3N+ = [M+]: m/z = 357.1359, found: m/z = 357.1355.   
 
4-Nitrocinnamic acid-N, N-diphenylamide (356) 
 
 
To a stirred slurry of sodium hydride (144 mg, 6.00 mmol, 1.20 equiv) in THF (20 ml) at 0 oC 
was added phosphonate 339 (1.74 g, 5.00 mmol, 1.00 equiv) in THF (10 ml).  The mixture 
was stirred for 1 h and 4-nitrobenzaldehyde (717 mg, 4.70 mmol, 0.95 equiv) in THF (10 ml) 
was added.  The mixture was stirred for 15 h then ammonium chloride (10 ml, sat. aq.) and 
DCM (10 ml) was added and the organic layer separated, washed with brine (25 ml) dried over 
magnesium sulfate and the solvent removed in vacuo.  Recrystalisation from ethanol afforded 
356 as colourless needle crystals, which were dried over molecular sieves (4 Å) in THF at 
room temperature for 18 h in a glovebox.  After filtration, the solvent was removed in vacuo, 
and the liquid dried in high vacuum before use in catalysis.   
Colourless solid  




Mp: 166–168 oC  
1H NMR (500 MHz, CDCl3): δ = 8.16 (d, J = 8.8 Hz, 2H), 7.79 (d, J = 15.6 Hz, 1H), 7.47 (d, J 
= 8.8 Hz, 2H), 7.45–7.35 (m, 5H), 7.34–7.27 (m, 5H), 6.59 (d, J = 15.6 Hz, 1H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 165.2, 148.1, 142.4, 141.3 (2C), 139.7 (2C), 129.5 (2C), 128.5 
(4C), 126.7, 124.1 (4C), 124.0 (4C) ppm.   
IR (neat):  = 3105, 1661, 1518, 1345, 960, 698 cm–1.   
HRMS (EI): calculated for C23H19O3N+ = [M+]: m/z = 344.1155, found: m/z = 344.1153.   
 
2-Chlorocinnamic acid-N, N-diphenylamide (357) 
 
 
To a stirred slurry of sodium hydride (144 mg, 6.00 mmol, 1.20 equiv) in THF (20 ml) at 0 o 
was added phosphonate 339 (1.74 g, 5.00 mmol, 1.05 equiv) in THF (10 ml).  The mixture 
was stirred for 1 h and 2-chlorobenzaldehyde (675 mg, 4.70 mmol, 1.00 equiv) in THF (10 ml) 
was added.  The mixture was stirred for 15 h then ammonium chloride (10 ml, sat. aq.) and 
DCM (10 ml) was added and the organic layer separated, washed with brine (25 ml) dried over 
magnesium sulfate and the solvent removed in vacuo.  Recrystalisation from ethanol afforded 
357 as colourless needle crystals, which were dried over molecular sieves (4 Å) in THF at 
room temperature for 18 h in a glovebox.  After filtration, the solvent was removed in vacuo, 
and the liquid dried in high vacuum before use in catalysis.   
Colourless solid  
Yield: 540 mg (35%). 
Mp: 161–162 oC  
1H NMR (500 MHz, CDCl3): δ = 8.15 (d, J = 15.5 Hz, 1H), 7.47–7.33 (m, 5H), 7.33–7.26 (m, 
7H) 7.22 (t, J = 8.0 Hz, 1H), 7.15 (t, J = 8.0 Hz, 1H), 6.48 (d, J = 15.5 Hz, 1H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 165.7, 142.7, 138.6 (2C), 134.9, 133.5, 130.4 (4C), 130.1 
(2C), 129.3, 127.8 (4C), 126.8 (2C), 122.6 (2C) ppm.   
IR (neat):  = 3055, 2361, 1655, 1487, 1352, 1273, 982, 762, 691 cm–1.   








4-Cyanocinnamic acid-N, N-diphenylamide (358) 
 
 
To a stirred slurry of sodium hydride (144 mg, 6.00 mmol, 1.20 equiv) in THF (20 ml) at 0 oC 
was added phosphonate 339 (1.74 g, 5.00 mmol, 1.05 equiv) in THF (10 ml).  The mixture 
was stirred for 1 h and 4-cyanobenzaldehyde (629 mg, 4.70 mmol, 1.00 equiv) in THF (10 ml) 
was added.  The mixture was stirred for 15 h then ammonium chloride (10 ml, sat. aq.) and 
DCM (10 ml) was added and the organic layer separated, washed with brine (25 ml) dried over 
magnesium sulfate and the solvent removed in vacuo.  Recrystalisation from ethanol afforded 
358 as colourless needle crystals, which were dried over molecular sieves (4 Å) in THF at 
room temperature for 18 h in a glovebox.  After filtration, the solvent was removed in vacuo, 
and the liquid dried in high vacuum before use in catalysis.   
Colourless solid  
Yield: 1.10 g (67%). 
Mp: 184–185 oC  
1H NMR (500 MHz, CDCl3): δ = 7.73 (d, J = 15.6 Hz, 1H), 7.59 (d, J = 8.4 Hz, 2H), 7.43–7.36 
(m, 6H), 7.32–7.22 (m, 6H), 6.55 (d, J = 15.6 Hz, 1H) ppm.   
13C NMR (125 MHz, CDCl3): δ = 165.3, 142.5 (2C), 140.2 (2C), 139.4 (2C), 132.5 (4C), 129.4, 
128.3 (4C), 126.6, 123.3 (2C), 118.5, 112.8 (2C) ppm.   
IR (neat):  = 3067, 2226, 1657, 1489, 1348, 1250, 698 cm–1.   
HRMS (EI): calculated for C22H16ON2+ = [M+]: m/z = 350.1414, found: m/z = 350.1416.  
 
4-Methylcinnamic acid-N, N-diphenylamide (359) 
 
 
To a stirred slurry of sodium hydride (144 mg, 6.00 mmol, 1.28 equiv) in THF (20 ml) at 0 oC 
was added phosphonate 339 (1.74 g, 5.00 mmol, 1.06 equiv) in THF (10 ml).  The mixture 
was stirred for 1 h and 4-methylbenzaldehyde (577 mg, 4.70 mmol, 1.00 equiv) in THF (10 ml) 




DCM (10 ml) was added and the organic layer separated, washed with brine (25 ml) dried over 
magnesium sulfate and the solvent removed in vacuo.  Recrystalisation from ethanol afforded 
359 as colourless needle crystals, which were dried over molecular sieves (4 Å) in THF at 
room temperature for 18 h in a glovebox.  After filtration, the solvent was removed in vacuo, 
and the liquid dried in high vacuum before use in catalysis.   
Colourless solid  
Yield: 1.15 g (77%). 
Mp: 165–165.5 oC  
1H NMR (500 MHz, CDCl3): δ = 7.65 (d, J = 15.5 Hz, 1H), 7.44–7.33 (m, 4H), 7.30– 7.21 (m, 
8H), 7.12–7.10 (d, J = 8.0 Hz, 2H), 6.44 (d, J = 15.5 Hz, 1H), 2.33 (s, 3H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 166.4, 142.9, 142.6 (2C), 140.0 (2C), 132.4 (2C), 129.5 (4C), 
129.2, 128.0 (4C), 127.7, 126.8, 118.8 (2C), 21.4 ppm.   
IR (neat):  = 3049, 1657, 1487, 1356, 1254, 984, 812, 693 cm–1.   
HRMS (EI): calculated for C22H19ON+ = [M+]: m/z = 313.1461, found: m/z = 313.1466.   
 
4-Chlorocinnamic acid-N, N-diphenylamide (360) 
 
 
To a stirred slurry of sodium hydride (144 mg, 6.00 mmol, 1.28 equiv) in THF (20 ml) at 0 oC 
was added phosphonate 339 (1.74 g, 5.00 mmol, 1.06 equiv) in THF (10 ml).  The mixture 
was stirred for 1 h and 4-chlorobenzaldehyde (675 mg, 4.7 mmol, 1.00 equiv) in THF (10 ml) 
was added.  The mixture was stirred for 15 h then ammonium chloride (10 ml, sat. aq.) and 
DCM (10 ml) was added and the organic layer separated, washed with brine (25 ml) dried over 
magnesium sulfate and the solvent removed in vacuo.  Recrystalisation from ethanol afforded 
360 as colourless needle crystals, which were dried over molecular sieves (4 Å) in THF at 
room temperature for 18 h in a glovebox.  After filtration, the solvent was removed in vacuo, 
and the liquid dried in high vacuum before use in catalysis.   
Colourless solid  
Yield: 850 mg (53%). 
Mp: 158–159 oC  
1H NMR (500 MHz, CDCl3): δ = 7.74 (d, J = 15.5 Hz, 1H), 7.50–7.37 (m, 4H), 7.36–7.21 (m, 




13C NMR (125 MHz, CDCl3): δ = 165.9, 142.7, 141.2 (2C), 135.6, 133.6 (2C), 129.3, 129.1 
(4C), 129.0 (4C), 127.0 (2C), 120.4 (2C) ppm.   
IR (neat):  = 3063, 1661, 1487, 1346, 976, 756, 700 cm–1.   





Benzofuran (2.50 g, 21.2 mmol, 1.00 equiv) was dissolved in THF (60 ml) and cooled to -78 
oC.  nBuLi (10.1 ml, 25.4 mmol, 1.13 equiv, 2.5 M) was added dropwise and the reaction stirred 
for 2 h at -78 oC before DMF (3.26 ml, 42.2 mmol, 2.00 equiv) was added and the reaction 
stirred for a further 14 h.  Ethyl acetate (25 ml) and ammonium chloride (25 ml, sat. aq.) was 
added and the organic layer separated.  The mixture was extracted with ethyl acetate (2 x 25 
ml) and the combined organic extracts dried over magnesium sulfate and the solvent removed 
in vacuo. 
Pale yellow liquid. 
Yield: 1.92 g (62%).  
1H NMR (500 MHz, CDCl3): δ = 9.90 (s, 1H), 7.78 (d, J = 8.0 Hz, 1H), 7.64 (d, J = 8.4 Hz, 1H), 
7.59 (d, J = 1.0 Hz, 1H), 7.55 (t, J = 8.4 Hz, 1H), 7.37 (d, J = 8.0 Hz, 1H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 179.8, 156.3, 152.7, 129.2, 126.7, 124.2, 123.7, 117.8, 
112.7 ppm.   
 
IR (neat):  = 2936, 1678, 1557, 1288, 1119, 947, 831, 733 cm–1.   
 
4-(2-Benzofuryl)cinnamic acid-N, N-diphenylamide (362) 
 
 
To a stirred slurry of sodium hydride (144 mg, 6.00 mmol, 1.28 equiv) in THF (20 ml) at 0 oC 
was added phosphonate 339 (1.74 g, 5.00 mmol, 1.06 equiv) in THF (10 ml).  The mixture 
was stirred for 1 h and 2-formylbenzofuran (700 mg, 4.70 mmol, 1.00 equiv) in THF (10 ml) 




DCM (10 ml) was added and the organic layer separated, washed with brine (25 ml) dried over 
magnesium sulfate and the solvent removed in vacuo.  Recrystalisation from ethanol afforded 
362 as colourless needle crystals, which were dried over molecular sieves (4 Å) in THF at 
room temperature for 18 h in a glovebox.  After filtration, the solvent was removed in vacuo, 
and the liquid dried in high vacuum before use in catalysis.   
Colourless solid  
Yield: 740 mg (46%). 
Mp: 192–194 oC  
1H NMR (500 MHz, CDCl3): δ = 7.65 (d, J = 15.2 Hz, 1H), 7.54 (d, J = 7.7 Hz, 1H), 7.47–7.34 
(m, 5H), 7.33–7.26 (m, 7H), 7.20 (t, J = 7.7 Hz, 1H), 6.87 (s, 1H), 6.63 (d, J = 15.2 Hz, 1H) 
ppm.  
13C NMR (125 MHz, CDCl3): δ = 165.8, 155.4, 153.1 (2C), 142.7, 129.7 (2C), 129.3, 128.5 
(2C), 127.0, 126.1 (2C), 123.2 (2C), 121.6 (2C), 120.3 (2C), 111.3 (2C), 110.6 (2C) ppm.   
IR (neat):  = 3051, 2357, 1665, 1620, 1489, 1271, 827, 731 cm–1.   
HRMS (EI): calculated for C23H17O2N+ = [M+]: m/z = 339.1254, found: m/z = 339.1257.   
 
4-(2-Benzothiophenyl)cinnamic acid-N, N-diphenylamide (363) 
 
 
To a stirred slurry of sodium hydride (144 mg, 6.00 mmol, 1.28 equiv) in THF (20 ml) at 0 oC 
was added phosphonate 339 (1.74 g, 5.00 mmol, 1.06 equiv) in THF (10 ml).  The mixture 
was stirred for 1 h and 2-formylbenzothiophene (761 mg, 4.70 mmol, 1.00 equiv) in THF (10 
ml) was added.  The mixture was stirred for 15 h then ammonium chloride (10 ml, sat. aq.) 
and DCM (10 ml) was added and the organic layer separated, washed with brine (25 ml) dried 
over magnesium sulfate and the solvent removed in vacuo.  Recrystalisation from ethanol 
afforded 363 as colourless needle crystals, which were dried over molecular sieves (4 Å) in 
THF at room temperature for 18 h in a glovebox.  After filtration, the solvent was removed in 
vacuo, and the liquid dried in high vacuum before use in catalysis.   
Colourless solid  
Yield: 820 mg (49%). 
Mp: 180–181 oC  
1H NMR (500 MHz, CDCl3): δ = 7.97 (d, J = 15.1 Hz, 1H), 7.78–7.69 (m, 2H), 7.49–7.38 (m, 




13C NMR (125 MHz, CDCl3): δ = 165.7, 142.6 (2C), 140.3, 140.0, 139.7, 135.7 (2C), 129.3 
(2C), 127.9 (2C), 126.9, 125.9 (2C), 124.8 (2C), 124.3 (2C), 122.3 (2C), 121.3 (2C) ppm.   
IR (neat):  = 3688, 2970, 1655, 1356, 1152, 1037, 988, 766 cm–1.   
HRMS (EI): calculated for C23H17ONS+ = [M+]: m/z = 355.1025, found: m/z = 355.1015.   
 
4-(2-Quinoline)cinnamic acid-N, N-diphenylamide (364) 
 
 
To a stirred slurry of sodium hydride (144 mg, 6.00 mmol, 1.28 equiv) in THF (20 ml) at 0 oC 
was added phosphonate 339 (1.74 g, 5.00 mmol, 1.06 equiv) in THF (10 ml).  The mixture 
was stirred for 1 h and 2-quinolinecarboxaldehyde (754 mg, 4.70 mmol, 1.00 equiv) in THF 
(10 ml) was added.  The mixture was stirred for 15 h then ammonium chloride (10 ml, sat. aq.) 
and DCM (10 ml) was added and the organic layer separated, washed with brine (25 ml) dried 
over magnesium sulfate and the solvent removed in vacuo.  Recrystalisation from ethanol 
afforded 364 as pale purple needle crystals, which were dried over molecular sieves (4 Å) in 
THF at room temperature for 18 h in a glovebox.  After filtration, the solvent was removed in 
vacuo, and the liquid dried in high vacuum before use in catalysis.   
Pale purple solid  
Yield: 580 mg (41%). 
Mp: 195–196 oC  
1H NMR (500 MHz, CDCl3): δ = 8.09 (d, J = 8.5 Hz, 1H), 8.00 (d, J = 8.5 Hz, 1H), 7.98 (d, J = 
15.4 Hz, 1H), 7.77 (d, J = 8.1 Hz, 1H), 7.68 (t, J = 6.9 Hz, 1H), 7.51 (d, J = 6.9 Hz, 1H), 7.43 
(d, J = 8.5 Hz, 2H), 7.41–7.36 (m, 2H), 7.35–7.26 (m, 6H), 7.09 (d, J = 15.4 Hz, 1H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 165.8, 153.9, 148.3, 142.7, 142.2 (2C), 136.5 (2C), 129.9 
(4C), 129.3, 127.9 (2C), 127.4, 127.0 (4C), 125.3 (2C), 120.7 (2C) ppm.   
IR (neat):  = 3204, 1641, 1576, 1356, 1132, 823, 734, 691 cm–1.   












4-(1-Napthyl)cinnamic acid-N, N-diphenylamide (365) 
 
 
To a stirred slurry of sodium hydride (144 mg, 6.00 mmol, 1.28 equiv) in THF (20 ml) 
at 0 oC was added phosphonate 339 (1.74 g, 5.00 mmol, 1.06 equiv) in THF (10 ml).  
The mixture was stirred for 1 h and 1-napthaldehyde (750 mg, 4.70 mmol, 1.00 equiv) 
in THF (10 ml) was added.  The mixture was stirred for 15 h then ammonium chloride 
(10 ml, sat. aq.) and DCM (10 ml) was added and the organic layer separated, washed 
with brine (25 ml) dried over magnesium sulfate and the solvent removed in vacuo.  
Recrystalisation from ethanol afforded 365 as colourless needle crystals, which were 
dried over molecular sieves (4 Å) in THF at room temperature for 18 h in a glovebox.  
After filtration, the solvent was removed in vacuo, and the liquid dried in high vacuum 
before use in catalysis.   
Colourless solid  
Yield: 620 mg (38%). 
Mp: 194–195 oC  
1H NMR (500 MHz, CDCl3): δ = 8.58 (d, J = 15.3 Hz, 1H), 8.21 (d, J = 8.3 Hz, 1H), 7.83 (t, J = 
8.3 Hz, 2H), 7.53 (d, J = 20.9, 7.8 Hz, 2H), 7.47–7.35 (m, 7H), 7.34–7.24 (m, 6H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 166.2, 142.8 (2C), 139.7 (2C), 133.6, 132.7, 131.5, 129.9 
(2C), 129.3, 128.6 (2C), 126.7 (2C), 126.2 (2C), 125.3 (2C), 124.8 (2C), 123.7 (2C), 122.7 
(2C) ppm.   
IR (neat):  = 3059, 2381, 1681, 1489, 1331, 976, 772, 693 cm–1.   
HRMS (EI): calculated for C25H19ON+ = [M+]: m/z = 349.1461, found: m/z = 349.1472.  
 
3-Methoxycinnamic acid-N, N-diphenylamide (366) 
 
To a stirred slurry of sodium hydride (144 mg, 6.00 mmol, 1.28 equiv) in THF (20 ml) at 0 oC 
was added phosphonate 339 (1.74 g, 5.00 mmol, 1.06 equiv) in THF (10 ml).  The mixture 




added.  The mixture was stirred for 15 h then ammonium chloride (10 ml, sat. aq.) and DCM 
(10 ml) was added and the organic layer separated, washed with brine (25 ml) dried over 
magnesium sulfate and the solvent removed in vacuo.  Recrystalisation from ethanol afforded 
366 as colourless needle crystals, which were dried over molecular sieves (4 Å) in THF at 
room temperature for 18 h in a glovebox.  After filtration, the solvent was removed in vacuo, 
and the liquid dried in high vacuum before use in catalysis.   
Colourless solid  
Yield: 1.25 g (81%). 
Mp: 163–164 oC  
1H NMR (500 MHz, CDCl3): δ = 7.73 (d, J = 15.5 Hz, 1H), 7.46–7.33 (m, 4H), 7.31–7.25 (m, 
5H), 7.22 (t, J = 7.8 Hz, 1H), 6.95 (d, J = 7.8 Hz, 1H), 6.89–6.84 (m, 2H), 6.46 (d, J = 15.5 Hz, 
1H), 3.77 (s, 3H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 166.1, 159.8, 142.8 (2C), 142.5, 136.6, 129.7 (2C), 129.3, 
126.9, 120.5 (4C), 120.2, 115.1 (2C), 113.5 (4C), 55.3 ppm.   
IR (neat):  = 3059, 2835, 1657, 1489, 1350, 1267, 985, 777, 694 cm–1.   
HRMS (EI): calculated for C22H19O2N+ = [M+]: m/z = 329.1410, found: m/z = 329.1416.  
 
4-Trifluoromethylcinnamic acid-N, N-diphenylamide (367) 
 
To a stirred slurry of sodium hydride (144 mg, 6.00 mmol, 1.28 equiv) in THF (20 ml) at 0 oC 
was added phosphonate 339 (1.74 g, 5.00 mmol, 1.06 equiv) in THF (10 ml).  The mixture 
was stirred for 1 h and 4-trifluoromethylbenzaldehyde (817 mg, 4.70 mmol, 1.00 equiv) in THF 
(10 ml) was added.  The mixture was stirred for 15 h then ammonium chloride (10 ml, sat. aq.) 
and DCM (10 ml) was added and the organic layer separated, washed with brine (25 ml) dried 
over magnesium sulfate and the solvent removed in vacuo.  Recrystalisation from ethanol 
afforded 367 as pale colourless needle crystals, which were dried over molecular sieves (4 Å) 
in THF at room temperature for 18 h in a glovebox.  After filtration, the solvent was removed 
in vacuo, and the liquid dried in high vacuum before use in catalysis.   
Colourless solid  
Yield: 515 mg (30%). 




1H NMR (500 MHz, CDCl3): δ = 7.70 (d, J = 15.5 Hz, 1H), 7.48 (d, J = 8.2 Hz, 2H), 7.36 (d, J 
= 8.2 Hz, 2H), 7.35–7.29 (m, 4H), 7.24–7.19 (m, 6H), 6.48 (d, J = 15.5 Hz, 1H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 165.6, 142.6, 140.7 (4C), 138.5, 131.2 (q, J = 32.9 Hz), 129.4 
(2C), 128.1 (4C), 127.1, 125.7 (q, J = 4.0 Hz, 2C), 125.0, 124.0 (q, J = 272.6 Hz), 122.8, 122.3, 
120.6 ppm.   
19F NMR (470 MHz, CDCl3): δ = -62.8 ppm 
IR (neat):  = 3065, 2361, 2160, 1661, 1491, 1310, 1123, 833, 698 cm–1.   
HRMS (EI): calculated for C22H16ONF3+ = [M+]: m/z = 367.1179, found: m/z = 367.1186.   
 
Cyclohexene-1-carboxylic acid (368)251 
 
To a solution of cyclohexanone (5.00 g, 50.0 mmol, 1.00 equiv) in tert-butanol (200 ml) was 
added LiOH (43.2 g, 1.02 mol, 2.00 equiv in 40 ml H2O) and benzyltriethylammonium bromide 
(1.14 g, 5.00 mmol, 0.10 equiv).  The mixture was stirred for 5 minutes after which bromoform 
(51.5 g, 200 mmol, 4.00 equiv) was added using a pressure equalising dropping funnel.  The 
reaction temperature was maintained below 50 oC and stirred for 24 h.  Water (200 ml) was 
added, shaken vigerously and separated.  The aqueous layer was further washed with toluene 
(2 x 100 ml) before acidification to pH 1 using HCl (20 %).  The oil that separated was dissolved 
in toluene and the aqueous extracted with toluene (2 x 50 ml).  The combined organic layers 
were dried over magnesium sulfate, filtered and the solvent removed under reduced pressure 
to afford a pale brown oil of sufficient purity.   
Colourless solid  
Yield: 6.15 g (97%). 
1H NMR (500 MHz, CDCl3): δ = 9.80 (br s, 1H), 7.16 (tt, J = 3.8, 1.7 Hz, 1H), 2.33–2.21 (m, 
4H), 1.75–1.61 (m, 4H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 173.0, 142.6, 129.7, 26.0, 23.7, 22.0, 21.3 ppm.   




To a solution of cyclohexene-1-carboxylic acid (2.00 g, 15.9 mmol, 1.00 equiv) in DCM (15 ml) 




temperature overnight.  Diphenylamine (2.42 g, 14.3 mmol, 0.90 equiv) was added followed 
by triethylamine (1.91 g, 15.9 mmol, 1.00 equiv).  The mixture was stirred at ambient overnight 
before water (20 ml) was added.  The reacton mixture was separated and washed with brine 
(25 ml) dried over magnesium sulfate and the solvent removed in vacuo.  Recrystalisation 
from ethanol afforded 1a as pale colourless needle crystals, which were dried over molecular 
sieves (4 Å) in THF at room temperature for 18 h in a glovebox.  After filtration, the solvent 
was removed in vacuo, and the liquid dried in high vacuum before use in catalysis. 
Colourless solid  
Yield: 320 mg (8%). 
Mp: 161.1–161.8 oC  
1H NMR (500 MHz, CDCl3): δ = 7.55–7.31 (m, 4H), 7.31–7.08 (m, 6H), 4.24–4.11 (m, 1H), 
3.12 (dt, J = 8.5, 4.1 Hz, 1H), 2.27–2.13 (m, 1H), 2.13–2.00 (m, 1H), 1.91–1.80 (m, 1H), 1.80–
1.68 (m, 1H), 1.64–1.57 (m, 1H), 1.57–1.50 (m, 1H), 1.44–1.31 (m, 1H), 1.31–1.16 (m, 1H) 
ppm.  
13C NMR (125 MHz, CDCl3): δ = 172.2, 143.1 (2C), 129.2 (br 4C), 128.9 (br 4C), 127.1, 126.1, 
59.4, 44.7, 33.5, 24.5, 22.9, 21.9 ppm.   












3.3.4 Other Michael Amides 
N-Methylmaleimide (300)252 
 
To a solution of N-Methylmaleamic acid (8.00 g, 62.0 mmol, 1.00 equiv) in acetic anhydride 
(150 ml) was added sodium acetate (9.80 g, 119.4 mmol, 1.90 equiv) and the mixture refluxed 
for 20 h.  After cooling the mixture was quenched with saturated sodium bicarbonate, extracted 
with chloroform (3 x 150 ml) and the solvent removed in vacuo.  The solid was recrystalised 
from ethyl acetate yielding colourless crsytasls which were was dried over molecular sieves 
(4 Å) in THF at room temperature for 18 h in a glovebox.  After filtration, the solvent was 
removed in vacuo, and the solid dried in high vacuum before use in catalysis.   
Colourless solid 
Yield: 900 mg (55%). 
Mp: 91–92 oC (Lit.: 92.1–93.1 oC). 
1H NMR (500 MHz, CDCl3): δ = 6.71 (s, 2H), 3.02 (s, 3H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 170.8 (2C), 134.2 (2C), 23.7 ppm.   
IR (neat):  = 3094, 2361, 1692, 1437, 937, 692 cm–1.   




To a stirred solution of trans-cinnamic acid (1.48 g, 10.0 mmol, 1.00 equiv) in DCM (25 ml) at 
ambient temperature under an argon atmosphere was added thionyl chloride (2.38 g, 20.0 
mmol, 2.00 equiv) and the solution stirred for 4 h.  The solvent and excess thionyl chloride 
was removed in vacuo affording a colourless solid which was dissolved in toluene (20 ml).  
Methanol (1 ml, 40 mmol, 4 equiv) was added followed by triethylamine (1.01 g, 10.0 mmol, 
1.00 equiv) and the reaction stirred for 15 h.  Water (20 ml) was added and the mixture was 
extracted with DCM (3 x 20 ml).  The combined organic fractions were dried over MgSO4, 
filtered, and the solvents were removed in vacuo.  Recrystallisation from methanol afforded 




temperature for 18 h in a glovebox.  After filtration, the solvent was removed in vacuo, and the 
solid ground and dried in high vacuum before use in catalysis.   
Colourless solid  
Yield: 1.46 g (90%). 
Mp: 33–34 oC (Lit.: 33–34 oC).246 
1H NMR (500 MHz, CDCl3): δ = 7.73 (d, J = 16.1 Hz, 1H), 7.59–7.52 (m, 2H), 7.45–7.36 (m, 
3H), 6.47 (d, J = 16.1 Hz, 1H), 3.83 (s, 3H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 167.4, 144.9, 134.4, 130.3, 128.9 (2C), 128.1 (2C), 117.8, 
51.7 ppm.   
IR (neat):  = 3034, 1724, 1636, 1306, 1144, 970, 762, 679 cm–1.   




To a stirred solution of trans-cinnamic acid (1.48 g, 10.0 mmol, 1.00 equiv) in DCM (25 ml) at 
ambient temperature under an argon atmosphere was added thionyl chloride (2.38 g, 20.0 
mmol, 2.00 equiv) and the solution stirred for 4 h.  The solvent and excess thionyl chloride 
was removed in vacuo affording a colourless solid which was dissolved in toluene (20 ml).  
Phenol (1.88 g, 20.0 mmol, 2.00 equiv) was added followed by triethylamine (1.01 g, 10.0 
mmol, 1.00 equiv) and the reaction stirred for 15 h.  Water (20 ml) was added and the mixture 
was extracted with DCM (3 x 20 ml).  The combined organic fractions were dried over MgSO4, 
filtered, and the solvents were removed in vacuo.  Recrystallisation from methanol afforded 
371 as a colourless solid, which was dried over molecular sieves (4 Å) in THF at room 
temperature for 18 h in a glovebox.  After filtration, the solvent was removed in vacuo, and the 
solid ground and dried in high vacuum before use in catalysis.   
Colourless solid  
Yield: 1.85 g (82%). 
Mp: 74–75 oC (Lit.: 74–75 oC).248 
1H NMR (500 MHz, CDCl3): δ = 7.88 (d, J = 16.0 Hz, 1H), 7.70–7.51 (m, 2H), 7.52–7.31 (m, 
5H), 7.25 (t, J = 7.5 Hz, 1H), 7.17 (d, J = 7.8 Hz, 2H), 6.64 (d, J = 16.0 Hz, 1H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 165.4, 150.8, 146.6, 134.2, 130.7, 129.4 (2C), 129.0 (2C), 
128.3 (2C), 125.8, 121.6 (2C), 117.4 ppm.   








To a stirred solution of phenyl acetylene (2.24 g, 22.0 mmol, 1.05 equiv) in THF (15 mL) at –
78 oC under an argon atmosphere was added nBuLi (1.6 M in hexane; 15.6 mL, 25.0 mmol, 
1.20 equiv) dropwise.  The reaction was stirred at ambient for 30 min before being cooled –
78 oC.  Dimethylcarbamoyl chloride (1.93 mL, 21.0 mmol, 1.00 equiv) was added dropwise 
and the mixture stirred for 1 h.  Ammonium chloride (sat aq.; 10 mL) was added, and the 
mixture was extracted with ethyl acetate (3 x 20 mL).  The combined organic fractions were 
dried over MgSO4, filtered, and the solvents were removed in vacuo.  Recrystallisation from 
methanol afforded 315 as a tan solid, which was dried over molecular sieves (4 Å) in diethyl 
ether at room temperature for 18 h in a glovebox.  After filtration, the solvent was removed in 
vacuo, and the solid ground and dried in high vacuum before use in catalysis.   
Tan solid. 
Yield: 2.21 g (65%). 
Mp: 94–96 oC (Lit.: 97–99 oC).258 
1H NMR (500 MHz, CDCl3): δ = 7.60–7.48 (m, 2H), 7.46–7.29 (m, 3H), 3.28 (s, 3H), 3.02 (s, 
3H) ppm.   
13C NMR (125 MHz, CDCl3): δ = 154.6, 132.3, 130.0 (2C), 128.5 (2C), 120.6, 90.1, 81.6, 38.4, 
34.2 ppm.   
IR (neat):  = 2928, 2208, 1620, 1491, 1395, 1253, 1136, 783, 729, 692 cm–1.   







N, N-Dimethyl-3-trimethylsilylpropiolamide (315)259 
 
To a stirred solution of trimethylsilyl acetylene (2.16 g, 22.0 mmol, 1.05 equiv) in THF (15 mL) 
at –78 oC under an argon atmosphere was added nBuLi (1.6 M in hexane; 15.6 mL, 25.0 mmol, 
1.20 equiv) dropwise.  The reaction was stirred at ambient for 30 min before being cooled –
78 oC.  Dimethylcarbamoyl chloride (1.93 mL, 21.0 mmol, 1.00 equiv) was added dropwise 
and the mixture stirred for 1 h.  Ammonium chloride (sat aq.; 10 mL) was added, and the 
mixture was extracted with ethyl acetate (3 x 20 mL).  The combined organic fractions were 
dried over MgSO4, filtered, and the solvents were removed in vacuo.  Recrystallisation from 
methanol afforded 315 as a tan solid, which was dried over molecular sieves (4 Å) in diethyl 
ether at room temperature for 18 h in a glovebox.  After filtration, the solvent was removed in 
vacuo, and the solid ground and dried in high vacuum before use in catalysis.   
Tan solid. 
Yield: 1.00 g (28%). 
Mp: 43–44 oC (Lit.: 42–43 oC). 
1H NMR (500 MHz, CDCl3): δ = 3.21 (s, 3H), 2.97 (s, 3H), 0.24 (s, 9H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 154.0, 97.1, 96.1, 38.3, 34.0, –0.7 ppm (3C).   
IR (neat):  = 2961, 2932, 1618, 1499, 1393, 1251, 1153, 764, 860 cm–1.   




To a solution of diphenyldiselenide (1.56 g, 4.50 mmol, 1.10 equiv) in THF (20 ml) under argon 
was added bromine (791 mg, 4.50 mmol, 1.10 equiv) and the mixture stirred for 1 h.  In a 
separate flask HNiPr2 (1.09 g, 10.8 mmol, 1.20 equiv) in THF (30 ml) was cooled to 0 oC and 
nBuLi (6.65 ml, 1.6 M, 9.00 mmol, 1.10 equiv) added dropwise and the mixture stirred for 1 h.   
The solution was cooled to -78 oC and N-methylcaprolactame (1.14 g, 9.00 mmol, 1.00 equiv) 
was added and the reaction slowly warmed to ambient temperature and stirred for 1 h.  The 
mixture was recooled to -78 oC and the phenyl selenylbromide solution added dropwise.   The 
reaction was allowed to warm to ambient and stirred for 16 h.  The mixture was poured onto 




dried over magnesium sulfate and the solvent removed in vacuo affording a brown solid.  The 
solid was dissolved in DCM (50 ml) and mCPBA (2.33 g, 13.5 mmol, 1.50 equiv) was added 
cautiously.  The reaction was stirred at ambient for 24 h and the solvent removed in vacuo 
affording the crude product which was purified using flash column chromatography eluting 
EtOAc:hexane (50:1).  
Pale yellow liquid 
Yield 150 mg (13%) 
1H NMR (500 MHz, CDCl3): δ = 6.09 (dt, J = 12.1, 5.1 Hz, 1H), 5.86 (dt, J = 12.1, 1.7 Hz, 1H), 
3.30–3.24 (m, 2H), 2.95 (s, 3H), 2.23 (tdd, J = 5.2, 1.7 Hz, 2H), 1.90–1.85 (m, 2H), 1.65–1.59 
(m, 1H), 1.55 (td, J = 10.2, 5.5 Hz, 1H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 168.6, 138.0, 126.5, 49.1, 35.7, 28.1, 27.6 ppm.   
IR (neat):  = 2928, 2232, 1645, 1601, 1396, 727 cm–1.   






3.3.5 Products of the Catalytic Conjugate Addition  




206 was prepared according to general procedure V using N,N-dimethylacrylamide (39.6 mg, 
0.40 mmol, 1.00 equiv) and acetonitrile (400 L), in the presence of 
hexaphenylcarbodiphosphorane (2.20 mg, 4.00 mol, 1.00 mol%) as the catalyst, at 40 oC for 
3 h. 206 was purified by filtering through a pad of silica eluting EtOAc/PE (1:5; 5 mL).   
Colourless liquid. 
Yield: 48.5 mg (87%). 
1H NMR (500 MHz, CDCl3): δ = 3.01 (s, 3H), 2.95 (s, 3H), 2.51 (t, J = 6.9 Hz, 2H), 2.48 (t, J = 
6.9 Hz, 2H), 2.00 (pent, J = 6.9 Hz, 2H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 170.7, 119.6, 37.0, 35.4, 30.9, 20.7, 16.6 ppm. 
IR (neat):  = 2938, 2245, 1637, 1497, 1456, 1430, 1398, 1253, 1142, 1081 cm–1. 






303 was prepared according to general procedure V using N,N-dimethylacrylamide (39.6 mg, 
0.40 mmol, 1.00 equiv) and propionitrile (400 L), in the presence of hexaphenylcarbo-
diphosphorane (2.20 mg, 4.00 mol, 1.00 mol%) as the catalyst, at 40 oC for 3 h.  303 was 
purified by filtering through a pad of silica eluting EtOAc/PE (1:5; 5 mL).   
Colourless liquid. 
Yield: 56.7 mg (92%). 
1H NMR (500 MHz, CDCl3): δ = 3.04 (s, 3H), 2.97 (s, 3H), 2.86 (ddd, J = 10.2, 7.1, 4.9 Hz, 
1H), 2.56–2.53 (m, 2H), 2.04 (dtd, J = 13.8, 7.8, 4.9 Hz, 1H), 1.83 (dddd, J = 13.8, 10.2, 6.7, 
6.0 Hz, 1H), 1.37 (d , J = 7.1 Hz, 3H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 171.0, 122.8, 37.1, 35.5, 30.2, 29.4, 25.1, 18.2 ppm. 
IR (neat):  = 3377, 2938, 2237, 1640, 1504, 1221, 735 cm–1. 










305 was prepared according to general procedure V using N,N-dimethylacrylamide (39.6 mg, 
0.40 mmol, 1.00 equiv) and propionitrile (400 L), in the presence of hexaphenylcarbo-
diphosphorane (2.20 mg, 4.00 mol, 1.00 mol%) as the catalyst, at 40 oC for 3 h.  305 was 
purified by filtering through a pad of silica eluting EtOAc/PE (1:5; 5 mL).   
Colourless liquid. 
Yield: 20.1 mg (60%). 
1H NMR (500 MHz, CDCl3): δ = 3.05 (s, 3H), 2.98 (s, 3H), 2.72 (dddd, J = 10.6, 8.3, 5.9, 4.7 
Hz, 1H), 2.60–2.49 (m, 2H), 2.06 (dtd, J = 13.8, 7.8, 4.7 Hz, 1H), 1.83 (dddd, J = 13.8, 10.6, 
6.9 Hz, 1H), 1.75–1.66 (m, 2H), 1.12 (t, J = 7.4 Hz, 3H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 171.1, 122.1, 37.1, 35.5, 32.8, 30.3, 27.3, 25.8, 11.6 ppm. 
IR (neat):  = 3705, 2938, 2236, 1636, 1400, 1057, 1011 cm–1. 






304 was prepared according to general procedure V using N,N-dimethylacrylamide (39.6 mg, 
0.40 mmol, 1.00 equiv) and isopropionitrile (400 L), in the presence of hexaphenylcarbo-
diphosphorane (2.20 mg, 4.00 mol, 1.00 mol%) as the catalyst, at 40 oC for 24 h.  304 was 
purified by filtering through a pad of silica eluting EtOAc/PE (1:5; 5 mL)   
Colourless liquid. 
Yield: 67.3 mg (73%). 
1H NMR (500 MHz, CDCl3): δ = 3.06 (s, 3H), 2.97 (s, 3H), 2.59–2.48 (m, 2H), 1.98–1.88 (m, 
2H), 1.39 (s, 6H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 171.3, 124.7, 37.2, 36.0, 35.6, 32.0, 29.4, 26.7 ppm. 
IR (neat):  = 3493, 2930, 2234, 1639, 1398, 1144, 731 cm–1. 









306 was prepared according to general procedure V using N, N-dimethylacrylamide (9.90 mg, 
0.10 mmol, 1.00 equiv) and α-methylbenzylcyanide (200 L), in the presence of 
hexaphenylcarbodiphosphorane (2.70 mg, 5.00 mol, 5.00 mol%) as the catalyst, at 40 oC for 
20 h.  The crude reaction mixture was purified by PTLC eluting EtOAc/hexane (20:80).  
Colourless liquid. 
Yield: 21.5 mg (93%). 
1H NMR (500 MHz, CDCl3): δ = 7.49–7.46 (m, 2H), 7.44–7.39 (m, 2H), 7.37–7.32 (m, 1H), 
2.92 (s, 6H), 2.57–2.49 (m, 1H), 2.42–2.30 (m, 2H), 2.15 (ddd, J = 15.7, 10.5, 5.6 Hz, 1H), 
`1.77 (s, 3H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 171.1, 139.4, 129.1 (2C), 127.9, 125.4 (2C), 123.1, 42.1, 
37.0, 36.8, 35.4, 29.5, 28.5 ppm. 
IR (neat):  = 2936, 2236, 1639, 1398, 1142, 910, 727, 698 cm–1. 





308 was prepared according to general procedure V using acrylamide 330 (11.4 mg, 0.05 
mmol, 1.00 equiv) and trimethylsilylacetonitrile (200 L), in the presence of hexaphenylcarbo-
diphosphorane (2.70 mg, 5.00 mol, 5.00 mol%) as the catalyst, at 40 oC for 12 h.  The crude 
reaction mixture was purified by PTLC eluting EtOAc/hexane (20:80). 
Colourless liquid. 
Yield: 15.1 mg (90%). 
1H NMR (500 MHz, CDCl3): δ = 7.63–6.87 (m, 10H), 2.52 (t, J = 7.0 Hz, 1H), 2.45 (t, J = 6.8 
Hz, 2H), 2.02 (pent, J = 6.8 Hz, 1H), 1.17–1.15 (m, 1H), 0.25 (s, 9H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 171.1, 142.3, 130.0 (2C), 129.3 (4C), 126.3 (4C), 121.4 (2C), 
119.4, 33.2, 21.0, 16.5, -0.6 (3C) ppm. 
IR (neat):  = 3680, 2957, 2208, 1670, 1254, 843, 692 cm–1. 











281 was prepared according to general procedure V using acrylamide 331 (23.7 mg, 0.10 
mmol, 1.00 equiv) and acetonitrile (200 L), in the presence of hexaphenylcarbo-
diphosphorane (2.70 mg, 5.00 mol, 5.00 mol%) as the catalyst, at 40 oC for 20 h.  281 was 
purified by filtering through a pad of silica eluting EtOAc/PE (1:5; 5 mL).   
Colourless solid. 
Yield: 28.2 mg (91%). 
1H NMR (500 MHz, CDCl3): δ = 3.74 (s, 3H), 3.21 (s, 3H), 2.64 (t, J = 6.7 Hz, 2H), 2.51 (t, J = 
7.2 Hz, 2H), 2.01 (tt, J = 6.7, 7.2 Hz, 2H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 172.5, 119.4, 61.3, 32.2, 29.9, 20.2, 16.7 ppm. 
IR (neat):  = 2924, 2245, 1653, 1420, 1179, 991 cm–1. 





282 was prepared according to general procedure V using acrylamide 332 (23.7 mg, 0.10 
mmol, 1.00 equiv) and acetonitrile (200 L), in the presence of hexaphenylcarbo-
diphosphorane (2.70 mg, 5.00 mol, 5.00 mol%) as the catalyst, at 40 oC for 20 h.  The crude 
reaction mixture was purified by PTLC eluting EtOAc/hexane (20:80). 
Colourless solid. 
Yield: 25.5 mg (92%). 
1H NMR (500 MHz, CDCl3): δ = 7.56–7.12 (m, 10H), 3.86 (dqd, J = 9.3, 6.9, 4.9 Hz, 1H), 2.51–
2.39 (m, 2H), 2.16 (dddd, J = 13.6, 9.4, 6.7, 5.9 Hz, 1H), 1.70 (dddd, J = 13.6, 8.6, 7.0, 4.9 Hz, 
1H), 1.19 (d, J = 6.9 Hz, 3H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 175.0, 130.0 (2C), 129.0 (2C), 128.8 (4C), 126.4 (4C), 119.5, 
36.2, 29.4, 18.1, 15.2 ppm. 
IR (neat):  = 3061, 2916, 2247, 1663, 1491, 1267, 1003, 908, 729, 692 cm–1. 











309 was prepared according to general procedure V using acrylamide 332 (23.7 mg, 0.10 
mmol, 1.00 equiv) and propionitrile (200 L), in the presence of hexaphenylcarbo-
diphosphorane (2.70 mg, 5.00 mol, 5.00 mol%) as the catalyst, at 40 oC for 15 h.  The crude 
reaction mixture was purified by PTLC eluting EtOAc/hexane (20:80). 
Colourless solid. 
dr =1:1.5  
Yield: 25.6 mg (88%). 
Mp. = 62–63 oC 
1H NMR (500 MHz, CDCl3): δ = 7.56–7.13 (m, 10H), 2.96 (ddq, J = 13.7, 6.8, 3.4 Hz, 1H, 
major), 2.86–2.74 (m, 1H), 2.65 (dqd, J = 9.3, 7.1, 5.9 Hz, 1H, minor), 2.19 (ddd, J = 13.7, 9.3, 
6.8 Hz, 1H, minor), 2.13 (ddd, J = 13.4, 11.0, 4.5 Hz, 1H, major), 1.64 (ddd, J = 13.9, 7.0, 5.9 
Hz, 1H, minor), 1.52 (ddd, J = 13.4, 11.3, 3.7 Hz, 1H, major), 1.32 (d, J = 7.0 Hz, 3H), 1.21 (d, 
J = 6.8 Hz, 3H, minor), 1.17 (d, J = 6.9 Hz, 3H, major) ppm. 
13C NMR (125 MHz, CDCl3): δ = 175.4 (minor), 175.2 (major), 130.0 (2C), 129.0 (4C), 128.3 
(2C), 126.5 (4C), 123.0 (major), 122.3 (minor), 38.7 (major), 38.0 (minor), 36.0 (major), 35.5 
(minor), 29.7, 24.0 (major), 23.5 (minor), 18.8 (major), 18.6 (minor), 18.3 (major), 17.9 (minor) 
ppm. 
IR (neat):  = 2974, 2916, 2361, 2237, 1665, 1491, 1385, 1271, 756, 692 cm–1. 






310 was prepared according to general procedure V using acrylamide 332 (23.7 mg, 0.10 
mmol, 1.00 equiv) and α-methylbenzylcyanide (200 L), in the presence of hexaphenylcarbo-
diphosphorane (2.70 mg, 5.00 mol, 5.00 mol%) as the catalyst, at 40 oC for 15 h.  The crude 
reaction mixture was purified by PTLC eluting EtOAc/hexane (20:80). 
Colourless solid. 
Yield: 28.0 mg (76%). 
dr = 1:1.6 




1H NMR (500 MHz, CDCl3): δ = 7.49–7.41 (m, 2H), 7.41–7.33 (m, 4H), 7.32–7.25 (m, 4H), 
7.25–7.12 (br m, 2H), 7.11–7.00 (br m, 1H), 7.00–6.86 (br m, 1H), 2.97 (dd, J = 14.7, 6.9 Hz, 
1H), 2.90 (dd, J = 14.3, 8.7 Hz, 1H, minor), 2.72–2.65 (m, 1H, minor), 2.63 (td, J = 6.9, 3.9 Hz, 
1H), 1.91 (dd, J = 14.7, 3.9 Hz, 1H), 1.83 (dd, J = 14.3, 2.7 Hz, 2H, minor), 1.74 (s, 3H, minor), 
1.66 (s, 3H), 1.28 (d, J = 7.00 Hz, 3H), 1.10 (d, J = 6.9 Hz, 3H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 175.4, 142.3, 140.3, 139.5, 129.7, 129.0, 128.8, 128.6, 127.9, 
127.7, 126.7, 126.5, 126.2, 126.0, 125.3, 123.2, 123.0, 45.6 (minor), 44.8, 42.0, 41.9 (minor) 
34.9, 34.8 (minor), 29.7 (minor), 29.5, 28.4 ppm. 
IR (neat):  = 3061, 2976, 2236, 1667, 1491, 1273, 758, 698 cm–1. 






283 was prepared according to general procedure V using acrylamide 289 (15.0 mg, 0.10 
mmol, 1.00 equiv) and acetonitrile (200 L), in the presence of hexaphenylcarbo-
diphosphorane (2.70 mg, 5.00 mol, 5.00 mol%) as the catalyst, at 40 oC for 20 h.  The crude 
reaction mixture was purified by PTLC eluting EtOAc/hexane (20:80). 
Colourless tar. 
Yield: 13.4 mg (40%). 
1H NMR (500 MHz, CDCl3): δ = 7.38–7.28 (m, 5H), 7.26–7.22 (m, 3H), 7.22–7.13 (m, 3H), 
7.05–6.96 (m, 4H), 3.93–3.87 (m, 1H), 2.52–2.38 (m, 2H), 2.30–2.21 (m, 1H), 2.06–1.96 (m, 
1H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 171.7, 138.0, 129.6 (2C), 129.3 (2C), 128.9 (2C), 128.8 (4C), 
127.9 (4C), 127.6 (2C), 126.3, 119.3, 48.7, 30.2, 15.3 ppm. 
IR (neat):  = 3061, 2918, 2359, 1666.5, 1491, 1279, 756.1, 700 cm–1. 






284 was prepared according to general procedure V using acrylamide 337 (11.9 mg, 0.05 
mmol, 1.00 equiv) and acetonitrile (100 L), in the presence of hexaphenylcarbo-
diphosphorane (2.70 mg, 5.00 mol, 10.0 mol%) as the catalyst, at 80 oC for 42 h.  The crude 





Yield: 19.5 mg (70%). 
1H NMR (500 MHz, CDCl3): δ = 7.73–7.09 (m, 10H), 2.86 (dqd, J = 9.4, 6.8, 4.8 Hz, 1H), 2.52–
2.39 (m, 2H), 2.17 (dddd, J = 13.7, 9.4, 6.7, 5.9 Hz, 1H), 1.70 (dddd, J = 13.5, 8.5, 7.0, 4.8 Hz, 
1H), 1.19 (d, J = 6.8 Hz, 3H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 166.1, 142.8 (2C), 142.4 (4C), 129.2 (2C), 123.8 (4C), 
118.4, 40.3, 27.6, 23.8, 22.7 ppm. 
IR (neat):  = 2918, 2849, 2361, 1668, 1491, 1346, 1250, 735, 700 cm–1. 






285 was prepared according to general procedure V using acrylamide 336 (29.9 mg, 0.10 
mmol, 1.00 equiv) and acetonitrile (200 L), in the presence of hexaphenylcarbo-
diphosphorane (2.70 mg, 5.00 mol, 5.00 mol%) as the catalyst, at 40 oC for 20 h.  The crude 
reaction mixture was purified by PTLC eluting EtOAc/hexane (20:80). 
Colourless solid. 
Yield: 30.2 mg (89%). 
1H NMR (500 MHz, CDCl3): δ = 7.49–7.28 (m, 8H), 7.26–7.17 (m, 3H), 7.17–7.08 (m, 4H), 
3.72–3.64 (m, 1H), 2.91–2.67 (m, 4H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 170.2, 142.3, 141.0 (2C), 130.0, 129.9 (4C), 128.6, 127.7 
(2C), 127.3 (4C), 126.4, 118.3 (2C), 39.7, 38.6, 29.7, 24.0 ppm. 
IR (neat):  = 2916, 2849, 2253, 1662, 1492, 1383, 700 cm–1. 






307 was prepared according to general procedure V using acrylamide 336 (29.9 mg, 0.10 
mmol, 1.00 equiv), n-butyronitrile (100 µL), in the presence of hexaphenylcarbodiphosphorane 
(2.70 mg, 5.00 mol, 5.00 mol%) and stirred at 40 oC for 16 h.  The crude reaction mixture 
was purified by PTLC eluting EtOAc/hexane (20:80).  
Colourless solid 




dr = 1:1.5 
1H NMR (500 MHz, CDCl3): δ = 7.53–7.22 (m, 10 H), 7.22–7.08 (m, 4H), 7.06–6.87 (br m, 1H), 
3.58–3.48 (m, 1H), 3.18–3.11 (m, 1H, minor), 2.96–2.89 (m, 1H), 2.83–2.78 (m, 1H, minor), 
2.78–2.71 (m, 1H),1.58–1.45 (m, 1H), 1.43–1.31 (m, 1H, minor), 1.08–1.00 (m, 3H) ppm.  
13C NMR (125 MHz, CDCl3): δ = 170.6, 170.3(minor), 142.5, 140.1, 139.2, 130.0, 128.8, 128.6, 
128.5, 128.1, 127.7, 127.6, 126.4, 121.0 (minor), 120.9, 44.2 (minor), 43.0, 39.5 (minor), 39.4, 
39.1 (minor), 38.2, 24.3, 23.9 (minor), 12.0, 11.5 (minor) ppm.   
IR (neat):  = 3705, 2980, 1381, 1055, 903, 725 cm–1.   






286 was prepared according to general procedure V using acrylamide 335 (23.7 mg, 0.10 
mmol, 1.00 equiv) and acetonitrile (200 L), in the presence of hexaphenylcarbo-
diphosphorane (2.70 mg, 5.00 mol, 5.00 mol%) as the catalyst, at 40 oC for 20 h.  The crude 
reaction mixture was purified by PTLC eluting EtOAc/hexane (20:80). 
Colourless oil. 
Yield: 18.1 mg (84%). 
1H NMR (500 MHz, CDCl3): δ = 7.40–7.36 (m, 2H), 7.34–7.29 (m, 3H), 3.63 (ddt, J = 9.3, 7.0, 
4.8 Hz, 1H), 3.00 (s, 3H), 2.96 (s, 3H), 2.95–2.69 (m, 4H) ppm. 
13C NMR (125 MHz, CDCl3): δ 170.0, 141.6, 128.9 (2C), 127.6, 127.1 (2C), 118.5, 37.7, 37.5, 
37.1, 35.5, 24.0 ppm. 
IR (neat):  = 2930, 2243, 1634, 1398, 1145, 761, 700 cm–1. 






288 was prepared according to general procedure V using acrylamide 341 (14.5 mg, 0.05 
mmol, 1.00 equiv) and acetonitrile (200 L), in the presence of hexaphenylcarbo-
diphosphorane (2.70 mg, 5.00 mol, 5.00 mol%) as the catalyst, at 80 oC for 39 h.  The crude 





Yield: 15.8 mg (96%). 
1H NMR (500 MHz, CDCl3): δ = 7.49–7.34 (m, 5H), 7.33 (dd, J = 1.9, 0.8 Hz, 1H), 6.31 (dd, J 
= 3.3, 1.9 Hz, 1H), 6.14 (dt, J = 3.3, 0.8 Hz, 1H) 3.77 (tt, J = 6.9, 6.1 Hz, 1H), 2.95–2.65 (m, 
4H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 169.9, 153.7, 142.3, 142.0, 130.1 (2C), 129.0 (2C), 128.6 
(2C), 126.4 (2C), 117.8, 110.4, 106.4, 37.6, 32.4, 21.7 ppm. 
IR (neat):  = 2916, 2849, 2247, 1667, 1593, 1491, 1377, 1290, 756, 702 cm–1. 






289 was prepared according to general procedure V using acrylamide 362 (23.7 mg, 0.10 
mmol, 1.00 equiv) and acetonitrile (200 L), in the presence of hexaphenylcarbo-
diphosphorane (2.70 mg, 5.00 mol, 5.00 mol%) as the catalyst, at 40 oC for 20 h.  The crude 
reaction mixture was purified by PTLC eluting EtOAc/hexane (20:80). 
Colourless solid. 
Yield: 48.5 mg (87%). 
1H NMR (500 MHz, CDCl3): δ = 7.56–7.50 (m, 1H), 7.39–7.35 (m, 5H), 7.34–7.29 (m, 4H), 
7.26–7.18 (m, 5H), 6.67 (s, 1H), 3.97–3.90 (m, 1H), 3.01 (dd, J = 55.7, 5.6Hz, 1H), 2.92 (ddd, 
J = 72.4, 21.7, 5.5 Hz, 1H), 2.86 (dd, J = 8.6, 5.5 Hz, 1H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 169.6, 156.5, 154.9, 129.7, 128.5, 126.3, 126.1, 124.3 (4C), 
122.9, 121.0 (4C), 120.3, 117.6, 111.3, 111.0, 110.6, 103.6, 37.4, 32.9, 21.4 ppm. 
IR (neat):  = 3061, 2916, 2849, 2247, 1663, 1491, 1273, 752 cm–1. 






287 was prepared according to general procedure V using acrylamide 342 (30.0 mg, 0.10 




diphosphorane (2.70 mg, 5.00 mol, 5.00 mol%) as the catalyst, at 40 oC for 15 h.  The crude 
reaction mixture was purified by PTLC eluting EtOAc/hexane (20:80). 
Pale yellow liquid. 
Yield: 29.0 mg (85%). 
1H NMR (500 MHz, CDCl3): δ = 8.58 (dd, J = 4.8, 1.6 Hz, 1H), 8.49 (d, J = 2.1 Hz, 1H), 7.61–
7.57 (m, 1H), 7.50–7.29 (m, 6H), 7.26–7.10 (m, 5H), 3.72 (pent, J = 6.6 Hz, 1H), 2.89 (dd, J = 
30.0, 7.0 Hz, 1H), 2.86 (dd, J = 29.4, 7.0 Hz, 1H), 2.77 (dd, J = 36.3, 6.6 Hz,1H), 2.74 (dd, J 
= 36.3, 6.6 Hz, 1H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 169.6, 149.2 (4C), 148.9 (4C), 142.1, 135.0 (2C), 130.2, 
129.1, 128.6, 126.3, 123.7 (2C), 117.7, 39.1, 36.2, 23.8 ppm. 
IR (neat):  = 3067, 2918, 2851, 1668, 1491, 1383, 704 cm–1. 






291 was prepared according to general procedure V using acrylamide 350 (15.9 mg, 0.05 
mmol, 1.00 equiv) and acetonitrile (100 L), in the presence of hexaphenylcarbo-
diphosphorane (2.70 mg, 5.00 mol, 10.0 mol%) as the catalyst, at 40 oC for 70 h.  The crude 
reaction mixture was purified by PTLC eluting EtOAc/hexane (20:80). 
Colourless solid. 
Yield: 16.1 mg (90%). 
1H NMR (500 MHz, CDCl3): δ = 7.47–7.30 (br m, 5H), 7.18–7.06 (br m, 7H), 7.02 (ap t, J = 8.6 
Hz, 2H), 3.66 (ap pent, J = 6.9 Hz, 1H), 2.80 (d, J = 22.5, 7.1 Hz, 1H), 2.77 (dd, J = 22.5, 7.1 
Hz, 1H), 2.70 (dd, J = 28.1, 6.0 Hz, 1H), 2.67 (dd, J = 27.3, 6.0 Hz, 1H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 170.0, 161.8 (d, J = 246.5 Hz), 142.2, 136.7, 130.1 (2C), 
129.1 (4C), 128.9 (d, J = 8.0 Hz, 2C), 128.5 (4C), 128.5 (2C), 118.1, 115.9 (d, J = 21.4 Hz, 
2C), 39.8, 37.9, 24.2 ppm. 
19F NMR (470 MHz, CDCl3): δ = -110.0 ppm. 
IR (neat):  = 3696, 2918, 1665, 1491, 1055, 1032, 1012, 702 cm–1. 















292 was prepared according to general procedure V using acrylamide 360 (16.7 mg, 0.05 
mmol, 1.00 equiv) and acetonitrile (100 L), in the presence of hexaphenylcarbo-
diphosphorane (2.70 mg, 5.00 mol, 10.0 mol%) as the catalyst, at 40 oC for 70 h.  The crude 
reaction mixture was purified by PTLC eluting EtOAc/hexane (20:80). 
Colourless solid. 
Yield: 17.0 mg (91%). 
1H NMR (500 MHz, CDCl3): δ = 7.44–7.34 (br m, 5H), 7.31 (d, J = 8.4 Hz, 2H), 7.23–7.06 (br 
m, 5H), 7.13 (d, J = 8.4 Hz, 2H), 3.68–3.61 (m, 1H), 2.80 (d, J = 26.2, 7.5 Hz, 1H), 2.77 (dd, J 
= 25.1, 1.7 Hz, 1H), 2.70 (dd, J = 30.3, 7.0 Hz, 1H), 2.67 (dd, J = 28.8, 6.9 Hz, 1H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 169.9, 142.2 (2C), 139.4 (2C), 133.6 (2C), 130.1, 129.1 
(4C), 128.7 (4C), 128.3, 126.2 (2C), 118.0, 39.6, 37.9, 24.0 ppm. 
IR (neat):  = 2916, 2848, 2247, 1667, 1491, 1379, 908, 702 cm–1. 






294 was prepared according to general procedure V using acrylamide 352 (23.7 mg, 0.10 
mmol, 1.00 equiv) and acetonitrile (200 L), in the presence of hexaphenylcarbo-
diphosphorane (2.70 mg, 5.00 mol, 5.00 mol%) as the catalyst, at 90 oC for 22 h.  The crude 
reaction mixture was purified by PTLC eluting EtOAc/hexane (20:80).  
Colourless solid. 
Yield: 31.5 mg (85%). 
1H NMR (500 MHz, CDCl3): δ = 7.51–7.28 (m, 5H), 7.24–7.04 (m, 7H), 6.89–6.83 (m, 2H), 
3.80 (s, 3H), 3.61 (pent, J = 7.3 Hz, 1H), 2.79 (dd, J = 22.2, 7.3 Hz, 1H), 2.73 (ddd, J = 34.2, 
22.2, 7.0 Hz, 2H), 2.66 (dd, J = 25.5, 6.4 Hz, 1H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 170.3, 159.0 (2C), 142.3 (2C), 133.0 (2C), 130.0, 129.0, 128.6 




IR (neat):  = 2916.4, 2849, 1667, 1514, 1250, 702 cm–1. 






293 was prepared according to general procedure V using acrylamide 351 (23.7 mg, 0.10 
mmol, 1.00 equiv) and acetontrile (200 L), in the presence of hexaphenylcarbo-
diphosphorane (2.70 mg, 5.00 mol, 5.00 mol%) as the catalyst, at 40 oC for 20 h.  The crude 
reaction mixture was purified by PTLC eluting EtOAc/hexane (20:80).  
Colourless solid. 
Yield: 32.8 mg (79%). 
1H NMR (500 MHz, CDCl3): δ = 7.46 (d, J = 8.4 Hz, 2H), 7.44–7.28 (br m, 5H), 7.22–7.09 (br 
m, 5H), 7.07 (d, J = 8.4 Hz, 2H), 3.63 (ap pent, J = 6.8 Hz, 1H), 2.83–2.63 (m, 4H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 169.8, 142.2, 140.0, 132.0 (2C), 130.1 (4C), 129.0 (2C), 128.5 
(4C), 126.3 (2C), 121.6 (2C), 117.9, 39.6, 38.0, 23.9 ppm. 
IR (neat):  = 2916, 2849, 2251, 1663, 1489, 1379, 907, 727 cm–1. 






311 was prepared according to general procedure V using acrylamide 344 (22.1 mg, 0.1 mmol, 
1.00 equiv), α-methylbenzylcyanide (100 µL) in the presence of 
hexaphenylcarbodiphosphorane (2.70 mg, 5.00 mol, 5.00 mol%) and stirred at 40 oC for 16 
h.  The crude reaction mixture was purified by PTLC eluting EtOAc/hexane (20:80).  
Tan solid 
Yield: 25.4 mg (44%). 




Major 1H NMR (500 MHz, CDCl3): δ  = 8.04–7.98 (m, 2H), 7.70 (ddd, J = 7.8, 3.9, 1.2 Hz, 2H), 
7.51–7.46 (m, 2H), 7.42–7.38 (m, 2H), 7.33–7.31 (m, 1H), 7.23–7.19 (m, 3H), 7.14–7.08 (m, 
2H), 7.02–6.82 (m, 3H), 6.80–6.56 (m, 3H), 6.37–6.28 (m, 2H), 5.07 (dt, J = 9.8, 1.4 Hz, 1H), 
2.73 (ddd, J = 15.6, 9.8, 4.4 Hz, 1H), 2.40 (t, J = 4.3 Hz, 1H), 2.37 (s, 3H), 1.60 (s, 3H) ppm. 
Minor 1H NMR (500 MHz, CDCl3): δ = 7.87 (dt, J = 8.4, 2.0 Hz, 2H), 7.50–7.32 (m, 4H), 7.25 
(dd, J = 8.6, 0.6 Hz, 3H), 7.19 (tt, J = 7.3, 1.2 Hz, 3H), 7.14–7.09 (m, 3H), 7.08–7.07 (m, 2H), 
7.05–7.01 (m, 2H), 6.08 (t, J = 3.4 Hz, 1H), 5.94–5.91 (m, 1H), 2.91 (dd, J = 16.4, 6.0 Hz, 1H), 
2.62 (dd, J = 16.4, 6.9 Hz, 1H), 1.83 (s, 3H), 1.56 (s, 3H) ppm. 
Major 13C NMR (125 MHz, CDCl3): δ = 169.6, 144.7, 142.2, 139.7, 136.3, 134.3 (2C), 129.8 
(4C), 129.2 (2C), 128.4 (2C), 128.1 (2C), 127.8 (2C), 126.2 (4C), 123.6 (2C), 121.5, 113.5 
(2C), 112.3 (2C), 50.8, 41.2, 37.9, 27.1, 21.7 ppm.   
Minor 13C NMR (125 MHz, CDCl3): δ = 170.1, 144.7, 138.1, 136.4, 133.7 (2C), 130.0, 129.8 
(4C), 128.7, 128.0 (2C), 127.7 (2C), 127.6 (2C), 126.5 (4C), 126.1, 123.1, 122.9, 114.1 (2C), 
111.4 (2C), 47.7, 41.4, 39.1, 29.7, 26.0, 21.7 ppm 
Major IR (neat):  = 3061, 1665, 1491, 1366, 1175, 910, 700, 673 cm–1.     
Major HRMS (EI): calculated for C35H31O3N3S+ = [M+]: m/z = 573.2080, found: m/z = 573.2057.   
Major HRMS (EI): calculated for C35H31O3N3S+ = [M+]: m/z = 573.2080, found: m/z = 573.2084.   
 
2‐(cyanomethyl)‐N,N‐diphenylcyclohexane‐1‐ carboxamide (313) 
 
 
313 was prepared according to general procedure V using acrylamide 369 (13.9 mg, 0.05 
mmol, 1.00 equiv), MeCN (100 µL), and CDP (10 mol%) and stirred at 40 oC for 16 h.  The 
crude reaction mixture was purified by PTLC eluting EtOAc/hexane (20:80).  
Colourless liquid 
Yield: 13.6 mg (86%). 
dr = 1:1 
1H NMR (500 MHz, CDCl3): δ = 7.53–7.35 (m, 4H), 7.34–7.14 (m, 6H), 4.22–4.18 (m, 1H), 
3.14 (dt, J = 8.4, 4.1 Hz, 1H), 2.26–2.17 (m, 1H), 2.14–2.05 (m, 1H), 1.89 (ddt, J = 13.3, 6.6, 
3.1 Hz, 1H) 1.83–1.74 (m, 1H), 1.68–1.60 (m, 1H), 1.59–1.51 (m, 2H), 1.44–1.36 (m, 1H), 
0.94–0.84 (m, 2H) ppm. 
13C NMR (125 MHz, CDCl3): δ = 172.3, 143.1 (2C), 129.5 (2C), 129.0 (4C), 127.2 (4C), 59.4, 
44.8, 33.5, 31.9, 24.6, 22.9, 21.7, 14.1 ppm.  
IR (neat):  = 2924, 2853, 2361, 1676, 1491, 1267, 702 cm–1.   
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